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ABSTRACT 
 
 
EXPLORING THE IMPACT OF THE E. COLI PROTEOSTASIS NETWORK  
ON THE FOLDING FATE OF PROTEINS WITH DIFFERENT INTRINSIC  
BIOPHYSICAL PROPERTIES  
FEBRUARY 2016 
KRISTINE FAYE R. POBRE 
B.S., UNIVERSITY OF THE PHILIPPINES DILIMAN 
PhD., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Lila M. Gierasch 
 
 The three-dimensional (3D) native structure of most proteins is crucial for 
their functions. Despite the complex cellular environment and the variety of 
challenges that proteins experience as they fold, proteins can still fold to their 
native states with high fidelity. The reason for this is the presence of the cellular 
proteostasis network (PN), consisting of molecular chaperones and degradation 
enzymes, that collaborates to maintain proteostasis, in which the necessary 
levels of functional proteins are optimized. Although extensive research has been 
carried out on the mechanisms of individual components of the proteostasis 
network, little is known about how these components contribute to the functioning 
of the network as a whole. A new protein can have three folding fates: natively 
folded, aggregated, or degraded. The fate is determined by both a proteinʼs 
	   x 
intrinsic biophysical properties and the cellular proteostasis network through 
kinetic partitioning. To understand the interplay between a proteinʼs intrinsic 
biophysical properties and the cellular proteostasis network, an integrated 
computational and experimental approach was used. The folding fates of model 
proteins with different intrinsic biophysical properties under varying conditions of 
the proteostasis network were determined. Using FoldEco, the effects of the 
kinetic and thermodynamic properties of proteins on their folding fates were 
investigated systematically, and predictions were consistent with wet lab 
experiments. The folding fate of a protein is under a thermo-kinetic limitation, 
which indicates that the fate depends on either the kinetics or thermodynamics, 
but (for the most part) not on both at the same time. Different proteins behave 
according to the values of their limiting properties. Furthermore, up-regulation of 
the entire proteostasis network through the σ32 transcription factor has beneficial 
effects on model proteins with low stabilities and high aggregation propensities. 
However, the effects of up-regulation of individual chaperones or the major 
degradation enzyme, Lon are substrate-dependent and are related to their 
biophysical properties. Furthermore, KJE, GroELS, and Lon form an efficacious 
triad for maintaining proteostasis, and their contributions depend on the 
biophysical properties of their substrates, and on the concentrations of these PN 
components and substrates at any given time.  
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 1 
CHAPTER 1 	  
INTRODUCTION  
 
 Proteins have key roles in almost all biological processes. The three-
dimensional (3D) native structure of most proteins is crucial for their functions. 
How a protein folds inside the cell, and how the cellular environment maintains 
levels of functional proteins are important problems in biology, and my thesis 
research has been directed towards answering these questions. This chapter 
covers the following background topics to my thesis work: 1) challenges that 
proteins encounter as they fold inside the cell, 2) protein folding fates determined 
by both the intrinsic biophysical properties of proteins and the cellular 
proteostasis network (PN) through kinetic partitioning, and 3) the use of FoldEco 
model of proteostasis in understanding the mechanisms of folding in the cell. 
 
1.1 Protein folding in the cell 
 Our knowledge of protein folding is mostly based on in vitro experiments 
where proteins are denatured and are being refolded under optimized conditions 
and high dilution in order to prevent aggregation, as aggregation is concentration-
dependent. With these conditions, some proteins can refold efficiently. Their 
native structure is dependent on their amino acid sequence, which encodes the 
information about their fold (Anfinsen, 1973). However, other proteins (usually 
large, multidomain) cannot refold after being denatured in vitro (Fersht, 1999). 
 2 
Thus, protein folding models have been based only on “well-behaved” proteins 
that can be denatured and refolded in vitro (Clark, 2004). These in vitro models 
provide a picture of individual proteins that fold in isolation, which is different from 
the actual folding of proteins inside the cell where proteins fold in the presence of 
a variety of macromolecules (Vendruscolo, 2012).  
 There are many differences between folding in vitro and in vivo (Hingorani 
and Gierasch, 2014). First, in vitro, the solutions and buffers are highly dilute, 
while in vivo, the cellular environment is concentrated and crowded (20-30% of 
cell volume or ~300-400 mg/mL is occupied by macromolecules) (Zimmerman 
and Trach, 1991), which makes the unfolded polypeptide prone to interact with 
macromolecules (Zhou et al., 2008). Macromolecular crowding drives the 
compaction of folding intermediates or partially folded states, which means that it 
can enhance the formation of native states, oligomeric structures and aggregates 
(Cheung et al., 2005; Ellis, 2001a, b; McGuffee and Elcock, 2010; Minton, 2000; 
Minton and Wilf, 1981; Zhou et al., 2008). Second, in vitro, a full length chain of 
unfolded polypeptide is allowed to fold, while in vivo, folding can start while the 
polypeptide is still being made (co-translational folding), and the polypeptide can 
also bind to ribosome-associated chaperones (Gershenson and Gierasch, 2011). 
Third, in vitro, folding reactions happen in a homogeneous milieu, while in vivo, 
folding reactions take place in inhomogeneous environment that are 
compartmentalized and spatially organized (Gershenson and Gierasch, 2011). 
Fourth, in vitro, a protein can fold on its own, while in vivo, some proteins fold 
 3 
with the help of chaperones (Kim et al., 2013). Despite this complex cellular 
environment (Fig. 1.1) and the variety of challenges that proteins experience as 
they fold, proteins can still fold to their native states with high fidelity even in 
concentrations higher than the threshold for aggregation in vitro refolding 
experiments. The reason for this is the presence of the cellular protein 
homeostasis (“proteostasis”) network (PN), consisting of different processes 
(biogenesis, conformational maintenance, and protein clearance) as well as 
various players (molecular chaperones and degradation enzymes), that works 
together to maintain levels of functional proteins inside the cell. Our goal is to 
understand how a protein folds in the context of the cellular environment because 
this is where folding actually occurs (Gershenson and Gierasch, 2011; Hartl et al., 
2011; Vendruscolo, 2012).  
 
1.2 Proteostasis 
 A newly synthesized polypeptide (unfolded, U) can have three folding 
fates. First, it can fold to its native state (N) and become functional. Second, it 
can misfold (M) and when these misfolded states self-associate they can form 
aggregates (A). Third, it can be degraded (Cho et al., 2015) (Fig. 1.2). 
Aggregated and degraded proteins are not functional. Proteostasis is achieved 
when levels of proteins are sufficient to perform their functions, and levels of 
misfolded and aggregated proteins are minimized to avoid toxicity (Balch et al., 
2008; Powers et al., 2009).  
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 Aggregates can be amorphous, oligomers rich in β-sheets, or amyloid 
fibrils (Jahn and Radford, 2005; Mitraki and King, 1989; Wetzel, 1996). Amyloid 
fibrils are characterized by cross β-structure, in which β-strands run 
perpendicular to the long axis of the fibril (Tycko, 2004). Aggregation is 
concentration-dependent (Harper and Lansbury, 1997). Aggregates can be 
formed via nucleation-dependent polymerization, in which monomers form an 
aggregation nucleus that grows rapidly to form aggregates. When the monomer 
concentration of partially folded or misfolded states exceeds a certain level 
known as the critical concentration, polymerization starts. As protein 
concentration increases, polymer concentration also increases but the monomer 
concentration remains constant (Harper and Lansbury, 1997).  
 Degradation is the elimination of abnormal proteins or those that are not 
needed anymore. “Abnormal” proteins are those that are incomplete, misfolded, 
or damaged by the environment (postsynthetic denaturation or chemical damage) 
(Goldberg, 1972, 2003).  
 
1.2.1 Importance of proteostasis 
 Failure of proteostasis can cause disease. For example, in humans, 
conformational diseases arise if proteostasis is not maintained. Loss-of-function 
diseases such as cystic fibrosis (Riordan, 1999) and phenylketonuria (Waters et 
al., 2000) are due to insufficient amounts of functional proteins caused by 
variants that inefficiently fold and are rapidly degraded. Gain-of-toxicity diseases 
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such as Alzheimerʼs disease (AD), Parkinsonʼs disease (PD), Huntingtonʼs 
disease (HD), and amyotrophic lateral sclerosis (ALS) are associated with the 
formation of intracellular aggregates with amyloid-like properties as well as 
extracellular amyloid fibrils (usually toxic to the cells) (Brehme et al., 2014; Chiti 
and Dobson, 2006; Gregersen et al., 2005; Gregersen et al., 2000; Hipp et al., 
2014; Labbadia and Morimoto, 2015; Ross and Poirier, 2004; Serpell and Smith, 
2000). Understanding how proteostasis is maintained in the cell helps us design 
ways to ameliorate and/or prevent such diseases (Balch et al., 2008; Hopkins, 
2008; Powers et al., 2009).  
 
1.3 Intrinsic and extrinsic factors determine protein folding fate 
 An overarching question is, “What determines the folding fate of a 
protein?”. As mentioned earlier, an unfolded polypeptide can be folded, 
aggregated, or degraded. The folding fate of a protein is determined by both 
intrinsic and extrinsic factors, which are the proteinʼs intrinsic biophysical 
properties (Powers et al., 2012) and the cellular proteostasis network (PN), 
respectively (Cho et al., 2015).  
 
1.4 Biophysical properties of proteins 
 Each protein has its own intrinsic biophysical (e.g. kinetic and 
thermodynamic) properties dictated by its amino acid sequence. These include 
the folding rate constant (kf) and folding equilibrium constant (Kf), misfolding rate 
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constant (km) and misfolding equilibrium constant (Km), aggregation rate constant 
(ka), aggregation equilibrium constant (Ka) or the inverse of the critical 
concentration for aggregation (ccrit) and many others (Powers et al., 2009; 
Powers et al., 2012). The rate constant is a kinetic property that determines the 
rate of folding, misfolding, or aggregation. The equilibrium constant is a 
thermodynamic property, which is the ratio of forward and reverse rate constants 
at equilibrium. These values are measured in vitro or can be estimated using in 
silico techniques that are also based on in vitro data.  
 An unfolded polypeptide explores a funnel-shaped energy landscape as it 
folds towards its native state (Hartl and Hayer-Hartl, 2009; Jahn and Radford, 
2005) (Fig. 1.3). The native state, formed via intramolecular contacts, is the 
conformation that is usually the most thermodynamically stable (lowest energy). 
Partially folded or misfolded states can be kinetically trapped due to high free-
energy barriers that they need to cross in order to reach a favorable downhill path. 
When these partially folded or misfolded states form intermolecular interactions, 
aggregates (amorphous, oligomers, or amyloids) are formed (Jahn and Radford, 
2005). 
 
1.5 The Proteostasis network (PN) 
 The cellular proteostasis network (PN), consisting of different processes 
(biogenesis, conformational maintenance, and protein clearance) as well as 
various players (molecular chaperones and degradation enzymes), modulates a 
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proteinʼs folding fate. During its lifetime, a protein interacts with chaperones 
and/or degradation enzymes for help in its folding or degradation to minimize 
aggregation. Chaperones and degradation enzymes minimize aggregation by 
interacting with partially folded or misfolded states and then can perform the 
following: 1) help them fold to native, 2) hold them to prevent intermolecular 
interactions, or 3) degrade them, thereby lowering their concentrations.   
 
1.6 Processes of the proteostasis network (PN) 
 There are three main processes of the PN: 1) biogenesis, 2) 
conformational maintenance, and 3) clearance (Hipp et al., 2014). 
 
1.6.1 Biogenesis 
 Biogenesis consists of protein synthesis and folding. The synthesis 
(translation) of new proteins is a complicated process. Aside from the critical 
steps a ribosome performs in order to synthesize a new polypeptide chain, this 
new chain has to be folded, processed, or targeted to its proper location (Kramer 
et al., 2009). Translation is carefully managed inside the cell. The production of 
new proteins is time-dependent in terms of the levels of proteins produced at a 
time and how the different domains of a particular protein fold. Translation rates 
affect folding (Komar et al., 1999; Meriin et al., 2012; Tsai et al., 2008). Variations 
in rates can be due to local mRNA stability and codon sequence (Tsai et al., 
2008; Yu et al., 2015). In E. coli, for example, when the 16 consecutive rare 
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codons in chloramphenicol acetyltransferase (CAT) gene are replaced by 
frequent codons, the translation rate of CAT protein is increased; however, the 
specific activity of the protein is reduced (Komar et al., 1999). If the rate was too 
fast, it can cause an accumulation of misfolded states. By contrast, if the rate 
was too slow, it can cause the production of lower amounts of proteins that are 
insufficient to carry out their functions. Mild inhibition of synthesis or moderately 
slowing down the rate, though, improves the folding of nascent chains and 
recovers the function of a mutant protein (Meriin et al., 2012). In eukaryotes, 
synthesis rate is slower (~4 amino acids per second) compared to that in 
prokaryotes (~20 amino acids per second) (Hartl and Hayer-Hartl, 2009). The 
slower rate in eukaryotes may be due to bigger proteins (multi-domains) that are 
~52 kDa (in bacteria, only ~35 kdA). These domains may fold co-translationally 
because of their slow folding kinetics (Netzer and Hartl, 1998). In E. coli, in vivo 
translation kinetics (and not thermodynamics) of the ribosome nascent chain 
(RNC) influences co-translational folding. Faster rates delay co-translational 
folding causing longer nascent chains (Ciryam et al., 2013a).  
 
1.6.2 Conformational maintenance 
    Inside the cell, a proteinʼs conformation (either folded or unfolded, as long 
as it does not self-associate and aggregate) is maintained throughout its lifetime. 
This crucial task is performed by different groups of molecular chaperones and/or 
degradation enzymes by helping the proteins fold, refold, and solubilize 
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aggregated proteins. As mentioned earlier, the consequence of self-association 
of partially folded or misfolded states is aggregation. A fundamental feature of 
folding in the cell is the competition of folding and aggregation (Clark, 2004; Niwa 
et al., 2009; Pechmann et al., 2009; Tartaglia and Vendruscolo, 2010). Studies 
have shown how aggregation may happen in the cell and how it is prevented. 
Aggregation is a widespread phenomenon in the cell (David et al., 2010; 
Narayanaswamy et al., 2009; Tartaglia et al., 2007). Proteins are at high risk of 
aggregation either in normal or stressed conditions. Aggregation is a serious 
problem in the cell because it can cause gain-of-toxicity, or it may be a last-line of 
defense to cells under stress (Miller et al., 2015). In humans, expression levels of 
proteins in vivo are anti-correlated with their aggregation rates in vitro (Tartaglia 
et al., 2007). Widespread aggregation in neurodegenerative diseases and aging 
is also linked with supersaturation (Ciryam et al., 2013b). In yeast and mammals, 
misfolded proteins are sequestered in subcellular deposition sites such as the 
insoluble protein deposit (IPOD), intranuclear quality control compartment (INQ), 
and cytoplasm quality control compartment (CytoQ) (Kaganovich et al., 2008; 
Miller et al., 2015), while in E. coli, aggregates are typically localized to the cell 
poles (Rokney et al., 2009; Winkler et al., 2010). These deposits are being 
repaired by disaggregation chaperones and/or degraded by degradation 
enzymes, and also allows asymmetric distribution of aggregates during cell 
division (Miller et al., 2015). Some proteins can also co-aggregate with aberrant 
polypeptides such as amyloid-forming polypeptides (Gidalevitz et al., 2006) or 
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polyglutamine expansions (Olzscha et al., 2011). Such damaged proteins 
deregulate the proteostasis network by competing for the need for chaperones 
and degradation enzymes. In order to minimize aggregation, chaperones and 
degradation enzymes interact with partially folded or misfolded states, protecting 
the proteins from intermolecular interactions. Up-regulation of chaperones 
through heat shock or oxidative stress increases the capacity of the cell to 
prevent aggregation (Guisbert et al., 2008; Lindquist, 1986; Zhang et al., 2014).  
 
1.6.3 Protein clearance 
 Protein clearance, either by degradation or autophagy, has a critical role in 
proteostasis. In eukaryotes, the ubiquitin-proteasome system (UPS) is mainly 
responsible for the clearance of proteins (Hershko and Ciechanover, 1998; 
Varshavsky, 2012). Ubiquitin, a small protein with 76 residues, is enzymatically 
conjugated to proteins that have degrons (or tags for degradation). Then, this 
ubiquitin-protein complex is recognized and degraded by the 26S proteasome, a 
processive ATP-dependent protease. Since the proteasome complexes are 
located in the nucleus and cytosol, proteins in the endoplasmic reticulum (ER) 
that are targeted for degradation need to be retrotranslocated to the cytosol first 
before they are recognized by the UPS (Smith et al., 2011). About ~1% of the 
ribosome-bound nascent chains and ~0.5% of newly synthesized polypeptides 
are ubiquitinated, and then are degraded by the proteasome in vivo (Duttler et al., 
2013). In autophagy, large aggregates or insoluble deposits are engulfed by 
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double-membrane vesicles (autophagasomes) and degraded by lysosomal 
components (Kundu and Thompson, 2008).  
 In prokaryotes, degradation is mediated by different proteases such as 
Lon, ClpXP/ClpAP, HslUV, and FtsH, which belong to AAA+ family of proteins 
(ATPases associated with diverse cellular activities) (Gottesman, 2003; Gur et al., 
2011). Generally, they consist of AAA+ ring and an interior chamber with 
proteolytic active sites (Gur et al., 2011; Sauer and Baker, 2011). First, the 
substrate binds to the ATPase domain, and then cycles of ATP 
binding/hydrolysis cause conformational change to unfold the substrate and 
degrade it through the proteolytic chamber (Gottesman, 2003).   
 
1.6.4 Interplay among synthesis, folding, chaperoning and degradation 
 Is there interplay among synthesis and folding, chaperoning, and 
degradation? A balance among these processes is important for the efficiency of 
the PN. Chaperones and degradation enzymes work together (Sakr et al., 2010; 
Tomoyasu et al., 2001). The functional and physical features of chaperones and 
degradation enzymes overlap (Wickner et al., 1999). Some chaperones facilitate 
degradation (Arndt et al., 2007; Jubete et al., 1996; Kandror et al., 1999; Kettern 
et al., 2010; Rottgers et al., 2002; Sakr et al., 2010; Savel'ev et al., 1998; Wagner 
et al., 1994). An example is CHIP, a cochaperone and ubiquitin ligase, binds to 
Hsp70 and Hsp90 to initiate the destruction of abnormal proteins (Arndt et al., 
2007). Likewise, some degradation enzymes have chaperone activities 
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(Gottesman et al., 1997; Sauer and Baker, 2011; Suzuki et al., 1997). While 
these studies suggest that molecular chaperones and degradation enzymes work 
synergistically, they do not include the mechanisms by which they do it. 
 
1.7 Molecular chaperones of the proteostasis network (PN) 
 Chaperones have diverse roles in maintaining proteostasis, including de 
novo folding and refolding of proteins, disaggregation, and degradation (Hartl et 
al., 2011; Saibil, 2013). Some chaperones are present in high levels in the cell; 
others are in low amounts (Finka and Goloubinoff, 2013; Powers et al., 2009; 
Powers et al., 2012), depending on cell types. When the cell is stressed, their 
levels increase to different extents. The first chaperones that were identified were 
named “heat shock proteins” (Hsp) because they were induced by heat (Tissieres 
et al., 1974). Chaperones are grouped depending on their sequence homology, 
and are named according to their molecular weight. The four major groups are: 
Hsp60s, Hsp70s, Hsp90s, and Hsp100s. In the cytosol, the general pathway for 
folding is conserved among bacteria, archaea, and eukarya (Fig. 1.4) (Kim et al., 
2013). 
 
1.7.1 Ribosome-associated Chaperones 
 The ribosome-associated chaperones, including trigger factor (TF) in 
bacteria, and specialized Hsp70s such as ribosome-associated complex (RAC, in 
Saccharomyces cerevisiae, MP11 and HSP70L1 in mammals, and nascent 
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chain-associated complex (NAC) in archaea and eukarya are the first to interact 
with newly synthesized polypeptides. About ~70% of nascent chains interact with 
TF in E. coli  (Fig. 1.4) (Kim et al., 2013). A nascent polypeptide is restricted from 
folding until a complete protein domain or segments (~50-300 amino acid 
residues) is synthesized and emerges from the ribosome (Elcock, 2006; Kaiser et 
al., 2011). As the nascent chain is emerging, ribosome-associated chaperones 
bind to its hydrophobic sequences to prevent intramolecular or intermolecular 
interactions. In fungi, the ribosome-associated complex (RAC), which consists of 
Ssz1 (a specialized Hsp70) and zuotin (Hsp40), together with the Hsp70 isoform, 
Ssb, assist nascent chain folding (Kim et al., 2013).  
 
1.7.2 Chaperones acting downstream of the ribosome 
 Members of the Hsp70 family (DnaK/DnaJ/GrpE in bacteria, 
Hsp70/Hsp40/Nucleotide exchange factors in eukaryotes), mediate co- and post-
translational folding (Frydman, 2001; Hartl et al., 2011) by interacting with 
nascent and newly synthesized polypeptides (Calloni et al., 2012; Niwa et al., 
2012) (Fig. 1.4). ATP-regulated cycles modulate the binding and release of 
substrates (by kinetic partitioning). In most species of archaea, instead of Hsp70, 
prefoldin (also known as the Gim complex, GimC) binds to certain nascent chains 
in an ATP-independent manner (Hartl and Hayer-Hartl, 2002). These substrates 
are then transferred to downstream chaperones. 
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 The downstream chaperones include the chaperonins (Hsp60s): 
GroEL/GroES in bacteria, thermosome in archaea, and tailless complex 
polypeptide-1 (TCP-1) ring complex (TriC)/chaperonin-containing TCP-1 (CCT) in 
eukaryotes. Chaperonins promote folding by encapsulating proteins inside a 
large double-ring complex (7-9 rings, ~60 kDa subunits per ring) in a central 
cavity (Hartl, 1996), providing the protein an environment that is less crowded 
than the cell and avoids aggregation. About 10-15% newly synthesized proteins 
interact with chaperonins in bacteria and archaea (Kerner et al., 2005) while 5-
10% in eukarya (Yam et al., 2008). In eukaryotes, the Hsp90 system mediates 
folding of substrates from the heat shock cognate 70 (Hsc70) (Taipale et al., 
2010). In yeast and other fungi, Hsp70 cooperates with AAA+ chaperone Hsp104 
in untangling and resolubilizing aggregated proteins. In bacteria, ClpB 
(homologous to Hsp104) works with DnaK in protein disaggregation (Haslberger 
et al., 2010).  
 Small heat shock proteins (sHsp) are ubiquitous chaperones that can 
prevent irreversible aggregation. These chaperones form a complex with non-
native proteins in an ATP-independent manner (Haslbeck and Vierling, 2015). 
Their sizes range from 12 to 42 kDa, and they form large oligomeric ensembles. 
Their functions rely on the changes in the distribution in tertiary or quarternary 
structures of the ensembles (Haslbeck and Vierling, 2015).  
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1.8 E. coli as a model organism 
 E. coli is used as a simple model organism to study proteostasis in the cell. 
It only has ~4000 genes, and only about 1 femtoliter volume. It has two primary 
chaperone systems, DnaK (Hsp70) and its co-chaperones DnaJ (Hsp40) and 
GrpE (nucleotide exchange factor), and GroEL (Hsp60) and its co-chaperone 
GroES. It also has a ribosome-associated chaperone (trigger factor), a protein 
disaggregation chaperone system (ClpB/DnaK/DnaJ/GrpE), and degradation 
machinery (Lon, ClpXP, ClpAP, HslUV, FtsH). A wealth of biochemical and 
genetic data is also available for these chaperones and degradation enzymes 
(Powers et al., 2012).  
 
1.9 Proteostasis network in E. coli 
1.9.1 Trigger factor (TF) 
 The role of TF in protein folding in vivo was first found out by genetic 
studies in which Δtig mutants (lacking TF) were viable and had no major defects 
on the folding of newly synthesized polypeptides. However, when the E. coli 
Hsp70 chaperone (DnaK) was deleted, (ΔdnaK), at temperatures above 30 °C, 
the cells (with combined Δtig and ΔdnaK mutations) were not viable (synthetic 
lethality) (Deuerling et al., 1999). Deuerling and colleagues investigated the 
cause of synthetic lethality by depletion of DnaK and DnaJ in cells with trigger 
factor (tig+) and without (Δtig). The tig+ cells grew at 30 and 37 °C but not at 15 
and 42 °C (similar results for the cold-sensitive and heat-sensitive ΔdnaK 
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mutants) while Δtig cells did not grow at all the temperatures tested (15, 30, 37 
and 42 °C). In addition, when DnaK and DnaJ were depleted, aggregated newly 
synthesized proteins increased (~40 proteins) in Δtig cells compared to tig+ cells. 
These results show that TF is associated with the folding of newly synthesized 
proteins in cooperation with DnaK (Deuerling et al., 1999; Teter et al., 1999). 
Cells can tolerate individual deletions of TF or DnaK, suggesting that the two are 
functionally redundant (Bukau et al., 2000; Calloni et al., 2012; Genevaux et al., 
2004). TF serves like a cradle for folding space for most nascent chains to 
prevent them from being degraded or aggregated (Ferbitz et al., 2004; Hartl and 
Hayer-Hartl, 2002). 
 TF is a ~50 kDa protein that has an elongated structure with three 
domains: an N-terminal ribosome-binding domain (contains the ribosome-binding 
loop, Phe-Arg-Lys), a peptidyl-prolyl cis/trans isomerase (PPIase) domain, and a 
C-terminal domain (Fig. 1.5) (Ferbitz et al., 2004). The binding of monomeric TF 
to the ribosome (at subunit L23 and L29) is important for interaction with the 
nascent chain (Baram et al., 2005; Kramer et al., 2002; Schlunzen et al., 2005). 
TF binds to hydrophobic segments on nascent chains, and helps folding through 
ATP-independent cycles of binding and release from both ribosome and nascent 
chain. TF is released from the chain when the bound peptide starts to bury its 
hydrophobic sequences. Sometimes, TF may remain bound to the polypeptides 
even after their release from the ribosome, functioning as a holdase (binds to 
substrates and hold them, preventing them from aggregating) (Martinez-Hackert 
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and Hendrickson, 2009). Furthermore, hydrophobic chain collapse is slowed 
down and co-translational folding is delayed by TF (Agashe et al., 2004; Gupta et 
al., 2010; Hoffmann et al., 2012). TF can also adapt to and help different kinds of 
nascent polypeptides (Merz et al., 2008). TF also interacts with small basic 
proteins such as ribosomal proteins (Calloni et al., 2012; Lakshmipathy et al., 
2010; Martinez-Hackert and Hendrickson, 2009).  
 
1.9.2 DnaK/DnaJ/GrpE (KJE) family 
 DnaK is the major Hsp70 chaperone in bacteria. It is constitutively 
expressed and also induced during stress. It is not essential for viability under 
nonstress conditions at intermediate temperatures (at 30 °C), but it is absolutely 
necessary at high temperatures (42 °C) (Bukau and Walker, 1989). It is a ~70 
kDa protein that consists of N-terminal nucleotide-binding domain (NBD) and a 
C-terminal substrate-binding domain (SBD) connected by a highly conserved 
interdomain linker (Fig.1.6) (Bertelsen et al., 2009). ATP-binding to the NBD 
allosterically controls substrate affinity to the SBD. Higher affinity for substrate 
when ADP is bound (ADP-substrate-bound state) compared to when ATP is 
bound (ATP-bound state). In the ADP-bound state, NBD and SBD are 
independent of each other and they retain the structures that they adopt as 
separated domains joined by a flexible linker (Bertelsen et al., 2009). When ATP 
is bound (ATP-bound state), the two domains are docked; the hydrophobic linker 
and the α-helical lid of the SBD are attached to the NBD (Kityk et al., 2012; Qi et 
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al., 2013; Swain et al., 2007). The DnaJ (co-chaperone of DnaK) and GrpE 
(nucledotide exchange factor in E. coli) regulate the DnaK system. DnaJ delivers 
substrates to DnaK and activates ATPase activity on DnaK (Laufen et al., 1999) 
while GrpE catalyzes exchange of ADP for ATP (Packschies et al., 1997). 
 What is the basis of substrate recognition? For many years, peptide 
models have been used to determine how Hsps (in general) recognize their 
substrates (Clerico et al., 2015). Peptide studies on DnaK allow us to determine 
some preferences of DnaK, but the binding motifs are not very clear. However, 
based on these studies, predictive algorithms have been developed to identify 
potential DnaK binding sites (Rudiger et al., 1997; Van Durme et al., 2009). DnaK 
recognizes short polypeptides, which consists of a hydrophobic core of four to 
five residues that are enriched in Leu, Ile, Val, Phe, and Tyr and the two flanking 
regions are mostly basic residues (Rudiger et al., 1997). Does the mode of 
binding to peptides similar to that of the full-length substrates? One particular 
study shows that the preferred binding sequence of DnaK within the E. coli σ32 
transcription factor when peptide (by peptide scanning) is used is the same 
sequence as when full-length protein (by proteolysis footprinting) is analyzed 
(Clerico et al., 2015; Rodriguez et al., 2008). Recently, the interaction of DnaK 
with full-length proteins has been explored. Lee and colleagues showed that 
when the full-length SRC homology 3 domain (SH3) was bound to DnaK, it had 
multiple, slowly interconverting disordered conformations on different sequences 
that were distinct from the unfolded state without DnaK. The bound client has 
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structural and dynamical heterogeneity revealing that proteins may undergo 
conformational sampling when bound to DnaK (Lee et al., 2015). On the other 
hand, Sekhar and colleagues found that the conformation of human telomere 
repeat binding factor 1 (hTRF1) did not change when it was bound to ATP-, ADP- 
and nucleotide-free DnaK. They also showed that the bound hTRF1 retained its 
intrinsic structural propensities; when bound to DnaK, it acquired secondary 
structures determined by the intrinsic properties of the substrate. The nucleotide 
state of DnaK does not affect the overall conformation of the bound client 
(Sekhar et al., 2015). Using rhodanese as a model protein, Kellner and 
colleagues showed that the substrate expanded ~30 fold when bound to DnaK. 
This may prevent unwanted interactions within or between substrates (Kellner et 
al., 2014). How does DnaJ transfer substrates to DnaK? Do DnaJ and DnaK bind 
to the same site on their substrate? With the σ32 transcription factor as the 
substrate, researchers have found that DnaK and DnaJ bind to different sites on 
σ32. Their binding causes conformational changes that destabilize the protein and 
prepare it for degradation (Rodriguez et al., 2008).  
 Using quantitative proteomics, it is found that DnaK interacts with  ~700 
proteins of E. coli, mostly are cytosolic (Calloni et al., 2012). In addition, ~180 are 
aggregation-prone that use DnaK in their folding. Furthermore, DnaK interacts 
with newly synthesized and pre-existent proteins. The deletion of TF or GroEL 
changes the DnaK interactome. The deletion of TF causes more proteins to bind 
to DnaK, suggesting a functional redundancy of TF and DnaK (Calloni et al., 
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2012; Deuerling et al., 1999). The depletion of GroEL causes an accumulation of 
GroEL substrates, and DnaK and GroEL have ~119 overlapping substrates. Thus, 
DnaK cooperates with the upstream TF and downstream GroEL (Calloni et al., 
2012).  
 What kinds of substrates do DnaK/DnaJ/GrpE help? What are their 
properties? DnaK is both a holdase and an unfoldase (unfolds substrates). It is a 
holdase when it binds to newly synthesized proteins, protecting them from 
intramolecular and intermolecular interactions, and hands it off to downstream 
chaperones that help the proteins fold. It is also an unfoldase since it binds 
misfolded proteins and unfolds them. These proteins can then refold, or again 
misfolds and rebinds to the chaperone. For example, in vitro, DnaK binds to 
misfolded luciferase species, and releases them as unfolded proteins, which can 
refold to its native state (Sharma et al., 2010). Misfolding-prone proteins benefit 
the most from the KJE system as shown by a simulation with FoldEco (Powers et 
al., 2012). 
 
1.9.3 GroEL/GroES (GroELS) family 
 GroEL is a 15-nm long cylindrical structure with two large rings (7-9 
subunits, ~60 kDa each) (Braig et al., 1994). Each subunit contains an equatorial 
ATPase domain, intermediate hinge domain, and apical domain (Mayer, 2010). 
The apical domain provides the entrance to the cavity, and is covered with 
hydrophobic residues. GroES is a ring (7 units, ~10 kDa each) that binds the 
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GroEL apical domains (Fig. 1.7). A substrate or folding intermediate binds to the 
apical domain, which causes 1 ATP to bind to each subunit. This causes a 
conformational change in the apical domains that expose GroES binding sites. 
The substrate is then encapsulated with the GroES cap in the cis complex. Upon 
ATP hydrolysis and GroES dissociation, the substrate leaves the chamber in the 
trans ring. Substrates that are still misfolded can rebind and refold again in 
GroEL even without GroES (Horwich et al., 2007).  
 The GroEL/ES is the only E. coli chaperone that is essential for viability 
(Fayet et al., 1989; Horwich et al., 1993). It is shown to act downstream of TF 
and DnaK (Ewalt et al., 1997; Houry et al., 1999). Using proteome-wide analysis 
of GroEL/ES-dependent folding in E. coli, ~250 proteins interact with GroEL. 
Some of these proteins also interact with TF and DnaK (Kerner et al., 2005). 
GroEL substrates are categorized to classes based on their dependency to 
GroEL: I) proteins that fold with GroEL/ES-independent pathway, II) proteins that 
fold with a partial help from GroEL/ES, and III) proteins that are obligate 
substrates and highly-dependent on GroEL/ES (Ewalt et al., 1997). 
Approximately 85 proteins are in class III and this contributes to 75-80% of the 
total mass of GroEL (Kerner et al., 2005). Which particular protein fold does 
GroEL help for folding? Using a homology-based fold assignment and using 
SCOP database of structural domains, the GroEL interactors are found to be 
TIM-barrel fold (enriched in (βα)8). A more extensive search for a more detailed 
structural feature of class III substrates has been done; however, it is 
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unproductive. Researchers speculate that the final structure is not the main 
determinant for GroEL interaction; instead, it could be the folding intermediates 
(Kerner et al., 2005). Global aggregation of newly synthesized proteins has been 
observed when GroEL is deficient, suggesting that GroEL helps a majority of 
newly systhesized proteins. Here, Chapman and others used a temperature-
sensitive lethal E. coli mutant of GroEL and found that most newly made proteins 
aggregate (Chapman et al., 2006). GroEL/ES dependency is also correlated with 
aggregation propensity (Ishimoto et al., 2014). In silico, GroEL/ES is predicted to 
help slow-folding proteins (Powers et al., 2012). Another in silico work describes 
that the physicochemical properties of proteins determine their chaperone 
requirements (Tartaglia et al., 2010). Here, class III obligate substrates of GroEL 
are aggregation-prone, have poor solubility, and have low levels of both mRNA 
and protein expression.  
 
1.9.4 Disaggregation family, ClpB/DnaK/DnaJ/GrpE 
 Disaggregation is crucial in reversing protein aggregation by untangling 
and re-solubilizing aggregates (Mogk et al., 2003). For smaller aggregates, KJE 
can perform this function (Diamant et al., 2000), but for larger aggregates, ClpB 
is necessary (Mogk et al., 2003; Weibezahn et al., 2004). ClpB is a hexameric 
AAA+ protein. It consists of ATP domain with characteristic walker motifs (Walker 
A and Walker B) as well as sensor 1 and sensor 2 and Arg finger motifs (Doyle et 
al., 2013). The crystal structure from Thermus thermophilus shows that ClpB has 
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N-domain, nucleotide-binding domain 1 (NBD1), nucleotide-binding domain 2 
(NBD2) and a middle domain (M) that composed of four helices and coiled coil 
(Fig. 1.8) (Lee et al., 2003). ClpB is important in thermotolerance; its absence 
(clpB null mutation) causes the cells to have lower growth rate at 44 °C and have 
a higher death rate at 50°C (Squires et al., 1991). ClpB coordinates with KJE to 
untangle protein aggregates, thereby preventing aggregation (Mogk et al., 1999). 
DnaK couples aggregates to ClpB by binding to the M-domain motif 2 and this 
stimulates the ATPase activity of ClpB (Rosenzweig et al., 2013; Seyffer et al., 
2012). Which part of DnaK binds to the M domain? The GrpE binding site on the 
NBD of DnaK is the same site that interacts with the M domain. GrpE and M 
compete for DnaK binding. Thus, the proposed model is: DnaK/DnaJ acts on 
aggregates. Then, DnaK presents aggregates to ClpB by binding to M domain. 
Once bound to the M-domain, ATPase power of ClpB is increased. ClpB unfolds 
aggregates. Once unfolded, the substrates can refold or recovered by KJE 
(Rosenzweig et al., 2013). 
 
1.9.5 IbpA/IbpB 
 Inclusion body-binding protein A (IbpA) and IbpB in E. coli are associated 
with inclusion bodies and aggregates during heat stress (Allen et al., 1992; 
Laskowska et al., 1996). They are present in the cell under physiological 
conditions, and also upon heat stress, their levels increase up to ~300-fold more 
(Richmond et al., 1999). Their multimeric sizes can be as large as 3 MDa. The 
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two proteins physically interact and they cooperate with DnaK/DnaJ and ClpB in 
resolubilizing aggregation, synergistically (Matuszewska et al., 2005).  
 
1.9.6 HtpG 
 High temperature protein G (HtpG) is the E. coli chaperone that is 
homologous to the eukaryotic Hsp90 (Bardwell and Craig, 1987, 1988). Despite 
the extensive studies about Hsp90, the function of HtpG remains unclear. It is an 
ATP-dependent chaperone that is abundant in E. coli, and also up-regulated 
during heat shock (Grudniak et al., 2013). It is not essential for viability; however, 
its deletion causes slower growth at higher temperatures (Bardwell and Craig, 
1988) and increase in protein aggregation at 42 °C (Thomas and Baneyx, 2000). 
The only client protein that has been identified to date is the ribosomal protein L2 
(Motojima-Miyazaki et al., 2010), which activates the ATPase activity of HtpG. In 
addition, HtpG regulates the clustered regularly interspaced short palindromic 
repeats (CRISPR) system by maintaining functional levels of Cas3 (a protein 
essential for the activity of CRISPR) (Yosef et al., 2011).  
 
1.9.7 Degradation enzymes 
 Protein degradation in E. coli is crucial in minimizing aggregation (Rosen 
et al., 2002). In E. coli, there are four classes of energy-dependent proteases that 
have been found (Lon, FtsH, ClpAP/XP, HslUV), and these have also 
counterparts in the mitochondria and chloroplasts. A single polypeptide encodes 
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both ATPase and proteolytic sites for Lon and FtsH, while two subunits encode 
the ATPase and proteolytic sites of ClpAP/XP and HslUV (Gottesman, 2003). 
FtsH is the only essential protease in E. coli. The four classes share the following 
properties: 1) they depend on ATP-hydrolysis for degradation, 2) two separate 
domains for ATPase and proteolytic sites; ATPase domain affects substrate 
specificity, 3) called ʻself-compartmentalizingʼ proteases because of their 
organization as a multi-subunit complex where the access to the proteolytic 
acitive is gated by the ATPase domain, and 4) products are short peptides (10-15 
amino acids) (Gottesman, 2003). The overall mechanism is: first, the substrate 
binds to the ATPase domain, and then after several cycles of ATP hydrolysis, it 
undergoes conformational change, and then is unfolded (sometimes), and finally 
is degraded in the proteolytic chamber (Gottesman, 2003). Proteases may share 
the same substrates depending on the substrateʼs recognition motifs and 
conditions (Smith et al., 1999; Tsilibaris et al., 2006; Vera et al., 2005; Wu et al., 
1999).  
 
1.9.7.1 Lon  
 The E. coli Lon protease is the first ATP-dependent protease to be studied 
(Chung and Goldberg, 1981; Goldberg et al., 1994; Swamy and Goldberg, 1981). 
Mutations in the lon gene cause an increase in the levels of abnormal proteins, 
and a decrease in the elimination of these proteins (Goff and Goldberg, 1987). 
This suggests that Lon is the predominant protease in E. coli (Gottesman, 2003).  
 26 
 Lon is an oligomer of identical six subunits (~87 kDa each), with a serine-
lysine catalytic dyad (Botos et al., 2004). There is no detailed structure of an 
intact Lon from E. coli yet, but a crystal structure of Lon shown in Fig. 1.9 from 
Thermococcus onnurineus (TonLon) (Cha et al., 2010) gives us insight into the 
general structure of the protease. It forms a hexagonal cylinder with a large 
sequestered chamber. It consists of: 1) an amino-terminal domain (in TonLon is 
the insertion domain (I) that contains the membrane anchor), which is important 
for substrate recognition, allosteric regulation, and chaperone activity (Wohlever 
et al., 2014); 2) AAA+ ATPase domain (A) that contains the ATP-binding motif for 
substrate unfolding; 3) and a protease domain (P) that has the degradation 
chamber. 
 E. coli Lon degrades naturally unstable and misfolded or abnormal 
proteins (Christensen et al., 2004; Dervyn et al., 1990; Goff and Goldberg, 1987; 
Griffith et al., 2004; Langklotz and Narberhaus, 2011; Mizusawa and Gottesman, 
1983; Shah and Wolf, 2006; Stout et al., 1991; Van Melderen et al., 1996). Little 
is known about its substrate preference. It can degrade a folded protein like the 
α-crystallin domain of IbpA and IbpB (Bissonnette et al., 2010). It also recognizes 
either the C or N terminal regions of a protein like the His at the C-terminal region 
of SulA (Ishii and Amano, 2001) and the first 24 N-terminal amino acids of UmuD 
(Gonzalez et al., 1998), as well as the first 21 N-terminal residues of SoxS (Shah 
and Wolf, 2006). What Lon recognizes in abnormal/damaged proteins is not clear. 
It could access target sequences that are exposed in unfolded polypeptides but 
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inaccessible in the native structure. In the unstructured β-galactosidase, Lon 
recognizes specific sequences, mostly aromatic residues (Gur and Sauer, 2008).  
 
1.9.7.2 ClpAP/XP 
 ClpA is the ATPase domain while ClpP is the proteolytic domain of ClpAP. 
ClpX also associates with ClpP and it has another substrate specificity compared 
to ClpA. ClpP is a serine protease whose active site is at Ser-111 (Maurizi et al., 
1990; Maurizi et al., 1998). ClpX and ClpA both assemble as hexameric rings 
and interact with the seven-subunit rings of ClpP. At the entrance of the 
proteolytic chamber are the ATPase rings. ClpA and ClpX may also act as 
chaperones, just by unfolding substrates without proteolysis (Singh et al., 2000; 
Wickner et al., 1994). 
 
1.9.7.3 ClpYQ/HslUV 
 ClpY (HslU) is the ATPase domain, which is similar to ClpX. ClpQ (HslV) 
is the proteolytic domain with a threonine active site. ClpQ is a double-ring, with 
six identical subunits. ClpY has also six subunits. Unlike ClpAP and ClpXP with 
ring symmetry mismatch, ClpYQ rings do match (Kessel et al., 1996). 
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1.9.7.4 FtsH  
 FtsH is a cytoplasmic Zn metalloprotease that is anchored to the inner 
membrane. It degrades the heat-shock transcription factor, σ32 (Tomoyasu et al., 
1995).  
 Degradation takes part in kinetic partitioning of substrates, as discussed 
earlier (Fig. 1.3). When are proteins being degraded instead of being folded or 
aggregated? How do degradation enzymes modulate the fate of proteins with 
different properties? Many substrates have signals for degradation by a particular 
protease. Usually, the hydrophobic patches on a protein are being recognized by 
proteases such as Lon. The N-terminal amino acid is recognized by some 
proteases (N-end rule) (Varshavsky, 1992). But other proteases bind anywhere 
on the protein depending on the location of the recognition sequence. The ClpAP 
system degrades repA and the recognition sequences are between amino acids 
1 and 15 (Hoskins et al., 2000). The ClpXP system degrades lambda O protein 
and the sequences are in the first 18 amino acids (Gonciarz-Swiatek et al., 1999). 
In bacteria, some substrates are tagged with the tmRNA or SsrA tag, which is the 
11-amino acid tag (AANDENYALAA) added to the C-terminus of polypeptides by 
tmRNA (Keiler et al., 1996; Withey and Friedman, 2003). Most proteins with the 
tag are degraded by ClpXP, and to a lesser extent by ClpAP (Gottesman et al., 
1998). Another tagging system in bacteria is the binding of polyphosphate to 
ribosomal proteins and Lon, stimulating Lon degradation (Kuroda et al., 2001). 
But little is known about the mechanism of stimulation. Adaptor proteins also 
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regulate proteolysis by either facilitating degradation or preventing degradation of 
specific proteins (Dougan et al., 2002). 
 
1.10 Cooperation among chaperones and degradation enzymes in E. coli  
 As discussed earlier, chaperones and degradation enzymes of the 
prokaryotic and eukaryotic PN cooperate to maintain levels of functional proteins 
in the cell. Specifically, in E. coli, studies have shown a variety of important 
partnerships among chaperones and degradation enzymes. However, most of 
these studies are only functional relationships. The mechanisms by which they 
collaborate are unclear.  
 TF and DnaK cooperate to aid the folding of newly synthesized proteins 
(as discussed earlier) (Deuerling et al., 1999). In addition, TF and GroEL function 
together to promote the degradation of the fusion protein, CRAG. High levels of 
TF enhanced the capacity of GroEL to bind to CRAG, and, thus, increasing 
degradation. Low levels of TF reduced degradation. In addition, high levels of TF 
stimulated GroELʼs ability to bind and unfold other proteins (Kandror et al., 1997; 
Kandror et al., 1995). Furthermore, GroEL has overlapping substrates with TF 
and DnaK. In cells without TF and DnaK, GroEL interactors increased, but the 
amounts of Class III proteins was reduced. In addition, TF and DnaK can help in 
the folding of class I and II. They also facilitate GroEL to efficiently fold the class 
III substrates by removing the load of class I and II substrates on GroEL (Kerner 
et al., 2005). The overproduction of both DnaK/DnaJ and GroEL/ES systems 
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prevented the aggregation of proteins in E. coli rpoH mutants that were deficient 
in heat shock proteins (Gragerov et al., 1992). It has also been shown that DnaK 
and Lon act synergistically to prevent aggregation (Tomoyasu et al., 2001). 
IbpA/B are substrates of Lon (Bissonnette et al., 2010), and it is suggested that 
probably Lon degrades the IbpA/B (with its substrates) or IbpA/B (only, no 
substrates). Small heat shock proteins of E. coli (IbpA/B) cooperate with ClpB, 
and DnaK system in reversing aggregation in vitro and in vivo (Mogk et al., 2003). 
DnaJ is required for the degradation of PhoA (Huang et al., 2001). DnaJ protects 
presecretory proteins from being degraded by Lon (Sakr et al., 2010). HtpG, 
together with ClpB, helps in the de novo folding of proteins in stressed cells 
(Thomas and Baneyx, 2000). Lon and GroEL/ES compete for binding to folding 
intermediates of E. coli dihydrofolate reductase (DHFR) (Bershtein et al., 2013). 
TF + KJE and TF + GroELS cause a slight increase in solubility, whereas KJE + 
GroELS is more effective in increasing solubility. TF has only a marginal effect on 
solubility (Niwa et al., 2012).  
 
1.11 Heat shock response (HSR) in E. coli  
 The transcription of the cytosolic proteostasis network is regulated by the 
heat shock response signalling pathway (Lindquist, 1986; Zhang et al., 2014). 
The heat shock response (HSR) is a cellular response to temperature increase. 
In E. coli, it is regulated by σ32 transcription factor that causes the up-regulation 
of most components of the PN σ32 regulon. There are three major modes of 
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regulation for σ32 (Guisbert et al., 2008) (Fig. 1.10). First, at high temperatures, 
translation of σ32 is increased. This causes the up-regulation of chaperones and 
degradation enzymes. When unbound (or excess) DnaK/DnaJ and GroEL/ES 
chaperones bind to σ32, σ32 is inactivated. Second, σ32 is degraded by FtsH 
protease with the help of other chaperones. Third, a decrease in temperature 
alters the rate of translation for σ32 (Guisbert et al., 2008). Many proteins in E. coli 
(mostly, chaperones) are under the control of σ32. During normal conditions, the 
concentrations of the PN components are sufficient to aid the folding of proteins. 
However, during stress (e.g. heat) or when more proteins are synthesized in the 
cell, the basal levels of the PN components are insufficient to aid folding, which 
may cause aggregation. Some chaperones are limiting (Heldens et al., 2010), 
and this causes them to be saturated. In order to increase proteostasis capacity, 
the induction of HSR helps upregulate PN components. Each component is up-
regulated to different extents (Zhang et al., 2014).  
 
1.12 Proteinʼs intrinsic biophysical properties and the cellular PN dictate 
protein folding fate through kinetic partitioning 
 As discussed earlier, a newly synthesized polypeptide (U) can have three 
fates: it can fold to native (N) and be functional, it can misfold (M) and/or 
aggregate (A), or it can be degraded (Fig. 1.2). The fate is dictated by both the 
proteinsʼ intrinsic biophysical properties and the cellular PN (Cho et al., 2015) 
(Fig. 1.11). Kinetic partitioning exists among the processes of folding, misfolding, 
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aggregation, degradation, and chaperone interaction (Kim et al., 2013; Wickner 
et al., 1999). This determines whether a protein is folded, aggregated, or 
degraded at a given time. For example in E. coli, DnaK, DnaJ, and GrpE (the E. 
coli Hsp70/Hsp40/nucleotide exchange factor) decrease the concentrations of 
misfolded states by unfolding these states (Calloni et al., 2012; Mayer and Bukau, 
2005; Sharma et al., 2010). GroEL and GroES (the E. coli Hsp60/Hsp10) 
encapsulate unfolded states to promote their folding (Chapman et al., 2006; 
Horwich and Fenton, 2009). DnaK, DnaJ, GrpE with ClpB untangle and solubilize 
aggregates (Doyle et al., 2013). Lon protease prevents aggregation by degrading 
misfolded proteins (Gur and Sauer, 2008). 
 Previous studies have investigated the relationships of properties of client 
proteins and their folding fates, as well as their sensitivities to chaperones. The 
correlation between thermodynamic stability and aggregation using E. coli as 
host organism has been tested. Destabilized variants of single point mutants of 
HypF-N, an E. coli protein domain, invariably aggregated in cells (Calloni et al., 
2005). The extent of destabilization (as a result of mutations) is only roughly 
correlated with the aggregation propensity of cellular retinoic acid-binding protein-
1 (CRABP1) (Ferrolino et al., 2013). On the other hand, the levels of folded 
recombinant p53 in E. coli are correlated with its intrinsic thermodynamic stability 
(Mayer et al., 2007); however, it is not clearly shown how the levels of 
aggregates are affected. By contrast, the in vitro thermodynamic stability and in 
vivo solubility of SH3 domains have a strong correlation (Castillo et al., 2010). 
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They conclude that intracellular aggregation propensity is under thermodynamic 
rather than kinetic control. Using Foldeco model of protein folding in E. coli, 
predictions of substrate preferences of KJE and GroELS have been studied for 
clients with different biophysical profiles, and found that misfolding-prone proteins 
benefit the most from the KJE system while slow-folding proteins benefit the most 
from GroELS (Powers et al., 2012). Furthermore, integrating folding energetics 
with the PN capacity should be considered since the two are interdependent of 
each other (Powers et al., 2009). The FoldEx model captures how the inherent 
energetics of polypeptide chains are influenced by the PN components in the 
endoplasmic reticulum (Wiseman et al., 2007). The model is used to define 
“minimal export threshold” which is a boundary in the 3D space defined by 
protein stability, folding rate, and misfolding rate. The boundary depends on the 
proteostasis network capacity. Proteins with energetics that are within the 
boundary are exported, but those whose energetics outside the boundary are not. 
In another study using computation, protein unfolding rates correlate with folding 
rates, which means that proteins that fold quickly also unfold quickly and those 
that fold slowly also unfold slowly (Broom et al., 2015). 
 It is not clear how PN modulates the folding fate of different proteins with 
intrinsic biophysical properties. How does the PN work together as a whole? How 
do proteinʼs biophysical properties affect its fate inside the cell? These are the 
questions that we investigated in this thesis. We used both experimental and 
computational approach to address these questions.   
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1.13 FoldEco model of proteostasis in E. coli 
 We use FoldEco, a computational model of the proteostasis network (PN) 
of the E. coli cytoplasm (Fig. 1.11), to understand how the PN modulates the 
folding fates of proteins with different biophysical properties. It is a holistic 
approach to understand proteostasis, in which the cooperation and competition of 
the different processes and components of the PN are investigated when they 
are working simultaneously. Here, the folding fates of proteins-of-interest (“client 
proteins”) are tracked as they are produced in the cytoplasm.  
  
 This section on FoldEco is based on the work of Powers and colleagues 
(Powers et al., 2012).  
 
1.13.1 Parts of FoldEco 
 FoldEco consists of five systems: 1) synthesis and folding, 2) chaperoning 
by DnaK/DnaJ/GrpE or KJE system, 3) chaperoning by GroEL/GroES or GroELS 
system, 4) disaggregation by ClpB/DnaK/DnaJ/GrpE or B+KJE system, and 5) 
degradation (Powers et al., 2012). 
 Protein synthesis and folding (Fig. 1.12, light red area) start with a nascent 
client protein (protein “i”) that is unfolded (Ui) coming off from the ribosomal exit 
tunnel of a translationally active ribosome (Ra,i) to form a ribosome:unfolded 
protein complex (Ra,i:Ui). This complex can also bind to trigger factor (Ra,i:Ui:T). 
When the protein is completely synthesized, it is released from the ribosome as 
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an unfolded protein (Ui) or still bound to trigger factor (Ui:T). The unfolded protein 
then reversibly folds to native (Ni) state or misfolds to misfolded (Mi) state. 
Misfolded states can either self-associate to form aggregates, Ai,j (where “j” are 
the number of monomers in the aggregate) through nucleated polymerization or 
bind to chaperones (Powers et al., 2012).  
 The KJE system provides a channel for misfolded states (M) to unfold (Fig. 
1.12, light blue area). Here, unfolded (U) or misfolded (M) states enter the system 
and U is released. First, Ui or Mi binds to dimeric DnaJ (J2) or ATP-bound DnaK 
(KT) to form a binary complex (J2:Ui/Mi or KT:Ui/Mi, “/” indicates “either-or”). This 
complex then binds to either J2 or KT to form a ternary complex (KT:Ui/Mi:J2). U or 
M preferentially binds to DnaJ because KT binds weakly to substrates (Mayer et 
al., 2000). Upon DnaJ binding, ATP hydrolysis is stimulated by DnaK, which 
causes a conformational change within DnaK. This change in DnaK is 
transmitted to the bound client protein, and causes the client protein to unfold. 
DnaJ is released from the KD:Ui:J2 complex (KD indicates the ADP-bound DnaK) 
to give KD:Ui. Upon dimeric GrpE (E2) binding to the KD:Ui complex, ADP is 
exchanged to ATP to give KT:Ui:E2. When GrpE is dissociated, KT:Ui complex is 
left. Upon dissociation of KT, the unfolded protein, Ui, is released. In FoldEco, the 
total number of KJE cycles depends on the relative rates of entry of client 
proteins to the KJE cycle and folding. The model is partly based on that of Hu 
and others (Hu et al., 2006; Powers et al., 2012).  
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 The GroELS system (Fig. 1.12, light green area) promotes folding by 
encapsulating unfolded (U) or misfolded (M) states providing an isolated 
environment for the protein to fold (Horwich et al., 2006). The cycle starts with 
either U or M binding to the cis ring of GroEL (either ATP-bound, GrLT or not, 
GrL) to give GrLT:Ui/Mi or GrL:Ui/Mi. There should only be a few ATP-free GroEL, 
given the typical ATP concentrations in vivo (Tyagi et al., 2009). Upon ATP 
binding, GrL:Ui and GrL:Mi are both forcibly unfolded to give GrLT:Ui (Lin et al., 
2008). GroES then caps the GrLT:Ui/Mi complex, which causes the client protein 
to be released into the cis cavity (GrLT:Ui/Mi:GrS) to fold or misfold 
(GrLT:Ui/Mi/Ni:GrS). Upon ATP hydrolysis in the cis ring, there are two 
possibilities for GrLD:Ui/Mi/Ni:GrS: 1) binding of ATP in the trans ring yields 
GrLD:Ui/Mi/Ni:GrS::GrLT and causes the release of ADP, GrS, and the client 
protein from the cis ring, and 2) binding of U or M client protein in the trans ring 
forms GrLD:Ui/Mi/Ni:GrS::GrL:Uk/Mk (“k” indicates that the client protein can be 
different from the one in the cis cavity), and upon ATP binding, ADP, GrS, and 
client protein is released from the cis ring. GrLT:Uk is left and ready to reenter the 
cycle. The total number of GroELS cycle that a client protein experiences 
depends on the relative rates of entry into the cycle and folding (Jewett and Shea, 
2008; Powers et al., 2012; Tehver and Thirumalai, 2008). 
 The ClpB/DnaK/DnaJ/GrpE (B+KJE) system (Fig. 1.12, light yellow area) 
is important in reversing protein aggregation. In FoldEco, the model for the 
disaggregation system is based on studies that suggest that aggregates are 
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prepared by KJE for B (Acebron et al., 2008; Acebron et al., 2009) and then B 
removes monomers from aggregates. The cycle begins with the binding of J2 or 
ATP-bound DnaK to aggregates (Ai,j) to form the complex, J2:Ai,j or KT:Ai,j (the 
stoichiometry of chaperone:aggregate is assumed to be 1:1). This complex binds 
to either KT or J2 to form the ternary complex, KT:Ai,j:J2. ATP hydrolysis yields the 
complex KD:Ai,j*:J2, in which the aggregate is prepared for ClpB binding (as 
indicated by *). J2 is released to give KD:Ai,j*, which has two possible pathways. 
First, GrpE binds to KD:Ai,j* and induces nucleotide exchange to yield KT:Ai,j:E2. 
Upon the release of GrpE, either a monomer is lost to give KT:Ai,j-1 and Ui (for 
small oligomers, j < 4 in FoldEco) or no monomer is lost to yield KT:Ai,j (for larger 
aggregates, j > 4). KT:Ai,j can enter the cycle again or can dissociate. Second, 
ClpB binds to KD:Ai,j* to produce KD:Ai,j*:B. Upon GrpE binding, E2:KT:Ai,j*:B is 
formed. When E2 and KT dissociate, Ai,j*:B is left. The final step involves the 
translocation of a monomer through the central pore of B and the dissociation of 
the complex to yield Ai,j-1, Ui and B (Powers et al., 2012). 
 FoldEco consists of two degradation pathways-- the Lon and ClpAP-type 
proteases (Fig. 1.12, light purple). In the pathway with Lon, it starts with the 
interaction of Lon with U or M states to form a reversible complex, Lon:Ui/Mi. The 
client protein is then transferred to the proteolytic chamber (for misfolded protein, 
it is forcibly unfolded first) to yield Lon:Ui* (* indicates that the substrate is 
committed to be degraded). Here, degradation is processive, in which the 
ATPase domains of Lon feed the protein into the proteolytic chamber. In the 
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second pathway, ClpAP-type proteases (Dn) degrade native proteins (Ni) that 
have degradation signals or degrons. First, Dn binds to Ni (client protein may be 
delivered through an adaptor such as ClpS) to form the reversible complex, Dn:Ni. 
Then the client protein is forcibly unfolded and transferred to the proteolytic 
chamber to form Dn:Ni*. Degradation is also processive (Powers et al., 2012). 
 
1.13.2 Implementing and parametrizing FoldEco 
 FoldEco consists of ordinary differential equations describing the time-
dependent concentrations of each species (e.g. concentration of unfolded U, 
misfolded M, or native N states). In order to solve for the systems of equations, 
model parameters such as rate constants and initial concentrations are required. 
The parameters used in FoldEco are estimated from literature data, experiments, 
or models. Rate constants and folding parameters as well as the binding affinities 
of substrates to chaperones and on/off rates, which are protein-specific are 
estimated from literature. Initial concentrations are also derived from literature. 
Powers and colleagues converted primary data (from previous studies) of protein 
abundances for the major chaperones and degradation enzymes in E. coli to 
concentrations, and calculated the geometric mean (Table 1.1). Chaperone 
levels vary. They also differ in their active forms. Trigger factor (TF) and DnaK 
are active as a monomer, DnaJ and GrpE are dimer, GroEL is 14-mer, GroES is 
7-mer, Lon and ClpB are 6-mer. The concentrations of the active PN components 
are: [Tf] = 20 μM, [DnaK] = 30 μM, [DnaJ] = 0.5 μM, [GrpE] = 7.5 μM, [GroEL] = 
 39 
3 μM, [GroES] = 5 μM, [Lon] = 0.3 μM, and [ClpB] = 0.3 μM. In running FoldEco, 
users can change these parameter values depending on the proteins-of-interest. 
The outputs are the concentrations of all species at a given time (Powers et al., 
2012). 
 Like any biological network model, FoldEco has some approximations and 
assumptions (Powers et al., 2012). First, FoldEco is a deterministic model (not 
stochastic), in which the average state of proteostasis in populations of E. coli 
(not individual cells) is assessed. This captures some results of in vivo 
experiments, in which variables of interest are measured through the average of 
populations rather than individual cells. Second, FoldEco assumes that E. coli is 
a single compartment (the cytoplasm), in which components are mixed freely and 
their concentrations are the same across the cell. This is to simplify the model 
and not complicating it with spatial heterogeneous concentrations that we do not 
have estimates yet. Third, only the PN components of the cytoplasm, and not 
membrane or periplasmic proteins, are being studied. Fourth, FoldEco uses 
parameters measured in vitro to account for processes in vivo. Some in vitro and 
in vivo parameters (e.g. kinetic and thermodynamic properties) differ, while 
others are similar. In FoldEco, a conservative approach is used such that in vitro 
data without correction are utilized. These values will be replaced in FoldEco 
when specific information on rate and equilibrium constants become available. 
Fifth, in FoldEco, bacterial growth is not considered, which means that bacteria 
are not growing. This assumption may reflect bacteria that are in the lag or 
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stationary phase or when overexpressing heterologous proteins in vivo, in which 
growth is strongly inhibited. Sixth, the background proteome, which could 
compete with a client protein of interest for PN machineries, is absent in FoldEco. 
Given the FoldEco condition in which bacteria are not growing, only few proteins 
are produced and do not outcompete client proteins for PN components. Seventh, 
stress response (such as heat shock) is not included in FoldEco, but it can be 
estimated by increasing the concentrations of the relevant PN components. 
Further, in FoldEco, ATP concentration is assumed to be constant, and the 
concentrations of mRNA are supposed to be at a steady state. In addition, a 
simplified model of translation is used, in which translation is a three-step 
process: initiation of translation, elongation of nascent chain until it emerges from 
the ribosomal exit tunnel, and final translation of the remaining mRNA. FoldEco 
does not account for co-translational folding and misfolding. Furthermore, free 
aggregates composed of two or more monomers as well as those in complex 
with chaperones are considered as individual species. Lastly, some PN 
components (such as IbpA/IbpB and HtpG) are not included in FoldEco. However, 
they do not have a very significant effect on proteostasis (Bardwell and Craig, 
1988). In the future, these will be incorporated when more mechanistic 
information will be available (Powers et al., 2012).  
 FoldEco is a powerful tool to rationalize experimental observations and to 
generate hypotheses. We utilize FoldEco to do simulations with conditions similar 
to those in the lab, and we use these to guide other conditions to test 
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experimentally. We also input our in vivo data to the FoldEco program, and the 
program gives us the folding properties of the proteins. This integration of 
knowledge from computational and experimental approaches helps us 
understand the proteostasis network better (Powers et al., 2012). 
 
1.14 Statement of thesis  
 Despite our knowledge about the main functions of the individual 
components of the PN, little is known about how the whole PN functions as a 
system. In addition, it is not clear how the biophysical properties of a protein 
affect its folding fate in the context of the whole PN. How does the PN, consisting 
of molecular chaperones and degradation enzymes, modulate the folding fate of 
proteins with different intrinsic biophysical properties? We hypothesized that 
molecular chaperones and degradation enzymes modulate the folding fate of a 
protein by working together to maintain proteostasis. The sensitivity of a protein 
to a particular chaperone or degradation enzyme depends on the proteinʼs 
intrinsic biophysical properties, and on the concentrations of the protein and 
chaperones and degradation enzymes at any given time.  
 Understanding protein folding in the cell requires a holistic approach. We 
need to understand the cooperation and/or competition among the PN 
components when they are present and operating simultaneously. In order to 
understand the regulation of protein folding fate, we utilize an integrated 
computational and experimental approach. We use E. coli because it is a simple 
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model organism to understand protein folding in the cell. We perform wet lab 
experiments in E. coli by expressing proteins with different biophysical properties 
and determining their folding fates in vivo. In addition, we use FoldEco to provide 
us a better understanding about the mechanisms of the PN as a whole.  
 In Chapter 2 of this thesis, we investigate how the intrinsic biophysical 
properties of proteins (e.g. rate and equilibrium constants) dictate folding fate 
under basal levels of the PN components (molecular chaperones and 
degradation enzymes). We express in E. coli cells several variants of a model 
protein that have unique biophysical properties, and determine their fates at a 
given time. In combination with FoldEco, we are able to determine the effects of 
rate and equilibrium constants on folding fates of proteins. In Chapter 3, we 
explore how varying levels of some of the major PN components affect the 
folding fates of model proteins with low stabilities and high aggregation 
propensities. We express model proteins in E. coli cells and determine their 
folding fates under conditions of varying concentrations of individual chaperones 
and degradation enzymes or in combinations. Using FoldEco, we are able to 
determine the individual and collective contributions of chaperones and 
degradation enzymes to proteostasis. We have used FoldEco to perform 
simulations on the folding fates of proteins-of-interest given their biophysical 
properties, and we have also elucidated the biophysical properties of proteins 
given their folding fates in vivo (Powers et al., 2012). 
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Figure 1.1 Schematic depiction of the complex environment inside the E. 
coli cell where protein folding takes place 
 
Despite the complex environment, proteins can still fold very well inside the cell. 
The reason for this is the presence of the proteostasis network, consisting of 
molecular chaperones and degradation enzymes. The protein of interest (in 
orange) as it is being made from the ribosome (ribosomal proteins are purple, all 
RNA in salmon) is helped by molecular chaperones (GroEL in green, DnaK in red, 
and trigger factor in yellow). (Reproduced from (Gershenson and Gierasch, 
2011)).  	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Figure 1.2 Schematic diagram of folding fates of proteins  
 
An unfolded polypeptide when it comes off from the ribosome can have three 
fates: 1) folded and become functional, 2) misfolded and/or aggregated, and 3) 
degraded.  	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Figure 1.3 A proteinʼs energy landscape of folding and aggregation 
 
As an unfolded polypeptide folds to its native state (purple area) via 
intramolecular contacts, it explores a funnel-shaped energy landscape. The 
protein adopts different conformations such as folding intermediates, partially 
folded states, or misfolded states. Species (usually the partially folded or 
misfolded states) can be kinetically trapped and they need to cross free-energy 
barriers to reach a favorable downhill path. When these trapped species form 
intermolecular interactions, aggregates (amorphous aggregates, oligomers, or 
amyloid fibrils) are formed (pink area). (Reproduced from (Hartl et al., 2011)). 
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Figure 1.4 Chaperone pathways in the cytosol  
 
The general pathway of protein folding in the cytosol of a) bacteria, b) archaea, 
and c) eukarya is conserved. Newly synthesized polypeptides first interact with 
ribosome-associated chaperones (e.g. trigger factor (TF) in bacteria, nascent-
chain-associated complex (NAC) in archaea and eukarya) that protect the new 
polypeptide from intramolecular or intermolecular interactions. Longer nascent 
chains interact with Hsp70 (DnaK in bacteria, Hsp70 in eukarya), Hsp40 (DnaJ in 
bacteria) and nucleotide exchange factors (GrpE in bacteria) for co- and post-
translational folding. In archaea, prefoldin (PFD) acts downstream of NAC. Then, 
these partially folded states are transferred to the chaperonins (GroEL/GroES in 
bacteria, thermosome in archaea, and tailless complex polypeptide-1 (TCP1) ring 
complex (TriC)/chaperonin-containing TCP-1 (CCT) in eukarya. Hsp90 system 
(with additional co-factors) mediates folding of substrates from the heat shock 
cognate 70 (Hsc70). The insert in panel c shows the ribosome-associated 
complex (RAC) in fungi, which consists of Ssz1 (a specialized Hsp70) and zuotin 
(Hsp40). RAC and the Hsp70 isoform (Ssb) assist nascent chain folding. The 
estimated protein flux is shown as percentages. (Reproduced from (Kim et al., 
2013)). 	  	  
 47 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  
Figure 1.5 Structure of E. coli trigger factor (PDB 1W26, (Ferbitz et al., 2004)) 
 
TF consists of three domains: 1) N-terminal domain for ribosome binding), 2) 
peptidyl-prolyl isomerase (PPIase) domain for nascent chain binding, and 3) C-
terminal domain for primary binding site of nascent chain. 	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Figure 1.6 Structure of Hsp70  
 
A. In the ADP-bound state (PDB 2KHO, (Bertelsen et al., 2009)) of E. coli DnaK, 
the nucleotide-binding domain (NBD) and substrate-binding domain (SBD) are 
independent of each other, linked by a linker. B. A representation of the ATP-
bound state (PDB 2QXL, (Liu and Hendrickson, 2007)) for yeast Sse1 shows that 
the two domains are docked. 
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Figure 1.7 Structures of GroEL and GroES (PDB 1PF9, (Chaudhry et al., 
2003)) 
 
GroEL consists of two large rings (7 subunits each). Each subunit has an apical 
domain, hinge domain, and ATPase domain. GroES also forms a ring with 7 
subunits each. It binds to the apical domains of GroEL.  	  	  	  	  	  	  	  	  	  
GroEL 
GroES 
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Figure 1.8 Structure of ClpB from Thermus thermophilus (PDB 1QVR, (Lee 
et al., 2003)) 
 
ClpB consists of an amino-terminal domain (N-domain), two nucleotide-binding 
domains (NBD1 and NBD2), and a middle domain.  	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Figure 1.9 Structure of Lon from Thermococcus onnurineus (PDB 3K1J, 
(Cha et al., 2010) 
 
Lon is a hexamer of identical subunits (~87 kDa each). A. Each subunit consists 
of an insertion domain (I), AAA+ ATPase domain (A), and a protease domain (P). 
B. Lon shown as a hexamer. (Image from the RCSB PDB (www.rcsb.org) of PDB 
ID 3K1J).  
A.  
B.  
Insertion domain (I) 
AAA+ domain (A) 
Protease domain (P) 
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Figure 1.10 Three modes of regulation of σ32 
 
1) Translation increased at high temperatures, 2) Degradation by FtsH and other 
chaperones, 3) Inactivation mediated by chaperones DnaK/DnaJ and 
GroEL/GroES. (Reproduced from (Guisbert et al., 2008)) 
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Figure 1.11 Schematic of kinetic partitioning during protein folding in vivo  
 
When an unfolded (U) polypeptide is synthesized from the ribosome (Synthesis), 
it can have different folding fates: It can fold into native (N), it can misfold (M), 
and if M self-associates, it can aggregate (A), or it can be degraded (D). The fate 
of the protein is dictated by its intrinsic biophysical properties (red text). In 
addition, the PN components modulate its fate in vivo. Kinetic partitioning affects 
folding. For example, In E. coli, GroEL and GroES (Hsp60/Hsp10) promote 
folding by encapsulating unfolded states and helping them fold to native. DnaK, 
DnaJ, and GrpE (Hsp70/Hsp40/Nucleotide exchange factor) rescue misfolded 
states by binding to M and helping them to become unfolded. ClpB and KJE 
collaborate to untangle and solubilize aggregates. (Reproduced from (Cho et al., 
2015)). 
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Figure 1.12 The FoldEco model of proteostasis network (PN) in E. coli  
 
The five parts of FoldEco are: 1) synthesis and folding (light red), 2) 
DnaK/DnaJ/GrpE chaperone system (light blue), 3) GroEL/GroES chaperone 
system (light green), 4) ClpB/DnaK/DnaJ/GrpE disaggregation system (light 
yellow), and 5) degradation (light purple). The free states (bold fonts) are denoted 
as: unfolded (Ui), misfolded (Mi), native (Ni), and aggregated (Ai,j). Complexes 
between PN components and client proteins are separated by colons (key in 
upper right). The subscripts “T” and “D” are for ATP- and ADP-bound states, 
respectively. (Reproduced from (Powers et al., 2012)). 	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Table 1.1 Concentrations of some PN components 
The concentrations are converted from primary data of five databases. The 
values are when they are monomer or active. (Modified from (Powers et al., 
2012)).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 Concentration (μM), monomer 
Concentration 
(μM), active 
Trigger factor, active as monomer 20 20 
DnaK, active as monomer 30 30 
DnaJ, active as dimer 1 0.5 
GrpE, active as dimer 15 7.5 
GroEL, active as 14-mer 42 3 
GroES, active as 7-mer 35 5 
ClpB, active as 6-mer 1.8 0.3 
Lon, active as 6-mer 1.8 0.3 
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CHAPTER 2 
 
INFLUENCE OF INTRINSIC BIOPHYSICAL PROPERTIES ON PROTEIN 
FOLDING FATE IN E. COLI UNDER THE BASAL PROTEOSTASIS NETWORK 
 
 
This chapter is the result of collaboration with Evan T. Powers and Lila M. 
Gierasch.  
 
  
 This chapter investigates how the kinetic and thermodynamic properties of 
proteins determine their folding fates in the cell, using the FoldEco model and 
testing the predictions with wet lab experiments.  
 
2.1 Introduction 
 A newly synthesized polypeptide (U) can have different folding fates: 1) it 
can fold to native (N) and be functional, 2) it can misfold (M) and/or aggregate (A), 
or it can be degraded. Aggregated and degraded proteins are non-functional (Fig. 
2.1). Proteostasis is achieved when necessary levels of functional proteins are 
maintained, and non-functional proteins are minimized (Balch et al., 2008). A 
proteinʼs intrinsic biophysical properties and the cellular proteostasis network 
(PN) determine the folding fate of a protein inside the cell (Cho et al., 2015) (Fig. 
2.1). The intrinsic biophysical properties of proteins influence folding, misfolding, 
and aggregation (Powers et al., 2009; Powers et al., 2012). PN components 
interact with unfolded, partially or misfolded proteins and help them fold to native, 
hold them to prevent their self-association and aggregation, or degrade them to 
lower their concentrations (Cho et al., 2015). Kinetic partitioning occurs among 
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the processes of folding, misfolding, aggregation, and degradation. The PN, 
consisting of different processes (biogenesis, conformational maintenance, and 
protein clearance) as well as various players (molecular chaperones and 
degradation enzymes), collaborates to maintain proteostasis (Powers et al., 
2009; Powers et al., 2012). 
 While several attempts have been made to explore the correlation of 
intrinsic properties of proteins (e.g. stability) to their solubility and/or aggregation 
in E. coli (Calloni et al., 2005; Castillo et al., 2010; Ferrolino et al., 2013; Mayer et 
al., 2007), it is still not clear how intrinsic biophysical properties dictate protein 
folding fates in vivo. What are the limits of proteostasis for an unperturbed 
proteostasis network? Or in other words, what biophysical properties of proteins 
can the basal levels of the PN components tolerate? We utilized an integrated 
computational and experimental approach to address these questions.  
 We used E. coli as a model organism because it is a simple organism, 
with a PN consisting of the major chaperones (Trigger factor, DnaK/DnaJ/GrpE, 
GroEL/ES, ClpB/DnaK/DnaJ/GrpE) and proteases (Lon, ClpXP, ClpAP, HslUV), 
and because of the availability of the FoldEco model of E. coliʼs PN (Powers et al., 
2012). We used the E. coli strain, HMS174(DE3), which is under a K-12 
background (Novagen) and has Lon protease (Blattner et al., 1997; Marisch et al., 
2013; Studier et al., 2009). We utilized FoldEco to predict the folding fates of 
proteins (i.e. how they partition between folding, aggregation, and degradation) 
based on our current understanding of how the E. coli PN components work. We 
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performed wet lab experiments to determine the folding fates of proteins with 
different biophysical properties and compared their behavior to the predictions 
from FoldEco. The partitioning of a protein among its potential folding fates were 
measured in terms of the concentrations of soluble, aggregated, and degraded 
proteins at any given synthesis rate and time. It is assumed that soluble proteins 
include proteins that are natively folded (N) and those unfolded (U) and misfolded 
(M) proteins that are free or bound to chaperones making them soluble. 
Aggregated proteins (A) consist of proteins that are insoluble. Degraded proteins 
are from U and M states. 
 Knowledge about the levels of PN components inside the cell is necessary 
to understanding how the PN works. Inside the cell, the levels of PN components 
are different (Powers et al., 2009). For example, DnaK levels are high relative to 
DnaJ and GrpE despite the fact that the three work together as an Hsp70 ʻteamʼ. 
ClpB works with KJE, but its concentration is also low relative to that of DnaK. 
GroEL and GroES are present at similar levels (Lu et al., 2007; Powers et al., 
2012). Furthermore, PN components differ in their active forms. Trigger factor 
(TF) and DnaK are active as monomers, DnaJ and GrpE are dimers, GroEL is a 
14-mer, GroES is a 7-mer, and Lon and ClpB are 6-mers. The concentrations of 
the components in an unperturbed E. coli PN that were used in our calculations 
were taken from Cho et al. (2015) (Table A.1). Here, “unperturbed” or “basal” PN 
refers to the “adapted-basal” PN, which is the PN in the presence of heterologous 
expression of proteins (Cho et al., 2015; Gasser et al., 2008; Hoffmann and 
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Rinas, 2004). In our study, unperturbed or basal PN was also referred to as the 
“adapted-basal” PN.   
 To determine the levels of the major chaperones (DnaK and GroEL) and 
Lon protease in cells expressing the test proteins, we compared levels of DnaK, 
GroEL, and Lon in cells expressing the test proteins and cells not expressing the 
test proteins (or cells with empty vector). The levels of DnaK, GroEL, and Lon in 
cells expressing CRABP1 at 1, 2, and 3 h of induction were ~10-30% lower or 
~10-20% higher than those in cells without expressing CRABP1 (Fig. A.1). The 
PN as a result of these slight perturbations due to expression of test proteins is 
referred to as the “adapted-basal” PN.  
 We used a model protein, murine cellular retinoic acid-binding protein-1 
(CRABP1) and variants that have different biophysical properties (Budyak et al., 
2013). CRABP1 is a member of the intracellular lipid binding-protein family (iLBP) 
that binds and transports hydrophobic ligands. For CRABP1, its ligand is retinoic 
acid. CRABP1 is a ten-stranded β-barrel with 136 amino acids (Fig. 2.2) and a 
molecular weight of ~15 kDa. Our lab has generated a number of single-residue 
substitutions at different sites of the protein. The pseudo wild-type CRABP1 we 
have used has a stabilizing mutation, R131Q, and is termed WT* (Zhang et al., 
1992). WT* was used as the template for the other CRABP1 variants (Budyak et 
al., 2013). Their stabilities, folding, and unfolding kinetics have been studied in 
vitro (Budyak et al., 2013). In addition, the aggregation propensities of regions in 
the sequences have been determined (Ferrolino et al., 2013). We chose five 
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variants for our studies: WT*, M9A, V67A, L118V, and Y133S (Fig. 2.2). These 
variants have distinct properties (Table 2.1). CRABP1(WT*) is stable, with a ΔG° 
of -10.0 ± 0.2 kcal/mol at 25 °C (Kf = 2.17 x 107). It folds relatively fast (kf = 0.77 
s-1) and unfolds relatively slowly (ku = 1.67 x 10-5 s-1). CRABP1(M9A) is slightly 
destabilized (ΔΔG° = -1.8 ± 0.2 kcal/mol). It is a slow folder (kf = 0.31 s-1, ~2.5 
times slower than WT*) and a slow unfolder (ku = 1.01 x 10-5 s-1). By contrast, 
CRABP1(V67A) is highly destabilized (ΔΔG° = -3.3 ± 0.2 kcal/mol), but folds fast 
(kf = 0.57 s-1). It unfolds faster than WT* by ~2 orders of magnitude (ku = 1.50 x 
10-3 s-1). Furthermore, CRABP1(L118V) is moderately destabilized (ΔΔG° = -2.3 
± 0.4 kcal/mol), slow folder (kf = 0.41 s-1), and unfolds 3 times faster than WT* (ku 
= 5.02 x 105). Lastly, Y133S is highly destabilized (ΔΔG° = -4.8 ± 0.2 kcal/mol). It 
is the slowest folder (kf = 0.08 s-1, 10 times slower than WT*). It unfolds 5 times 
faster than WT* (ku = 8.96 x 105). The kf and ku values for WT* and Y133S were 
also determined at 30 °C (Table 2.1B). Also at this temperature, Y133S folds 10 
times slower than WT*.  
 
2.2 Results 
2.2.1 Comprehensive examination of protein folding fate versus 
biophysical properties using FoldEco 
 To determine the effect of intrinsic biophysical properties on protein folding 
fates under the adapted-basal PN, FoldEco simulations were performed. Most of 
the parameters in FoldEco are independent of, or weakly dependent on, the 
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nature of the protein substrate (Powers et al., 2012). Only the folding parameters, 
including the folding rate and equilibrium constants (kf and Kf), misfolding rate 
and equilibrium constants (km and Km), and aggregation rate and equilibrium 
constants (ka and Ka), and initial concentrations were varied in running 
simulations. The values for the other parameters were those from literature (Cho 
et al., 2015; Powers et al., 2012). The synthesis rate was set to 135 μM h-1 (a 
typical protein expression rate in E. coli) (Fig. A.2). Combinations of folding 
parameters were generated to cover the following ranges (that are physically 
reasonable): kf: 10-3 to 103 s-1; Kf: 102 to 108; km: 10-3 to 103 s-1; Km: 10-3 to 103; 
ka: 10-3 to 103 μM-1 s-1; Ka: 10-3 to 103 μM-1 (Fig. 2.3). Ka is the inverse of critical 
concentration. Each was varied in 10-fold steps to make 117,649 (76). The initial 
concentrations for the chaperones and degradation enzymes were their levels in 
the “adapted-basal” PN (Cho et al., 2015) (Table A.1). Degradation rate was set 
as constant. The model was solved for each set of parameters. The 
concentrations of soluble, aggregated, and degraded proteins were compared 
after 3 h (~405 μM of total protein synthesized) as a function of their intrinsic 
biophysical properties. Results of FoldEco modeling across parameter space are 
shown in the following sections. 
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2.2.1.1 Case 1: No aggregation, no misfolding 
Fifty-nine percent (59%) of all parameter sets are proteins that do not misfold and 
do not aggregate, which requires km < 0.1 or Km < 1. In these cases, folding only 
competes with degradation (Fig. 2.4A).  
 
2.2.1.1.1 Partitioning between folding and degradation depends exclusively 
on rate and equilibrium constants  
 The partitioning between folding and degradation depends exclusively on 
the folding rate constant (kf) and equilibrium constant (Kf) (Fig. 2.4B). The 
contour plots of the fraction of soluble protein (amount of soluble protein/total 
amount of protein synthesized) as a function of kf and Kf are L-shaped, which 
indicates that the fraction soluble depends on either the kinetics or 
thermodynamics of folding, but (for the most part) not on both at the same time. 
We describe this behavior as “thermo/kinetically limited behavior.” Fraction 
soluble depends on the limiting aspect of the proteinʼs biophysical properties. For 
example, if initially kf = 0.001 s-1 and Kf = ~103.5, as kf increases (from 0.001 to 
<0.1 s-1) with constant Kf, the fraction of soluble protein increases (Fig. 2.4C); the 
partitioning into soluble or degraded protein is under kinetic control. Further 
increase of kf (0.1 to <100 s-1) with constant Kf does not increase the fraction 
soluble; fraction soluble is independent of kf. As Kf increases (103.5 to 106) and 
with constant kf (100 s-1), the fraction of soluble protein also increases; at this 
point the fraction soluble or degraded is under thermodynamic control.  
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2.2.1.1.2 Rate and equilibrium constants affect the fraction of soluble 
protein similarly 
 The shapes of fraction soluble vs. kf (at high Kf) or Kf (at high kf) plots are 
very similar. At the maximum value of kf or Kf tested, the fraction of soluble 
protein (or fraction of non-degraded protein) depends on the other parameter that 
is not maximum. For example, at maximum Kf (108), as kf increases from 0.001 s-
1 to 1000 s-1, the fraction of soluble protein increases from 0.1 to 0.9. At 
maximum kf (1000 s-1), as Kf increases from 102 to 108, the fraction of soluble 
protein also increases (Fig. A.3). The folding rate and equilibrium constants affect 
the fraction of soluble protein similarly as shown in the graphs of fraction of 
soluble protein vs. kf or Kf (Fig. 2.5A). When plotted in one graph, the equilibrium 
constant needs to be offset by ~4.5 to 4.6 log units, or a factor of ~38,000, to 
match the rate constant (Fig. 2.5B). This result implies that there is a line along 
which the rate and equilibrium constants each give the same fraction soluble. We 
can map this line on the contour plot of fraction of soluble protein vs. kf and Kf 
(Fig. 2.5C). The line is called the “line of thermo-kinetic crossover”. This line 
separates rate- and equilibrium-limited regions. Above the line, fraction soluble 
depends on kf alone, and below the line the fraction soluble depends on Kf alone. 
Along the line, fraction soluble depends on both kf and Kf. The line of thermo-
kinetic crossover is: log10 kf = log10 Kf − 4.58. In the contour plot, using the line of 
thermo-kinetic crossover, we can collapse the two folding parameter dimensions 
into one by projecting points above the line and down to the kf axis and by 
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projecting points below over to the Kf axis and then offset. When plotted on one 
axis, the result is the Limiting Folding Parameter (LFP), in which log10 LFP = 
Min[log10 kf, log10 Kf -4.58). The best fit to the data is:  !! = 11  +  0.23  x  10-­‐0.57xMin log10!!,log10!!-­‐4.58   
The pre-factors (0.23 and -0.57) in this equation likely reflect the effects of the 
degradation rate and any other PN components or processes on the folding vs. 
degradation partitioning.  
 
2.2.1.2 Case 2: Misfolding, but no aggregation 
 Proteins that misfold but do not aggregate are characterized by km ≥ 0.1 
s−1 and Km ≥ 1, ka < 10 μM−1 s−1 or Ka < 10 μM−1. “No aggregation” means that 
less than 5 μM of aggregates are produced at 3 h. Thirty-eight percent (38%) of 
parameter sets are in this category (Fig. 2.6A). 
 
2.2.1.2.1 Without aggregation, misfolding increases degradation  
 For proteins that misfold but do not aggregate, folding still only competes 
with degradation, but degradation is increased because the M state is susceptible 
to degradation. An example is shown in Fig. 2.6B. The fraction soluble for 
proteins that have higher propensity to misfold (km = 100 s−1 and Km = 100) is 
lower compared to those that do not misfold (km < 0.1 s−1 and Km < 1) at any 
given pair of kf and Kf. The shapes of the contours are similar, but the positions 
differ. In this case, the contours for proteins that misfold “shrink”; that is, they shift 
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upward and to the right, which means that more of the protein is degraded, 
leaving less soluble protein at the 3 h time point. Proteins with high misfolding 
propensity accumulate M states that are being degraded.  
 
2.2.1.2.2 “Misfolding penalty” is also thermo/kinetically-limited  
 The “misfolding penalty” refers to the change in the fraction of soluble 
protein (Δ Fs) due to misfolding. For a given kf and Kf (e.g. kf = 1 s− 1 and Kf = 
105), the misfolding penalty exhibits thermo/kinetically-limited behavior similar to 
folding (Fig. 2.7A). It is controlled by the limiting aspect of the misfolding 
parameters. The line of thermo-kinetic crossover separates the kinetic vs. 
thermodynamic control regions. The misfolding penalty depends on km above the 
line, on Km below the line, or on both along the line. The effect of misfolding can 
be expressed using a single parameter, the Limiting Misfolding Parameter (LMP) 
(Fig. 2.7B). The fraction of soluble proteins for proteins that misfold but do not 
aggregate depends on two parameters, the LFP and LMP (Fig. 2.7B). The best fit 
to the data is:  !! = 11  +  0.59  x  100.38xMin log10!!,log10!!-­‐0.48 -­‐0.63xMin[log10!!,log10!!-­‐4.30  
As above, the parameters in the equation are a function of the PN components. 
The effect of misfolding, which contributes a positive term in the exponential, 
counters the effect of folding, which contributes a negative term. 
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2.2.1.3 Case 3: MIsfolding and aggregation 
 Only 3% of proteins described by the parameter sets tested misfold and 
aggregate substantially. Aggregation requires very specific combinations of 
parameters. By “substantial aggregation”, we mean that the concentration of 
aggregated protein is greater than or equal to 5 μM at the 3 h time point. Proteins 
that misfold and aggregate require km ≥ 0.1 s−1 and Km ≥ 0.1, ka ≥ 10 μM−1 s−1 
and Ka ≥ 10 μM−1. Proteins with an unstable misfolded state, an unstable 
aggregated state, or those with low aggregation rate do not aggregate (Fig. 2.8A).  
 
2.2.1.3.1 Aggregation following misfolding further suppresses native 
folding 
 Aggregation competes with folding and degradation. Aggregation following 
misfolding further suppresses the folding of native states. For example, the 
fraction soluble of proteins that misfold and aggregate (e.g., km = 100 s−1, Km = 
100, ka = 10 μM−1 s−1 and Ka = 1000 μM−1) is generally lower than those of 
proteins that misfold and do not aggregate (km = 100 s−1, Km = 100, ka = 10 μM−1 
s−1 and Ka = 1 μM−1) at any given pair of kf and Kf (Fig. 2.8B). The contours have 
the same shapes, but the positions differ. In this case, the contours shift to the 
right, which means that there is a smaller fraction of soluble proteins. 
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2.2.1.3.2 “Aggregation penalty” and fraction of aggregated protein are also 
thermo/kinetically limited  
 “Aggregation penalty” refers to the change in the fraction of soluble protein 
(Δ Fs) due to aggregation. For a given kf, Kf, km and Km (e.g. kf = 1 s− 1, Kf = 105, 
km = 100 s− 1, Km = 100), the aggregation penalty exhibits thermo/kinetically 
limited behavior similar to folding and misfolding (Fig. 2.9A). It can also be 
expressed in terms of a single parameter, the Limiting Aggregation Parameter 
(LAP). In addition, the fraction of aggregated protein (aggregated protein/total 
protein synthesized) is also thermo/kinetically limited (Fig. 2.9B).  
 The fractions of both soluble (Fs) and aggregated (Fa) proteins are 
important in describing the behavior of aggregation-prone proteins. These 
quantities can be estimated by solving equations using three parameters: LFP, 
LMP, and LAP (Fig. 2.10). The best fits to the data are:  !! = 11  +  0.026  x  100.39xMin log10!!,log10!!-­‐0.07 +0.69xMin log10!!,log10!!+0.40 -­‐0.85xMin[log10!!,log10!!-­‐4.40   !! = 11  +  1600  x  10-­‐0.90xMin log10!!,log10!!-­‐0.03 -­‐0.48xMin log10!!,log10!!+0.77 +0.18xMin[log10!!,log10!!-­‐4.64  
  
 Fig. 2.10 shows the fraction of soluble and aggregated proteins as 
indicated by the points on the contour surfaces. The mostly soluble proteins (Fs 
~>.0.9, at lower-left-back) are with high LFP, low LMP, and low LAP. The mostly 
aggregated proteins (Fa ~>0.7, at upper-right-front) are with high LAP, high LMP, 
and low LFP. The mostly degraded proteins (Fa ~>0.1, at lower-right-front) are 
with high LMP, low LAP, and low LFP.   
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 Our collaborator, Evan T. Powers, performed the simulations that I just 
discussed in this section. He extended my initial observations, which were based 
on FoldEco simulations (which will be discussed briefly in section 2.2.3) and wet 
lab experiments that I had performed. 
 
2.2.2 Investigating the effects of biophysical properties on protein folding 
fates and testing FoldEco predictions using wet lab experiments  
 To determine the effects of biophysical properties on protein folding fates 
and to test for thermo-kinetic limiting behavior in vivo under adapted-basal PN 
condition, we expressed CRABP1 variants with different biophysical properties in 
E. coli. It is assumed that mutations affect folding parameters (kf and Kf) more 
than misfolding (km and Km) or aggregation (ka and Ka) parameters. Mutations 
can affect aggregation propensities, but the native state should be more sensitive 
to changes in amino acids. The variants that were used were WT*, M9A, V67A, 
L118V, and Y133S (Fig. 2.2). Their folding parameters were shown on Table 2.1. 
  
2.2.2.1 The folding fates of CRABP1(M9A), CRABP1(V67A), and 
CRABP1(L118V) are similar to CRABP1(WT*) while the folding fate of 
CRABP1(Y133S) is different from the others 
 To determine the folding fates of different CRABP1 variants under the 
adapted-basal PN of E. coli, the variants were expressed in E. coli K12 HMS174 
(DE3) cells by induction of plasmid under the control of a T7 promoter with 
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isopropyl β-D-1-thiogalactopyranoside (IPTG) for 1, 2, and 3 h at 30 °C. Cells 
were lysed and partitioned into total, soluble and aggregated fractions. Soluble 
(i.e. supernatant) and aggregated (i.e. pellet) fractions were separated by 
centrifugation. Fractions were run on SDS-PAGE and analyzed through 
quantitative Coomassie staining. In the wet lab experiments, “folding fate” is 
determined by quantitating the total, soluble, and aggregated proteins. These are 
the existing proteins after 1, 2, and 3 h of protein expression. It is assumed that 
soluble proteins are natively folded proteins and may also include unfolded or 
misfolded proteins that are free or bound to chaperones. It is also assumed that 
the pellet consists of the aggregated proteins. Absolute amount of proteins were 
quantitated by using a standard curve constructed with purified recombinant 
protein (Fig. A.4; Methods).  
 Fig. 2.11 A-C shows the gel for Coomassie blue stain for the expression of 
CRABP1(WT*), and graphs for cytoplasmic concentration and fraction of soluble 
and aggregated proteins at different induction times. The total protein 
concentrations increased with longer induction times: 95 ± 15 μM, 202 ± 25 μM, 
and 275 ± 28 μM after 1, 2, and 3 h of induction, respectively. The soluble protein 
concentrations were also increasing: 95 ± 15 μM, 192 ± 22 μM, and 251 ± 19 μM 
after 1, 2, and 3 h of induction, respectively. Furthermore, the aggregated protein 
concentrations were increasing: 0 ± 0, 10 ± 5 μM, and 24 ± 9 μM after 1, 2, and 3 
h of induction, respectively. The proteins were not aggregated after 1 h of 
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induction. At 2 h, the proteins were 5% ± 2% aggregated. After 3 h, the proteins 
were 8% ± 3% aggregated (Table A.2).   
 Fig. 2.12 A-C shows the Coomassie blue stain for the expression of 
CRABP1(M9A), its cytoplasmic concentration, and fraction of soluble and 
aggregated proteins at different induction times. The levels of total, soluble, and 
aggregated proteins increased with longer induction times. The levels of total 
protein were: 115 ± 17 μM, 202 ± 27 μM, and 281 ± 36 μM after 1, 2, and 3 h of 
induction, respectively. The levels of soluble protein were:  111 ± 14 μM, 189 ± 
24 μM, and 240 ± 29 μM after 1, 2, and 3 h of induction, respectively. In addition, 
the levels of aggregated proteins were: 4 ± 4 μM, 13 ± 3 μM and 41 ± 6 μM after 
1, 2, and 3 h of induction, respectively. At 1 h, the proteins were 3% ± 3% 
aggregated, at 2 h, 6% ± 1%, and at 3 h, 15% ± 0% (Table A.2). 
 Fig. 2.13 A-C shows the Coomassie blue stain for the expression of 
CRABP1(V67A), its cytoplasmic concentration, and fraction of soluble and 
aggregated proteins at different induction times. The concentrations of total 
protein were: 125 ± 5 μM, 189 ± 11 μM, and 294 ± 32 μM after 1, 2, and 3 h of 
induction, respectively. The soluble protein concentrations were:  108 ± 6 μM, 
159 ± 11 μM, and 240 ± 27 μM after 1, 2, and 3 h of induction, respectively. The 
aggregated protein concentrations were: 17 ± 2 μM, 30 ± 5 μM, and 54 ± 5 μM 
after 1, 2, and 3 h of induction, respectively. The fractions of aggregated proteins 
were 14% ± 2% at 1 h of induction, 16% ± 2% at 2 h, and 18% ± 0% at 3 h (Table 
A.2).  
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 Fig. 2.14 A-C shows the Coomassie blue stain for the expression of 
CRABP1(L118V), its cytoplasmic concentration, and fraction of soluble and 
aggregated proteins at different induction times. The [total protein] were: 94 ± 11 
μM, 182 ± 44 μM, and 257 ± 86 μM after 1, 2, and 3 h of induction, respectively. 
The [soluble protein] were:  82 ± 5 μM, 156 ± 35 μM, and 212 ± 64 μM after 1, 2, 
and 3 h of induction, respectively. The [aggregated protein] were: 12 ± 7 μM, 26 
± 13 μM, and 45 ± 23 μM after 1, 2, and 3 h of induction, respectively. The 
fractions of aggregated proteins were 12% ± 6% at 1 h induction, 13% ± 7% at 2 
h, and 16% ± 5% at 3 h (Table A.2).  
 Fig. 2.15 A-C shows the Coomassie blue stain for the expression of 
CRABP1(Y133S), its cytoplasmic concentration, and fraction of soluble and 
aggregated proteins at different induction times. The total, soluble, and 
aggregated protein concentrations increased with longer induction times. The 
total protein concentrations were: 67 ± 5 μM, 109 ± 13 μM, and 125 ± 25 μM 
after 1, 2, and 3 h of induction, respectively. The soluble protein concentrations 
were:  22 ± 1 μM, 34 ± 2 μM, and 35 ± 7 μM after 1, 2, and 3 h of induction, 
respectively. The aggregated protein concentrations were: 45 ± 4, 75 ± 12 μM, 
and 90 ± 18 μM after 1, 2, and 3 h of induction, respectively. The fractions of 
aggregated proteins were 67% ± 1 % at 1h, 68% ± 3% at 2 h, and 72 % ± 2% at 
3 h (Table A.2).  
 Results showed that M9A, L118V, V67A behaved similarly to WT*. They 
were mostly soluble (> ~82%) after 1, 2, and 3 h of induction. The levels of 
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chaperones and degradation enzymes of the PN are sufficient to aid their folding. 
By contrast, Y133S is very prone to aggregation. It aggregated ~70% starting at 
1 h. Thus, the levels of the PN are insufficient to aid its folding.    
 
2.2.2.1.1 Low levels of total protein for Y133S is due to the presence of Lon  
 The total protein concentration for Y133S is much lower than that of the 
WT* (Table A.2). What accounts for this? There are two possible reasons: 1) Lon 
degradation of unfolded or misfolded states of CRABP1(Y133S) (assuming that 
the synthesis rates for CRABP1(WT*) and CRABP1(Y133S) are similar), or 2) 
the synthesis rate for CRABP1(Y133S) is slower than that of CRABP1(WT*). The 
first possibility was tested. To determine the effect of Lon on the total protein, 
CRABP1(Y133S) and CRABP1(WT*) were expressed in Δlon E. coli K12 
HMS174(DE3) cells after 0.5, 1, and 2 h. Results showed that both 
CRABP1(WT*) and CRABP1(Y133S) had more total protein in Δlon cells than in 
cells with Lon (Fig. A.2). For CRABP1(Y133S), in –Lon cells, the [total protein] 
was 98 ± 7 μM, 201 ± 30 μM, 415 ± 36 μM, at 0.5, 1, and 2 h, respectively. By 
contrast, in +Lon cells, it was 37 ± 9 μM, 67 ± 6 μM, 155 ± 14 μM at 0.5, 1 and 2 
h, respectively. The concentrations were reduced by a factor of three; 2/3 of the 
total protein synthesized was degraded. For CRABP1(WT*), ~1/3 of the total 
protein synthesized was degraded. The total protein concentrations for Y133S 
and WT* in –Lon cells were similar. 
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2.2.2.2 Experimental data are consistent with computational expectations 	   We assess the predictions in the preceding section in the light of our 
experimental data. Table 2.2 shows the biophysical properties of the CRABP1 
variants and their folding fates after 3 h of protein induction. According to the 
FoldEco results, all CRABP1 variants should be kinetically limited (LFP = kf) due 
to their high Kf. This is consistent with the results from experiments. 
CRABP1(WT*), CRABP1(M9A), CRABP1(V67A), and CRABP1(L118V) had 
similar levels of total protein with 275 μM, 281 μM, 294 μM, and 257 μM, 
respectively, and degraded protein with 130 μM, 124 μM, 111 μM, and 148 μM, 
respectively (assuming, in each case, that the total amount of protein synthesized 
was 405 μM). The folding fates of these four proteins are not very different from 
each other because their kf does not change much (changes only by a factor of 
2.5) despite the variation in their Kf (changes by 2.5 orders of magnitude). 
CRABP1(Y133S) behaves differently because its kf is an order of magnitude (10-
fold) lower than that of CRABP1(WT*). This behavior is consistent with what we 
expect for a thermo/kinetically limited system. Unfortunately, the LMP and LAP 
are not known. 
 Using FoldEco, the known folding properties were combined with the 
known in vivo folding fates in order to semi-quantitatively localize the LMP and 
LAP. A graphical example of combinations of parameters for CRABP1(WT*) is 
shown in Fig. 2.16A. Given the fraction soluble (0.63), the fraction aggregated 
(0.06) and the LFP (0.77), the LMP and LAP can be estimated. Thus, the 
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biophysical properties of CRABP1 variants in terms of its thermo-kinetically 
limited parameters can be localized. The LFP, LMP, and LAP values for the 
CRABP1 variants are shown (Fig. 2.16B). For WT*, LFP is the kf, which means 
that kf is limiting. The LMP (3.4) is either km or Km, and the LAP (90) is either ka or 
Ka, depending on the limiting factor. This is also true for the other variants. Using 
this method we can also deduce that in addition to Y133S folding the slowest 
among the CRABP1 variants, it also has the highest misfolding propensity (Fig. 
2.16B).  
 
2.2.3 Preliminary analyses of the effects of biophysical properties on 
folding fates of proteins using FoldEco 
 Here, I discuss my preliminary analyses on the effects of biophysical 
properties on protein folding fates using FoldEco.  
 To determine how biophysical properties of proteins affect their folding 
fates, I used CRABP1 variants (as discussed earlier) with known folding 
parameters (kf and Kf) from in vitro measurements (Table 2.1) but unknown 
misfolding (km and Km) and aggregation (ka and Ka) parameters. Different 
combinations of the six parameters (kf, Kf, km, Km, ka, Ka) were run in FoldEco. 
The combinations include estimates for the upper (“high”) and lower (“low”) 
bounds for misfolding and aggregation parameters; the corresponding 
parameters for a real protein may be within the range. For each variant, the km 
(low) is 10-fold lower than kf and km (high) is 10-fold higher than kf; Km (low) is 0.3 
and Km (high) is 30; ka (low) is 0.3 and ka (high) is 30; Ka (low) is 1 and Ka (high) 
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is 1000. There were 64 different combinations that were run, under the basal PN 
condition for 1, 2, 3 h of protein expression. These combinations of parameters 
resulted to proteins (for all the variants) that were ~>98% soluble. These 
predictions were tested with wet lab experiments by expressing the variants in E. 
coli (as discussed in section 2.2.2.1). The FoldEco predictions were not 
consistent with the wet lab experiments, which means that none of the 
combinations of parameters are consistent with the behavior of the proteins.  
 I performed another set of FoldEco simulations, in which combinations of 
parameters were run (kf and Kf from in vitro measurements while km, Km, ka, and 
Ka are changed) until they matched the in vivo folding fates. Determining kf and 
Kf of a protein is relatively easy in vitro, however, determining km and Km are 
difficult. Thus, FoldEco is very useful in estimating such parameters. Simulations 
were run under the basal PN for 1, 2, and 3 h protein expression time. The 
effective parameters are shown in Table A.3. Fig. A.5-A.9 show the images from 
the simulations. On the image, the middle part shows where the fluxes of proteins 
from one state (or chaperone) to another are going. On the left is the time of 
simulation and % chaperone use. On the right is the total protein, % of ongoing 
degradation, and ATP use. On the bottom is the list of the concentrations of each 
species (either bound to chaperones or free) at a given time. Based on these 
results, each variant has distinct properties (i.e. unique combination of kf, Kf, km, 
Km, ka, and Ka). However, for each variant, the solution for each parameter is not 
unique (but there is only a defined range). For example, for M9A, the km can be 
10 or 20, and still gives the same result. It is also possible that the variants can 
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have similar Km or Ka (or probably even same km and ka). Despite the similarities, 
the combinations of the other folding, misfolding, and aggregation parameters 
make them unique. Further detailed investigation about the kinetic and 
thermodynamic properties of proteins should be done to have a full 
understanding about the influence of these properties to protein folding fates in 
vivo.  
 
2.3 Discussion 
 Our results show that a proteinʼs intrinsic biophysical properties, 
specifically, its kinetic and thermodynamic properties, determine protein folding 
fates in E. coli under the adapted-basal PN. 
 The schema that we used in FoldEco to describe how biophysical 
properties influence protein folding fates is fairly simplified (Fig. 2.3). Using this 
simple schema, we are able to determine that the folding fate of a protein is 
under a thermo/kinetic limitation (Fig. 2.5) Thermo/kinetic limitation indicates that 
the fraction of soluble protein depends on either the kinetics or thermodynamics, 
but (for the most part) not on both at the same time (as shown by the “L-shaped” 
contours). Three parameters dictate protein fates. Folding is limited by the 
Limiting Folding Parameter (LFP), misfolding by the Limiting Misfolding 
Parameter (LMP), and aggregation by the Limiting Aggregation Parameter (LAP). 
In the simulations, degradation rate was set as constant. Changing the 
degradation rate would give contours that are also “L-shaped”, but the positions 
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of the contours are different. They either “grow” or “shrink”; they “grow” if more 
fraction soluble, and “shrink” if less fraction soluble. More degradation would 
“shrink” the contours, while less degradation would “grow” the contours. 
Furthermore, increasing concentrations of chaperones (for example, KJE) may 
also “grow” the contours. The time of expression also affects the positions of 
contours; at earlier times (for example 1 and 2 h), the fraction soluble is higher, 
which means that the contours would be bigger.  
  Based on FoldEco runs, proteins are categorized into three cases: 1) 
those that do not misfold and do not aggregate, 2) those that misfold but do not 
aggregate, and 3) those that misfold and aggregate. In the first case, protein fate 
is either folded or degraded. Folding and degradation compete over the unfolded 
states (U). The partitioning between folding and degradation depends on the LFP 
(Fig. 2.4 and 2.5). In the second case, folding still competes with degradation, but 
degradation is increased because misfolded states (M) are prone to be degraded 
(Fig. 2.6). The fraction of soluble protein depends on both LFP and LMP (Fig. 
2.7). Only a few proteins (3% of all cases) are prone to aggregation and therefore 
fit into the third category, because aggregation requires very specific parameter 
combinations. Here, folding, degradation and aggregation all compete for U and 
M states. Native folding is decreased because more proteins are prone to both 
degradation and aggregation. The behavior of aggregation-prone proteins is fairly 
well described by just three parameters: LFP, LMP, and LAP (Fig. 2.10).  
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 The data from wet lab experiments done using five CRABP1 variants 
(WT*, M9A, V67A, L118V, and Y133S) with distinct kinetic and thermodynamic 
properties are broadly consistent with our computational expectations (Table 
2.2). At 3 h expression, the amounts of soluble protein are similar for WT*, M9A, 
V67A, and L118V due to their having similar kf values, despite the ~2.5 orders of 
magnitude differences in their Kf. However, further decreasing kf (by an order of 
magnitude relative to WT*) changes the fate of the Y133S variant from mostly 
soluble to mostly aggregated. This behavior reflects the thermo/kinetic limitation 
that we expect. The FoldEco simulations were done at 3 h expression, and since 
we have also experimental data for 1 and 2 h, simulations at these expression 
times can also be performed. We expect that thermo/kinetic limitation will also be 
observed at these time points.  
 In addition, we have used FoldEco to translate the behavior of proteins in 
vivo into information about their biophysical properties (Fig. 2.16). Given LFP and 
the in vivo folding fate data, LMP and LAP can be estimated.  
 Furthermore, based on the predictions, in general, aggregation of proteins 
under the basal PN of E. coli is only ~3%, which suggests that the PN is robust to 
most sets of protein folding and misfolding parameters and is capable of 
maintaining proteostasis. This result is also consistent with wet lab experiments, 
in which four out of five of the proteins under study are mostly soluble after 1, 2, 
and 3 h of induction (Fig. A.4-9). Here, the basal PN is sufficient to maintain more 
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soluble states and to minimize aggregation. Only Y133S aggregates significantly; 
the basal PN is insufficient to prevent its aggregation.  
 Moreover, the ranges of the values of kf (10-3 to 103 s-1) and Kf (102 to 108) 
in our simulations cover the folding rates (Zou et al., 2014) and equilibrium 
constants (Ghosh and Dill, 2010) of most proteins in the E. coli proteome, which 
suggest selective pressure and evolution have enabled the PN to handle proteins 
with different biophysical properties. 
 Overall, the simple schema that we use to describe what is happening is 
adequate to recapitulate the behaviors that we see. The fits are good and the 
correlations that are emerging explain a lot about the behavior of proteins in vivo. 
This suggests that the contributions of other chaperones, like HtpG (the E. coli 
Hsp90) and IbpA/IbpB in FoldEco, while probably important in some cases, can 
often be neglected. In addition, including on-pathway intermediates (I) in FoldEco 
likely would not offer first-order improvements in our results in most cases, 
although there almost certainly are some instances in which such intermediates 
are important.  
   
2.4 Conclusion 
 The use of an integrated computational and experimental approach has 
enabled us to investigate systematically the effects of the kinetic and 
thermodynamic properties of proteins on their folding fates. The folding fates of 
proteins are thermo/kinetically limited, based on their biophysical properties.  
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We were able to understand how proteins behave under one set of conditions, 
that is, the basal PN. Having an understanding about the intrinsic kinetic and 
thermodynamic properties of proteins, we can now change conditions and 
determine the sensitivity of different proteins under various PN conditions. This is 
the subject of the next chapter. 
 
2.5 Materials and Methods 
2.5.1 E. coli strains and plasmids 
 The E. coli strain, K12 HMS174(DE3) (Novagen) was used as the 
background strain in all the experiments. The Δlon K12 HMS174(DE3) (kindly 
provided by Kelly Lab), in which lon gene was deleted/replaced by a kanamycin-
resistant (KanR) cassette, was used for control experiments. The cells (K12 
HMS174(DE3)) that were used in the overexpression experiments were with a 
plasmid containing the DnaK/DnaJ/GrpE system (KJE) (chloramphenicol-
resistant) under a pBAD promoter. The KJE system was not induced in all the 
experiments; its expression was suppressed by adding 0.2% w/v D-glucose, 
which represses the arabinose operon (Tokuriki and Tawfik, 2009). This was the 
“adapted-basal” condition.  
 The murine CRABP1 was used as a model protein. A variant with an N-
terminal (His)10-tag and with R131Q mutation to stabilize the protein (Clark et al., 
1998). Here, it is referred to as WT*. WT* was used as the template for the other 
CRABP1 variants (M9A, V67A, L118V, and Y133S) (Budyak et al., 2013). 
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CRABP1 was inserted into pET16b vector (ampicillin-resistant) under a T7 
promoter. 
 
 2.5.2 Protein expression in E. coli 
  Bacterial transformations with the pET16b (with CRABP1) were done on 
Luria-Bertani (LB) plates. Bacterial cultures were grown in LB with ampicillin (100 
μg/mL) and chloramphenicol (34 μg/mL) at 30 °C until OD600 was ~0.4. Glucose 
(0.2% w/v) was added to suppress KJE expression. After 1 h, CRABP1 
expression was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) for 1, 2, and 3 h. Cells were harvested by centrifugation for 15 min. Cells 
were lysed by resuspending with Bacterial Protein Extraction Reagent (BPER-II) 
(ThermoFisher Scientific), lysozyme (0.05 mg/mL) and DNase I (1 μg/mL). Cell 
lysates were incubated at room temperature for ~15-30 min. A fraction of the 
lysate was transferred to one tube (this was the “T”-total lysate). An equal 
amount of volume of the lysate was transferred to another tube, which was then 
centrifuged at 13,500xg for 10 min at 4 °C to partition the supernatant from the 
pellet. The supernatant was collected as soluble (“S”) while the pellet as 
aggregated (“A”). The pellet was resuspended with the same volume of buffer. 
Gel loading buffer was added to each sample. Samples were boiled for 10 min. 
Samples were loaded on a 15% glycine gel, and were run on sodium dodecyl 
sulfate-polyacrylamide agarose gel electrophoresis (SDS-PAGE). Proteins were 
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detected by Coomassie blue staining and imaged with Odyssey Infrared Imaging 
System (Li-COR Biosciences).  
 The wild-type CRABP1 (WT*) and another variant CRABP1(Y133S) were 
also expressed in Δlon cells (-Lon) to determine the typical protein expression in 
E. coli (without degradation by Lon). Cells were grown in LB with ampicillin (100 
μg/mL) at 30 °C until OD600 was ~0.7 (same OD600 when CRABP1 was induced 
in cells with KJE plasmid described above). CRABP1 (WT* or Y133S) expression 
was induced with 0.5 mM IPTG for 0.5, 1, and 2 h. Another set of experiment with 
+Lon cells (K12 HMS174(DE3)) was run in parallel in order to compare folding 
fates in –Lon and +Lon cells. 
 
2.5.3 Quantitative Coomassie blue staining and Western blotting 
 For the quantitation, recombinant CRABP1 purified proteins with known 
amounts (pmol) were used as standards. These were also loaded on the same 
gel where the samples of unknown amounts were loaded. Each volume of 
sample loaded corresponded to 1x108 cells, which is equivalent to 1 mL of 
bacteria with OD600 ~0.1. After running samples and detecting them with 
Coomassie staining, they were imaged using Li-COR. A standard curve was 
generated based on the known amounts of proteins, and the value of the 
unknown was determined by extrapolation (Fig. A.4). The concentration of 
samples was calculated by dividing the amount of protein (mole) by the volume of 
cell cytoplasm (L). It is assumed that for E. coli grown in LB, the total cell volume 
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is 2.9 μL per mL of cells per OD600 unit (Volkmer and Heinemann, 2011). 
Subtracting the periplasm, which is ~10% of the cell volume, the volume of cell 
cytoplasm is 2.6 μL per mL per OD600.  
 Western blotting was performed to detect and confirm the presence of 
CRABP1 in the samples. The primary antibody used was anti-CRABP1 (Abcam, 
monoclonal, mouse, 1:5000). The secondary antibody was Li-COR antibody, 
anti-mouse (emission at 800 nm, from Li-COR Biosciences). 
 The concentrations of total (T), soluble (S), and aggregated (A) protein 
and the fractions of soluble (fs) and fraction of aggregated (fa) protein that are 
existing after 1, 2, and 3 h were calculated as follows: [T] = [S] + [A], fs = [S]/[T], fa 
= [A]/[T]. The concentration of degraded protein was calculated by subtracting 
the total existing protein from the total synthesized protein after 1, 2, and 3 h, 
assuming that the total synthesized protein after 1 h is 135 μM, 2h is 270 μM, 
and 3 h is 405 μM. Note that the calculated concentration for total protein was the 
sum of the concentrations of soluble and aggregated protein, and not the 
concentration of the total lysate (“T”) run on the “T” lane on Coomassie stained-
gels or Western blots. The total lysate (“T”) lane was a control to check for mass 
balance; the sum of soluble and aggregated relative to the total lysate should be 
1. The mass balance was good in all samples; the difference of the 
concentrations of total lysate on “T” lane ([T]) from the total of soluble and 
aggregated ([S] + [A]) was less than 20%. This difference can be due to errors in 
resuspending and loading the samples. 
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2.5.4 Measurement of relative levels of PN components 
 A control, in which bacteria were transformed with an empty pET16b 
vector (without the CRABP1 gene), was also performed in parallel to the 
experiments described above (section 2.5.2). The total lysates (“T”) of each 
sample were run together with the control. Proteins were detected with 
Coomassie blue stains. Using the Li-COR imaging, the levels of DnaK, GroEL, 
and Lon under the “adapted-basal” conditions, in which heterologous CRABP1 
was expressed, were compared to those under the basal conditions, in which 
CRABP1 was not expressed.     
 Western blotting was also performed. The primary antibodies used were 
anti-DnaK (Enzo Life Sciences, monoclonal, mouse, 1:10000), anti-GroEL (Enzo 
Life Sciences, monoclonal, mouse, 1:2000), and anti-Lon (kindly provided by Prof. 
R. T. Sauer, 1:10000). The secondary antibodies were Li-COR antibodies 
(emission at 680 or 800 nm, from Li-COR Biosciences). 
 
2.5.5 FoldEco simulations 
 Evan T. Powers performed this set of FoldEco simulations. 
 FoldEco has many parameters to consider for a simulation. Most of the 
parameters, however, are independent of the nature of the protein substrate 
(Powers et al., 2012). For the simulations, FoldEco was run under conditions in 
which synthesis rate, initial concentrations of PN components, and folding 
energetics parameters, were adjustable. Synthesis rate was set to 135 μM h-1. 
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This was based on a typical protein expression in E. coli, which was determined 
by expressing CRABP1 in Δlon K12(DE3) cells (see section 2.5.2). The folding 
biophysical parameters comprised of folding rate and equilibrium constants (kf 
and Kf), misfolding rate and equilibrium constants (km and Km), and aggregation 
rate and equilibrium constants (ka and Ka). Combinations of these parameters 
were generated to cover the following ranges (that are physically reasonable): kf: 
10-3 to 103 s-1; Kf: 102 to 108; km: 10-3 to 103 s-1;  Km: 10-3 to 103; ka: 10-3 to 103 
μM-1 s-1; Ka: 10-3 to 103 μM-1. Each was varied in 10-fold steps to make 117,649 
(76) combinations. Degradation rate was set as constant. The model was solved 
for each set of parameters. The concentrations of soluble, aggregated, and 
degraded proteins were compared after 3 h (~405 μM of protein synthesized) as 
a function of their folding energetics. The concentration of soluble protein ([S]) 
was calculated as total protein synthesized minus aggregated ([T] – [A]). The 
concentration of degraded protein was total minus the sum of soluble and 
aggregated, [T] – ([S] + [A]).  
 In each case/observation, data were plotted using contour plots. The 
Limiting Folding Parameter (LFP) was determined by projecting points above the 
line of thermo-kinetic equivalence down to the kf axis and by projecting points 
below over to the Kf axis and then offset. This was also done with the Limiting 
Misfolding Parameter (LMP) for km and Km, and Limiting Aggregation Parameter 
(LAP) for ka and Ka. The data were fit and the best fit for fraction soluble was 
calculated.  
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2.5.5.1 Preliminary FoldEco simulations 
 I performed this set of FoldEco simulations. Different combinations of the 
six parameters (kf, Kf, km, Km, ka, Ka) were run through brute force. With known 
folding parameters (kf and Kf) from in vitro measurements (Table 2.1), estimates 
for the upper (“high”) and lower (“low”) bounds for misfolding and aggregation 
parameters were run; the corresponding parameters for a real protein may be 
within the range. For each variant, the km (low) was 10-fold lower than kf and km 
(high) was 10-fold higher than kf; Km (low) was 0.3 and Km (high) was 30; ka (low) 
was 0.3 and ka (high) was 30; Ka (low) was 1 and Ka (high) was 1000. There 
were 64 different combinations that were run, under basal PN condition for 1, 2, 3 
h of protein expression.  
 Another batch of FoldEco simulations were performed to translate the in 
vivo folding fate of proteins (from wet lab experiments) into information about 
their biophysical properties. Determining folding rate and folding equilibrium 
constants (kf, Kf) of a protein is relatively easy in vitro, however, determining 
misfolding rate and misfolding equilibrium constants (km, Km) are difficult. Thus, 
FoldEco is very useful in estimating such parameters. The kf and Kf were kept 
constant for each variant while the parameters to be estimated were km, Km, ka, 
and Ka. Simulations were run under basal PN for 1, 2, and 3 h protein expression 
time. FoldEco results were matched to the data from in vivo experiments through 
different combinations of the six parameters (kf, Kf, km, Km, ka, Ka). The synthesis 
rate used was 0.001 s-1, which is the rate constant when the ribosomes are 
translationally active (Powers et al., 2012). Other parameters were assigned 
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values based on literature. Degradation was by Lon; for Y133S, degradation 
equilibrium constant was higher (by a factor of 10) than that of the other variants 
to match the observation in vivo that more proteins were degraded for Y133S 
compared to the others. 
 
2.5.6 Protein sequences 
The sequences of CRABP1 variants are the following. The font in bold letter is 
the new residue from the mutation. 
R131Q CRABP1 (CRABP1-WT*) 
 
PNFAGTWKMR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKVGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDELIL TFGADDVVCT QIYVRE 
 
M9A/R131Q CRABP1 (CRABP1-M9A) 
 
PNFAGTWKAR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKVGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDELIL TFGADDVVCT QIYVRE 
 
V67A/R131Q CRABP1 (CRABP1-V67A) 
 
PNFAGTWKMR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKAGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDELIL TFGADDVVCT QIYVRE 
 
L118V/R131Q CRABP1 (CRABP1-L118V) 
 
PNFAGTWKMR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKVGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDEVIL TFGADDVVCT QIYVRE 
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Y133S/R131Q CRABP1 (CRABP1-Y133S): 
 
PNFAGTWKMR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKVGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDELIL TFGADDVVCT QISVRE 
 
2.5.7 Protein purification 
 CRABP1(WT*) and CRABP1(Y133S) were purified to use as protein 
standards for the quantitation of absolute concentrations of CRABP1 in the in 
vivo experiments, as well as for in vitro refolding/unfolding experiments. The 
other variants (M9A, V67A, and L118V) had already been purified and available 
to use (from (Budyak et al., 2013). CRABP1 was expressed in E. coli BL21DE3 
cells (Novagen) (carrying CRABP1 gene) by induction with 0.4 mM IPTG when 
OD600 was ~0.8, at 37 ºC for 4 h. In the case of Y133S, which tends to partition to 
the insoluble pellet fraction, in order to improve its solubility, when OD600 was 
~0.4, the temperature was decreased to 30 ºC and L-proline (20 mM) and NaCl 
(0.3 M) were added. Cells were grown at 30 ºC for 4 h. After the cells were lysed, 
proteins were purified from the soluble fraction by using Ni-NTA (Qiagen) affinity 
chromatography. The molar extinction coefficient that was used to determine 
protein concentration was ε280 = 20,970 M−1cm−1. The identity of variants was 
confirmed by electrospray ionization mass spectrometry of the purified proteins 
(Budyak et al., 2013). 
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2.5.8 Folding kinetics measurements 
 Refolding and unfolding kinetics for CRABP1(WT*) and CRABP1(Y133S) 
were performed as described (Budyak, et. al., 2013), with the modification of 
measuring kinetics at 30 ºC. Kinetics traces were averaged and fit to a 
multiexponential equation using Origin (OriginLab). 	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Figure 2.1 Schematic of kinetic partitioning during protein folding in vivo  
 
When an unfolded (U) polypeptide is synthesized from the ribosome (Synthesis), 
it can have different folding fates: It can fold into native (N), it can misfold (M), 
and if M self-associates, it can aggregate (A), or it can be degraded. The fate of 
the protein is dictated by its intrinsic biophysical properties (red text). In addition, 
the PN components modulate its fate in vivo. Kinetic partitioning affects folding. 
For example, In E. coli, GroEL and GroES (Hsp60/Hsp10) promote folding by 
encapsulating unfolded states and helping them fold to native. DnaK, DnaJ, and 
GrpE (Hsp70/Hsp40/Nucleotide exchange factor) rescue misfolded states by 
binding to M and helping them to become unfolded. ClpB and KJE collaborate to 
untangle and solubilize aggregates. (Reproduced from (Cho et al., 2015)). 
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Figure 2.2 Structure of murine CRABP1 (PDB 2CBR (Kleywegt et al., 1994)) 
 
Residues that are substituted are shown in spheres. The substitutions are: M9A, 
V67A, L118V, and Y133S. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
M9 
L118 
Y133 
V67 
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Table 2.1 Thermodynamic and kinetic parameters of CRABP1 variants 
measured in vitro  
A. The values were measured at 25 °C. (Table is modified from (Budyak et al., 
2013)). 
The ΔΔG°U-N is the energetic effect of the mutations of the unfolded state (U) with 
respect to the native state (N). ΔΔG°U-N  = ΔG°U-N WT - ΔG°U-N mut, ΔG°U-N WT = 
10.0 ± 0.2 kcal/mol.  
The kf and kU values were converted from ln values determined from in vitro 
experiments at 25 °C. The Kf values were converted from ΔG°. 
aThe kf for Y133S at 25 °C was extrapolated from the measured value at 30 °C.  
B. The kf values for WT* and Y133S measured in vitro at 30 °C. Y133S folds 10-
fold slower than WT*. It unfolds 4-fold faster than WT*. 	  	   	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
CRABP1 
variants 
ΔΔG°U-N 
(kcal/mol) kf (s
-1) ku (s-1) Kf 
WT* -- 0.77 1.67 x 10-5 2.17 x 107 
M9A -1.8 ± 0.2 0.31 1.01 x 10-5 1.04 x 106 
V67A -3.3 ± 0.2 0.57 1.50 x 10-3 8.23 x 104 
L118V -2.3 ± 0.4 0.41 5.02 x 10-5 4.45 x 105 
Y133S -4.8 ± 0.2 0.08a 8.96 x 10-5 6.53 x 103 
CRABP1 
variants kf (s
-1) ku (s-1) 
WT* 3.0 ± 0 1.04 x 10-4 ± 0.119 x 10-4 
Y133S 0.32 ± 0.04 4.32 x 10-4 ± 1.79 x 10-4 
A. 
B. 
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Figure 2.3 Parameters and conditions used in FoldEco simulations 
 
The synthesis rate was set to 135 μM h-1 (a typical protein expression in E. coli). 
Combinations of folding, misfolding, and aggregation parameters were generated. 
The initial concentrations for the chaperones and degradation enzymes were 
their levels in the “adapted-basal” PN (Cho et al., 2015). Degradation rate was 
set as constant. The concentrations of soluble, aggregated, and degraded 
proteins were compared after 3 h as a function of their intrinsic biophysical 
properties. Soluble proteins include proteins that are natively folded (N) and 
those unfolded (U) and misfolded (M) proteins that are bound to chaperones 
making them soluble. Aggregated proteins (A) consist of proteins that are 
insoluble. Degraded proteins are from U and M states.  
 	  	  	  	  	  	  	  	  	  	  
135 µM h-1 
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Figure 2.4 Fraction soluble vs. kf and Kf of proteins that do not misfold and 
do not aggregate 
 
A. Schematic of the partitioning between folding and degradation for proteins that 
do not misfold and do not aggregate B. and C. L-shaped contour plots showing 
that the fraction of soluble protein depends on kf and Kf but (most of the time) not 
on both parameters. Example of the dependency of fraction of soluble protein to 
kf or Kf is shown in C.  
A. 
B. 
C. B. 
135 µM h-1 
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A. 
B. 
C. 
 96 
Figure 2.5 Fraction of soluble protein vs. kf (at high Kf) and Kf (at high kf)  
 
Fraction of soluble protein vs. kf or Kf (A) in separate plots. When plotted in one 
graph (B), the equilibrium constant needs to be offset by ~4.5 to 4.6 log units to 
match the rate constant. C. Line of thermo-kinetic crossover on the contour plot. 
Above the line, fraction soluble depends on kf alone, and below the line the 
fraction soluble depends on Kf alone. Along the line, fraction soluble depends on 
both kf and Kf. 	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Figure 2.6 Comparison of fraction soluble vs. kf and Kf of proteins that do 
not misfold and those that misfold, but no aggregation 
 
A. Schematic for proteins that misfold but do not aggregate. B. The fraction of 
soluble protein for proteins that have higher propensity to misfold (km = 100 s−1 
and Km = 100) (right) is lower compared to those that do not misfold (km < 0.1 s−1 
and Km < 1) (left) at any given pair of kf and Kf.  
 	  
A. 
B. 
B. 
135 µM h-1 
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Figure 2.7 Effect of misfolding, but no aggregation 
 
A. Misfolding penalty vs. km and Km. B. The fraction of soluble protein depends 
on Limiting Folding Parameter (LFP) and Limiting Misfolding Parameter (LMP).  
 	  	  	  
A. 
B. 
LF
P 
LMP 
Fraction 
soluble  
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Figure 2.8 Comparison of fraction soluble vs. kf and Kf of proteins that 
misfold and do not aggregate and those that misfold and aggregate 
 
A. Schematic for proteins that misfold and aggregate. B. The fraction of soluble 
protein for proteins that have higher propensity to aggregate is lower (right) 
compared to those that do not aggregate (left) at any given pair of kf and Kf.  
 
  
A. 
B. 
135 µM h-1 
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Figure 2.9 Effect of aggregation 
 
A. Aggregation penalty vs. ka and Ka. B. Fraction aggregated vs. ka and Ka  	  	  	  
A. 
B. 
Aggregation rate constant (ka; µM-1 s-1) 
Aggregation rate constant (ka; µM-1 s-1) 
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Figure 2.10 The behavior of aggregation-prone proteins  
 
The behavior of aggregation-prone proteins as described by Least Folding 
Parameter (LFP), Least Misfolding Parameter (LMP), and Least Aggregation 
Parameter (LAP). Points on the contour surfaces give the indicated fraction of 
soluble or aggregated protein. 	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P 
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Figure 2.11 Folding fate of CRABP1(WT*) upon expression in E. coli under 
adapted-basal conditions 
A. Coomassie blue stain for CRABP1(WT*) induced with 0.5 mM IPTG for 1, 2 
and 3 h at 30 °C. B. Cytoplasmic concentration of CRABP1(WT*). C. Fraction of 
soluble and aggregated proteins. 
 
A. 
B. 
C. 
                              1 h                    2 h                     3 h        
                       T     S     A       T     S     A        T      S      A     
CRABP1 
 T: total, S: soluble, A: aggregated 
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Figure 2.12 Folding fate of CRABP1(M9A) upon expression in E. coli under 
adapted-basal conditions 
A. Coomassie blue stain for CRABP1(M9A) induced with 0.5 mM IPTG for 1, 2, 
and 3 h at 30 °C. B. Cytoplasmic concentration of CRABP1(M9A). C. Fraction of 
soluble and aggregated proteins 
                              1 h                    2 h                  3 h        
                       T     S     A       T     S     A       T     S     A     
CRABP1 
A. 
B. 
C. 
 T: total, S: soluble, A: aggregated 
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Figure 2.13 Folding fate of CRABP1(V67A) upon expression in E. coli under 
adapted-basal conditions 
A. Coomassie blue stain for CRABP1(V67A) induced with 0.5 mM IPTG for 1, 2, 
and 3 h at 30 °C. B. Cytoplasmic concentration of CRABP1(V67A). C. Fraction of 
soluble and aggregated protein 
                              1 h                    2 h                  3 h        
                       T     S     A       T     S     A        T      S      A     
CRABP1 
A.
B. 
C. 
 T: total, S: soluble, A: aggregated 
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Figure 2.14 Folding fate of CRABP1(L118V) upon expression in E. coli 
under adapted-basal conditions 
A. Coomassie blue stain for CRABP1(L118V) induced with 0.5 mM IPTG for 1, 2, 
and 3 h at 30 °C. B. Cytoplasmic concentration of CRABP1(L118V). C. Fraction 
of soluble and aggregated proteins. 
                          1 h                   2 h                   3 h        
             T     S      P    T      S      P      T     S      P            
CRABP1 
B. 
C. 
A. 
 T: total, S: soluble, A: aggregated 
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Figure 2.15 Folding fate of CRABP1(Y133S) upon expression in E. coli 
under adapted-basal conditions 
A. Coomassie blue stain for CRABP1(Y133S) induced with 0.5 mM IPTG for 1, 2, 
and 3 h 30 °C. B. Cytoplasmic concentration of CRABP1(Y133S). C. Fraction of 
soluble and aggregated proteins. 
                          1 h                   2 h                   3 h        
             T     S      P    T      S      P      T     S      P            
CRABP1 
A. 
B. 
C. 
 T: total, S: soluble, A: aggregated 
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Table 2.2 Biophysical properties of CRABP1 variants and their folding fates 
in E. coli after 3 h of protein expression under the adapted-basal PN 
condition 
*Total protein- This is the total existing protein (not total protein synthesized). 
**Based on control experiments with CRABP1(WT*) expressed in Δlon E. coli 
K12 cells, in which ~1/3 of the protein that is synthesized is degraded. The total 
amount of protein synthesized is ~405 μM in all cases. 	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
CRABP1 
Variant 
kf 
(s−1) Kf LFP 
Total  
Protein* 
(μM) 
Aggregated 
protein 
(μM) 
Degraded 
protein** 
(μM) 
WT* 0.77 2.2 × 107 0.77 275 μM 24 μM 130 μM 
M9A 0.31 1.0 × 106 0.31 281 μM 41 μM 124 μM 
V67A 0.57 8.2 × 104 0.57 294 μM 54 μM 111 μM 
L118V 0.41 4.4 × 105 0.41 257 μM 45 μM 148 μM 
Y133S 0.08 6.5 × 103 0.08 125 μM 90 μM 280 μM 
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Figure 2.16 Biophysical properties of CRABP1 variants in terms of thermo-
kinetically limited parameters 
 
A. Graph for CRABP1 biophysical properties. Shown is an example for WT*.  
B. Table for the thermo-kinetically limited parameters of CRABP1. 	  	  	  	   	  
CRABP1 
Variant LFP LMP LAP 
WT* 0.77 3.4 90 
M9A 0.31 0.6 360 
V67A 0.57 1.2 400 
L118V 0.41 1.7 250 
Y133S 0.08 10.9 170 
LM
P 
LFP 
LA
P 
A. 
B. 
LFP = 0.77 
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CHAPTER 3 
DISSECTING THE IMPACT OF THE PROTEOSTASIS NETWORK  
ON PROTEIN FOLDING FATE  
 
Parts of this chapter are the result of collaboration with Younhee Cho, Xin Zhang, 
Yu Liu, David L. Powers, Jeffery W. Kelly, Evan T. Powers and Lila M. Gierasch 
(Cho, Y., Zhang, X., Pobre, K.F., Liu, Y., Powers, D.L., Kelly, J.W., Gierasch, 
L.M., and Powers, E.T. (2015). Individual and collective contributions of 
chaperoning and degradation to protein homeostasis in E. coli. Cell Rep 11, 321-
333. (Publication 1)). 
 
 This chapter investigates the impact of different components of the PN on 
the folding fates of unstable and aggregation-prone variants of our model 
proteins: 1) cellular retinoic acid-binding protein-1 (CRABP1) expressed at 
different times, and 2) dihydrofolate reductase (DHFR), and retroaldolase (RA) 
expressed for 2 h. It also discusses the use of two quantitative models, a 
phenomenological model and FoldEco, to understand how PN components 
contribute to proteostasis and how their contributions differ depending on the 
substrateʼs biophysical properties.  
 
3.1 Introduction 
 A proteinʼs intrinsic biophysical properties and the cellular proteostasis 
network (PN) dictate the folding fate of a protein inside the cell (Cho et al., 2015) 
(as discussed in Chapters 1 and 2) (Fig. 1.11). In Chapter 2, we have examined 
about how the intrinsic biophysical properties, particularly kinetic and 
thermodynamic properties of proteins, influence protein folding fate under the 
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adapted-basal PN condition. Here, in Chapter 3, we now dissect the impact of 
different PN components on the folding fate of a protein.  
 The cellular PN, consisting of various processes (such as protein 
synthesis and folding, chaperone interactions, and degradation) and different 
components (molecular chaperones and degradation enzymes), collaborates to 
maintain proteostasis (Balch et al., 2008; Cho et al., 2015; Powers et al., 2009). 
The levels of PN components are well controlled inside the cell. For example, in 
E. coli, some components are regulated by the σ32 transcription factor (Zhang et 
al., 2014). The concentrations of PN components during normal conditions are 
different from those under stressed conditions. During normal conditions, for 
example in E. coli, DnaK is an abundant protein (~10000 copies) (Genevaux et 
al., 2007), and its monomer concentration is 30 μM (Powers et al., 2012) (Table 
1.1). The concentration of DnaK is high relative to those of DnaJ (1 μM) and 
GrpE (15 μM) (Table 1.1). The ClpB concentration is also low relative to DnaK. 
GroEL and GroES are present at similar levels (Lu et al., 2007; Powers et al., 
2012). During stress, such as heat, normal levels of the PN components are 
insufficient. The concentration of σ32 is increased at high temperatures, causing 
the up-regulation of chaperones and degradation enzymes (that are under its 
regulon) (Guisbert et al., 2008; Yura et al., 2007; Zhang et al., 2014). Increasing 
the levels of PN components enhances proteostasis capacity (Lindquist, 1986; 
Zhang et al., 2014) (see section 1.11, Fig. 1.10). Furthermore, increasing the 
levels of chaperones improves the yields of soluble proteins of overexpressed 
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heterologous proteins in E. coli (de Marco, 2007; de Marco et al., 2007; Makino 
et al., 2011; Zhang et al., 2014). The σ32 is present at low levels and is inactive at 
low temperatures, as well as when FtsH (with the help of other chaperones) 
degrades it. It is also inactivated when free DnaK/DnaJ and GroEL/GroES bind to 
it (Guisbert et al., 2008). Under this condition, the concentrations of PN 
components are present at their normal levels.  
 Although extensive research has been carried out on the main functions of 
individual PN components, the mechanism by which these components function 
as a whole has not been clear (Dickson and Brooks, 2013; Kim et al., 2013; 
Powers et al., 2012). How does the PN, consisting of molecular chaperones and 
degradation enzymes, modulate the folding fate of proteins with different intrinsic 
biophysical properties? Which molecular chaperones and/or degradation 
enzymes affect the folding fate of a model protein? We hypothesized that 
molecular chaperones and degradation enzymes modulate the folding fate of a 
protein by working together to maintain proteostasis. The sensitivity of a protein 
to a particular chaperone or degradation enzyme depends on the proteinʼs 
intrinsic biophysical properties, and on the concentrations of the protein and 
chaperones and degradation enzymes at any given time. We used an integrated 
computational and experimental approach to address the questions presented 
above. 
 We explored the impact of different PN components on the folding fates of 
model proteins with low stabilities and high aggregation propensities because 
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these proteins challenge proteostasis capacity (Gidalevitz et al., 2006; Olzscha et 
al., 2011). We expressed model proteins in E. coli cells and determined their 
folding fates in vivo under varying PN components. We then used FoldEco to 
estimate the biophysical properties of the model proteins based on their in vivo 
folding fates. In our study, protein “folding fate” refers to the amount of existing 
total, soluble and aggregated proteins at any given synthesis rate and time. It is 
assumed that soluble proteins include proteins that are natively folded (N) and 
those unfolded (U) and misfolded (M) proteins that are free or bound to 
chaperones making them soluble. Aggregated proteins (A) consist of proteins 
that are not soluble.  
 Three model proteins were used. These were the unstable and 
aggregation-prone variants of murine cellular retinoic acid-binding protein 1 
(CRABP1), E. coli dihydrofolate reductase (EcDHFR) and a de novo designed 
retroaldolase enzyme (RA114.3) (Cho et al., 2015). These three proteins differ in 
ancestral origins (mammalian for CRABP1, endogenous E. coli for DHFR, and de 
novo designed for RA), folds (β barrel for CRABP1, αβα sandwich for DHFR, and 
α/β for RA) and sequences (no significant sequence similarity) (Cho et al., 2015). 
By using a diverse set of proteins, we hoped to understand more about the 
qualities of the PN as a system, and determine the key players for the different 
functions of the PN (Cho et al., 2015). I will focus my discussion on results using 
CRABP1 as a model, because this was the protein that my studies focused on. 
The other two proteins were primarily investigated by our collaborators, Younhee 
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Cho, Xin Zhang, and Yu Liu (Cho et al., 2015). The CRABP1 variant that was 
used in this study was CRABP1(Y133S) because it is the most destabilized, most 
aggregation-prone, and slowest folder among the CRABP1 variants (Fig. 2.2, Fig. 
2.15).  
 
3.2 Results 
 To recap, our data from Chapter 2 showed that CRABP1(Y133S) was 
mostly aggregated (~>70% aggregated) after 1, 2, and 3 h of expression (Fig. 
2.15) under the adapted-basal PN condition. The results suggest that the 
adapted-basal levels of chaperones and degradation enzymes are insufficient to 
prevent the aggregation of CRABP1(Y133S). Note that in our study, “adapted-
basal” PN refers to the condition of PN as a result of slight perturbations in the 
levels of PN components due to heterologous expression of proteins in E. coli (as 
discussed in Chapter 2, Fig. A.3).  
 
3.2.1 Enhancement of the whole proteostasis network (PN) through I54N 
σ32 overexpression reduces the fraction of aggregated protein  
 To assess the impact of the full PN on the folding fate of CRABP1(Y133S), 
the heat shock transcription factor, σ32, was co-expressed with CRABP1(Y133S) 
to up-regulate PN components that are under its regulon. The mutant I54N of σ32 
was used because this variant is not affected by post-translational regulation 
unlike the wild-type (Guisbert et al., 2008; Yura et al., 2007; Zhang et al., 2014).  
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The I54N σ32 and CRABP1(Y133S) were expressed on two different vectors and 
under the control of orthogonal promoters so that they could be induced 
independently. The I54N σ32 gene was introduced into pBAD vectors (Fig. B.1). 
The CRABP1(Y133S) gene was inserted into a pET vector. The expression of 
I54N σ32 for 1 h prior to expression of CRABP1(Y133S) for 2 h caused the major 
PN components to increase by ~3-fold compared to those in adapted-basal 
condition (Table B.1). The induction of the HSR through I54N σ32 expression was 
performed to ensure sufficiently high levels of KJE, GroELS, and Lon, and other 
PN components. Results showed that the up-regulation of the PN components 
through I54N σ32 overexpression virtually eliminated CRABP1(Y133S) 
aggregates (Fig. 3.1). The concentrations of total, soluble and aggregated protein 
were all decreased. The up-regulated PN through I54N σ32 overexpression had a 
beneficial effect on CRABP1(Y133S) (Fig. 3.1). 
 
3.2.2 Up-regulation of PN components decreases CRABP1(Y133S) 
aggregation to different extents  
 To dissect which components of the PN are responsible for the facilitation 
of folding and decrease in aggregation under the I54N σ32 overexpression 
condition, chaperones and/or degradation enzymes are overexpressed 
individually or in combinations. For individual up-regulation, the PN components 
and CRABP1(Y133S) were expressed on two different vectors and under the 
control of orthogonal promoters. The KJE system, GroELS system, Lon, TF, 
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HtpG, and IbpA/B were introduced into pBAD vectors (Fig. B.1). The 
CRABP1(Y133S) gene was inserted into a pET vector. In our experiments, the 
expression of PN components was induced with arabinose, and then after 1 h, 
CRABP1 was induced with IPTG for 2 h. Different concentrations of arabinose 
were added to up-regulate PN components. Furthermore, the combinations of 
KJE and GroELS (KJE+GroELS), KJE and Lon (KJE+Lon), GroELS and Lon 
(GroELS+Lon), KJE and HtpG (KJE+HtpG), KJE and ClpB (KJE+ClpB) were 
inserted into vectors controlled by two promoters for each pair: one was under an 
arabinose promoter and the other was under the tetracycline promoter (Fig. B.1). 
 
3.2.2.1 Up-regulation of KJE, GroELS, or Lon individually decreases 
CRABP1(Y133S) aggregation 
 To determine the effects of individual up-regulation of PN components on 
the folding fate of CRABP1(Y133S), individual components of KJE, GroELS, Lon, 
TF, HtpG, and IbpA/B were up-regulated by inducing each with appropriate 
concentrations of arabinose for 1 h, and then expressing CRABP1 for 2 h. The 
levels of PN components are controlled by the concentration of added arabinose. 
High concentration of arabinose is added to induce TF, HtpG and IbpA/B. High 
and low concentrations are added to induce KJE, GroELS, and Lon. There were 
two conditions for KJE (KJE-low and KJE-high), two for GroELS (GroELS-low 
and GroELS-high), and three for Lon (Lon-low, Lon-medium or Lon-med and Lon-
high). Higher arabinose concentrations were added in KJE-high, GroELS-high 
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and Lon-high, lower levels in KJE-low, GroELS-low, and Lon-low, and medium 
levels in Lon-med. The Lon-med condition was done because total protein in the 
Lon-high condition decreased drastically. The resulting concentrations of PN 
components were increased in these conditions compared to those under 
adapted-basal conditions (Table B.1, Fig. B.2). 
  Fig. 3.2 shows the representative gels and bar graphs for the folding fates 
of CRABP1(Y133S) after 2 h of expression under the conditions of adapted-basal 
PN and when individual components of the PN were up-regulated in E. coli cells. 
Under adapted-basal conditions, the concentration of total CRABP1 was 106 ± 5 
μM. The fraction of aggregated protein was 76% ± 1% aggregated (Fig. 3.2C) 
(Cho et al., 2015).  
 Up-regulation of KJE in KJE-high condition decreased the concentration of 
the total protein. The fraction aggregated also decreased (from 76% ± 1% to 46% 
± 5%), but aggregates were not eliminated (Fig. 3.2). In KJE-low, the 
concentrations of total protein and fraction aggregated also decreased, but to a 
lesser extent (Cho et al., 2015).  
 Up-regulation of GroELS under GroELS-high condition did not eliminate 
aggregates and had no significant effect on the fraction of aggregates (from 76 ± 
1% to 66 ± 11%) (Fig. 3.2C).  
 Up-regulation of Lon decreases total protein. Under Lon-low and Lon-med 
conditions, the concentration of aggregated protein was decreased (Fig. 3.2) 
while the concentration of soluble protein was not significantly affected. In Lon-
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high conditions, the concentration of total, soluble, and aggregated proteins were 
decreased drastically. The fraction of aggregated protein was decreased while 
the fraction of soluble protein was increased because of the ongoing degradation 
(Cho et al., 2015). 
 Up-regulation of TF, HtpG, and IbpA/B did not have a significant effect on 
the fraction of aggregated protein (data not shown). 
 
3.2.2.2 The beneficial effects of up-regulation of KJE, GroELS, and Lon in 
pairs is largely additive  
 To determine the effects of the pairwise up-regulation of PN components 
on the folding fate of CRABP1(Y133S), KJE+GroELS, KJE+Lon, GroELS+Lon, 
KJE+HtpG, KJE+ClpB were co-expressed with CRABP1 with the same method 
as described above except that high concentration of arabinose (0.2% (w/v) 
(similar concentration of arabinose for KJE-high, GroELS-high, and Lon-high) 
and 5 × 10−7% (w/v) (5 ng/mL) tetracycline were added. The levels of major 
chaperones were ~2- to 4- fold higher than those in adapted-basal condition 
(Table B.1). These levels were lower than when they were up-regulated on their 
own (see section 3.2.2.1; Table B.1). 
 Up-regulation of KJE+Lon and GroELS+Lon decreased the fraction of 
aggregated protein significantly, from 76 ± 1% to 19 ± 3% and 10 ± 5%, 
respectively (Fig. 3.3). The aggregated fraction was also decreased with 
KJE+GroELS but to a lesser extent, from 76 ± 1% to 54 ± 5%. KJE+Lon and 
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GroELS+Lon were the most effective pairs in decreasing aggregation (Cho et al., 
2015). The beneficial effects of KJE+GroELS, KJE+Lon, and GroELS+Lon are 
largely additive. For example in KJE+GroELS pair, it was mostly KJE that was 
helping in decreasing aggregation. 
 Both combinations of KJE+ClpB and KJE+HtpG decreased the fraction of 
aggregated protein similarly to when KJE was expressed alone even with low 
levels of KJE (in KJE-low) (see Fig. 3.2B-C and Fig. B.3). (Cho et al., 2015).  
 Together, these results indicate that KJE, GroELS, and Lon are primarily 
responsible for the observed effects of I54N σ32 overexpression. Moreover, the 
up-regulation of PN components through induction of heat shock response via 
σ32 overexpression enables the PN to prevent the aggregation of aggregation-
prone protein CRABP1(Y133S) even at high expression levels (Cho et al., 2015). 
 
3.2.3 Up-regulation of PN components decreases the aggregation of other 
model proteins (from work of Younhee Cho, Xin Zhang, Yu Liu) 
 As mentioned earlier, we wanted to understand about the qualities of the 
PN as a system, and determine the key players to the different functions of the 
PN. We then used a broad selection of proteins, including CRABP1(Y133S). With 
our collaborators, we studied two other proteins with low stabilities and high 
aggregation-propensities— an unstable variant of E. coli DHFR (m-EcDHFR with 
M42T/H114R mutation) and a de novo designed enzyme retroaldolase (m-RA114 
with E10K/D120V/N124S/L225P mutation). These variants were less stable than 
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their wild-type counterparts (Cho et al., 2015). We performed the same sets of 
experiments described above. We determined the folding fates of these model 
proteins upon expression in E. coli for 2 h at 30 °C under PN conditions similar to 
those used for CRABP1. I will discuss the results briefly.  
 Under adapted-basal conditions, the total protein concentrations for m-
EcDHFR and m-RA114 were 498 ± 58 μM and 385 ± 40 μM, respectively. The 
fractions of aggregated protein were 46 ± 3% and 86 ± 1% for m-EcDHFR and m-
RA114, respectively (data not shown, but in (Cho et al., 2015)). To determine the 
effect of up-regulation of the whole PN, we also overexpressed I54N σ32. Results 
showed that increased levels of PN components through I54N σ32 expression 
virtually eliminated aggregation of m-EcDHFR and m-RA114 (similar results for 
CRABP1(Y133S)) (Cho et al., 2015). 
 To investigate which chaperones and/or degradation enzymes are 
responsible for the observed effects, we overexpressed individual PN 
components, and in pairs (same PN components used in CRABP1(Y133S). Their  
levels were also those presented in Table B.1 and Fig. B.2. Results show that up-
regulation of KJE (in KJE-high condition) decreased the aggregated fraction of m-
EcDHFR significantly from 46 ± 3% to 25 ± 4% and from 86 ± 1% to 37 ± 3% for 
m-RA114. The total test protein concentrations also decreased by 30-40% (Cho 
et al., 2015). Up-regulation of GroELS (in GroELS-high condition) decreased the 
fraction of aggregated protein for both m-EcDHFR and m-RA114. The 
aggregated fractions decreased from 46 ± 3% to 22 ± 9% for m-EcDHFR and 
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from 86 ± 1% to 39 ± 3% for m-RA114 (Cho et al., 2015). The results were in 
contrast to those of CRABP1(Y133S) (Fig. 3.2). Furthermore, up-regulation of 
Lon decreased the levels of both the soluble and aggregated protein of m-
EcDHFR similarly. The decrease was larger for the aggregated fraction of m-
RA114 (similar to CRABP1(Y133S)). Moreover, the up-regulation of TF, HtpG, 
and IbpA/B had no significant effect on the fraction aggregated. The pairwise up-
regulation of GroELS+Lon and KJE+Lon decreased the fraction of aggregated 
protein for both m-EcDHFR and m-RA114, while the GroELS+KJE was less 
effective in suppressing aggregation (Cho et al., 2015). Furthermore, KJE+ClpB 
and KJE+HtpG had no significant effect on the fraction of aggregated protein. 
Overall, results showed that the major contributors of the effects we observed 
under the I54N σ32 were KJE, GroELS, and Lon.  
 
3.2.4 Low levels of expression of CRABP1(Y133S) 
 In section 3.2.2 we determined the effects of varying PN conditions on the 
folding fate of CRABP1(Y133S) expressed at 2 h. To assess the sensitivity of 
lower levels of CRABP1(Y133S) on increasing levels of PN components, 
CRABP1(Y133S) expression was induced for 1 h under adapted-basal and 
varying chaperone conditions. The same sets of experiments described above 
were performed except that the induction time was 1 h, in which total synthesized 
protein was half what it was after 2 h induction.  
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 Based on quantitative Western blotting, under adapted-basal conditions, 
the total protein concentration of CRABP1(Y133S) was 57 ± 4 μM (Fig. 3.4, 
Table B.2). The fraction of aggregated protein was 71% ± 4% aggregated (Fig. 
3.4C) (Cho et al., 2015).  
 The expression of I54N σ32 for 1 h prior to expression of CRABP1(Y133S) 
caused the major PN components to increase by ~2- to 3-fold compared to those 
in adapted-basal condition (Table. B.3, Fig. B.4). Results showed that the up-
regulation of the PN components through I54N σ32 overxpression eliminated 
CRABP1(Y133S) aggregates. Proteins are ~100% soluble; however, the 
concentrations of total, soluble and aggregated protein were all decreased (Fig. 
3.4, Table B.2). 
 To investigate which PN components are responsible for the observed 
effects, we up-regulated KJE, GroELS, and Lon individually and in pairs. We 
chose to up-regulate these three because our results from sections 3.2.1 and 
3.2.2 (Fig. 3.1-3, Fig. B.3) indicate that these were the major contributors of what 
we observed when I54N σ32 was expressed with CRABP1.  
 Individual up-regulation of KJE, GroELS, and Lon resulted to 
concentrations of major PN components (DnaK, GroEL, and Lon) to increase ~2- 
to 8- fold compared to those under adapted-basal condition (Table B.3).  
 Up-regulation of KJE under KJE-high condition decreased the 
concentrations of total, soluble and aggregated protein (35 ± 10 μM, 17 ± 5 μM, 
and 18 ± 5 μM, respectively) as well as fraction aggregated (50% ± 1% 
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aggregated) (Fig. 3.5, Table B.2) compared to those under adapted-basal 
conditions. The total protein decreased by ~40%. Under the KJE-low condition, 
the concentrations of total, soluble and aggregated protein (42 ± 10 μM, 16 ± 5 
μM, and 26 ± 6 μM, respectively) (Fig. 3.5B), and the fraction aggregated (62% ± 
2%) (Fig. 3.5C) were decreased, but proteins were mostly aggregated. The total 
protein decreased by ~30%.  
 Up-regulation of GroELS decreased the fraction of aggregated protein and 
increased the fraction of soluble protein compared to adapted-basal conditions. 
Under GroELS-high condition, the concentrations of total, soluble and aggregated 
proteins were 45 ± 9 μM, 35 ± 4 μM, and 10 ± 5 μM, respectively (Fig. 3.5B). The 
aggregated fraction decreased significantly from 71% ± 4% to 21% ± 6%, while 
increasing the fraction of soluble protein from 29% ± 4% to 79% ± 6% (Fig. 3.5C). 
The concentrations of total, soluble and aggregated proteins were 53 ± 4 μM, 26 
± 2 μM, and 27 ± 2 μM, respectively (Fig. 3.5B), and the aggregated fraction was 
51% ± 1% (Fig. 3.5C) under GroELS-low condition. These results were different 
from those when CRABP1(Y133S) was expressed for 2 h under GroELS-low and 
GroELS-high conditions (compare Fig. 3.2 and Fig. 3.5). The observed increase 
in the levels of soluble proteins and decrease in aggregated proteins could be 
due to misfolded or unfolded proteins being helped by GroELS to fold to their 
native states before they can aggregate. Further, the slight decrease in total 
protein could also be due to misfolded proteins being rescued and then are 
degraded before they can fold.  
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 Up-regulation of Lon decreased the levels of total protein, but increased 
the fraction of soluble and decreased fraction of aggregated proteins compared 
to those under the adapted-basal levels. Under Lon-low conditions, the 
concentrations of total, soluble and aggregated proteins were 25 ± 2 μM, 22 ± 1 
μM, and 3 ± 1 μM, respectively (Fig. 3.5B). The aggregated fraction decreased 
from 71% ± 4% to 13% ± 1% (Fig. 3.5C). The concentration of total protein was 
decreased by ~60%, the concentration of soluble protein was increased by ~30%, 
and the concentration of aggregated protein was decreased by ~90% (Fig. 3.5B, 
Table B.2). Under Lon-med conditions, the concentrations of total, soluble and 
aggregated proteins were 12 ± 1 μM, 11 ± 1 μM, and 1 μM, respectively. 
Aggregation was almost eliminated. The aggregated fraction decreased from 
71% ± 4% to 9% ± 1%. The total protein was decreased by ~80%. Under Lon-
high conditions, the concentrations of total, soluble and aggregated proteins were 
0.6 μM ± 0.2 μM, 0.6 μM ± 0.2 μM, and 0 μM, respectively. The aggregated 
proteins were virtually eliminated, but the total protein was very low. Apparently, 
the concentration of aggregated protein was greatly reduced under all Lon 
conditions while the concentration of soluble protein was not affected as much 
(except under Lon-high conditions when almost all proteins that were produced 
were degraded) (Fig. 3.2). The increase in the amount of soluble protein under 
Lon-low conditions could be due to the degradation of misfolded states, which 
leads to a decrease in the pool of M states that would otherwise saturate the 
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other PN components; thus, making the other PN components more efficient in 
helping the folding of other states to their native state.  
 Pairwise up-regulation increased the levels of major chaperones by ~2- to 
6- fold compared to those in adapted-basal condition (Table B.3, Fig. B.4), but 
lower than their levels when they were expressed individually.  Fig. 3.6 shows the 
representative gels and bar graphs for the quantitation of the absolute protein 
concentrations and the fraction of soluble and aggregated protein of 
CRABP1(Y133S) under the adapted-basal conditions and the pairwise up-
regulation of PN components. In KJE+GroELS condition, the concentrations of 
total, soluble and aggregated proteins were 41 ± 20 μM, 37 ± 17 μM, and 4 ± 3 
μM, respectively (Fig. 3.6B, Table B.2). The fraction of aggregated protein 
decreased from 71% ± 4% to 6% ± 4% (Fig. 3.6C). In the KJE+Lon condition, the 
concentrations of total, soluble and aggregated proteins were 43 ± 11 μM, 35 ± 7 
μM, and 8 ± 4 μM, respectively (Fig. 3.6B, Table B.2). The fraction of aggregated 
protein decreased from 71% ± 4% to 18% ± 4% (Fig. 3.6C). In GroELS+Lon, the 
concentrations of total, soluble and aggregated proteins were 54 ± 3 μM, 50 ± 2 
μM, and 4 ± 2 μM, respectively (Fig. 3.6B). The aggregated fraction decreased 
from 71% ± 4% to 8% ± 3% (Fig. 3.6C). All the pairwise conditions were efficient 
in suppressing aggregation of CRABP1(Y133S), and their effects were mostly 
additive. In all these conditions, the concentration of soluble protein increased 
while the levels of aggregated protein decreased (Fig. 3.6).  
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 In sum, the sensitivity of CRABP1(Y133S) to molecular chaperones and 
degradation enzymes, particularly to KJE, GroELS, and, Lon is concentration-
dependent. 
 
3.2.5 Analysis of CRABP1(Y133S) Protein Folding Fates  
 In order to understand how the E. coli PN maintains proteostasis for our 
test proteins, we performed a quantitative analysis of our data. First, we utilized a 
phenomenological method to extract protein-specific trends, and then secondly, 
we used the FoldEco program to model mechanistically how the sensitivity of a 
protein to the PN reports on its biophysical properties. These quantitative 
analyses were done by our collaborator, Evan Powers and are reported (Cho et 
al., 2015). I will only focus on the analysis for CRABP1(Y133S) expressed for 2 h. 
 
3.2.5.1 Phenomenological Models 
 To quantify the effect of KJE, GroELS, and Lon on the test proteins, the in 
vivo folding fate data for each test protein were fit to the phenomenological 
models below:  
[Agg]rel,X = cAgg,X + aK,X[DnaK]rel + aG,X[GroEL]rel + aL,X[Lon]rel  (Equation 1) 
[Sol]rel,X = cSol,X + SK,X[DnaK]rel + SG,X[GroEL]rel + SL,X[Lon]rel   (Equation 2) 
where “X” is the test protein; “Agg” is aggregated and “Sol” is soluble; [Agg]rel,X 
and [Sol]rel,X are the concentrations of the aggregated and soluble protein 
normalized to the total concentration under adapted-basal conditions; [DnaK]rel, 
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[GroEL]rel, and [Lon]rel are the concentrations DnaK, GroEL, and Lon relative to 
their adapted-basal concentrations; aK,X, aG,X, and aL,X are the gradients of 
[Agg]rel,X for [DnaK]rel, [GroEL]rel, and [Lon]rel, respectively; sK,X, sG,X, and sL,X are 
the gradients of [Sol]rel,X for [DnaK]rel, [GroEL]rel, and [Lon]rel, respectively; and 
cAgg,X and cSol,X are the model intercepts. The efficacies of the PN components 
are quantified by the gradient parameters. For example, a large, positive value of 
sG,X  increases value of [Sol]rel,X as the concentration of GroEL increases, which 
means that the protein benefits from GroELS (Cho et al., 2015). 
 The in vivo folding fate data of CRABP1(Y133S) were fit to equations (1) 
and (2). The quality of the fit of Equation (1) to the normalized concentrations of 
aggregated protein is moderately good (adjusted R2 = 0.68) (Fig. 3.7A, red data 
points). The negative values for the parameters aK, aG, and aL indicate that all of 
the PN components decrease aggregation (Fig. 3.7B, red bars). However, their 
effects differ. KJE is the most effective in decreasing aggregation, followed by 
Lon and GroELS (aK,X < aL,X < aG,X). The fit of Equation (2) to the normalized 
concentrations of soluble protein is good (adjusted R2 = 0.71) (Fig. 3.7A, blue 
data points). The negative value for the parameter sL,CRABP1 indicates that Lon 
decreases the amount of soluble protein (Fig. 3.7B). The value of sL,CRABP1 is 
much smaller in magnitude than aL,CRABP1, which suggests that Lon up-regulation 
preferentially decreases the levels of aggregated protein. In addition, sK,CRABP1 is 
substantial and positive indicating that KJE is effective in increasing the 
concentration of soluble protein and in decreasing the concentration of 
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aggregated protein (Fig. 3.7B). The value of sG,CRABP1 is much smaller than that 
of sK,CRABP1 (Fig. 3.7B), which suggests that GroELS is not effective in increasing 
the soluble protein of CRABP1(Y133S) (Cho et al., 2015). 
 The phenomenological models described above were used to quantify the 
effects of KJE, GroELS, and Lon on the folding fate of CRABP1(Y133S); however, 
these models cannot inform us about the mechanism by which the protein 
behaves. A proteinʼs intrinsic biophysical properties influence folding fate as 
discussed in Chapter 2, and also based on FoldEco results in which a proteinʼs 
sensitivity to different chaperoning mechanisms should be influenced by a 
proteinʼs intrinsic biophysical properties (Dickson and Brooks, 2013; Powers et 
al., 2012). Thus, a proteinʼs intrinsic biophysical properties should reflect the 
values of the best-fit parameters for Equations (1) and (2) (Cho et al., 2015). To 
investigate the relationship between its biophysical properties and how 
CRABP1(Y133S) behaves under varying PN conditions, we used FoldEco to fit 
our in vivo folding fate data by using the proteinʼs intrinsic biophysical properties 
as adjustable parameters. 
 
3.2.5.2 Analysis of protein folding fate of CRABP1(Y133S) using FoldEco 
 FoldEco models the proteostasis network in E. coli, in which processes 
such as protein synthesis and folding, chaperoning by KJE and GroELS systems, 
and degradation by Lon, as well as PN components are interconnected 
(discussed in Chapter 1, section 1.13; Fig. 1.12) (Powers et al., 2012). FoldEco 
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consists of ordinary differential equations that describe the kinetics of these 
processes in vivo and the time-dependent concentrations of each species (e.g. 
concentration of unfolded U, misfolded M, or native N states). We fit FoldEco to 
our in vivo folding fate data (i.e. the concentrations of soluble and aggregated 
protein) by changing the parameters in FoldEco until the output folding fates (i.e. 
concentrations of soluble and aggregated protein) optimally matched our data in 
vivo. FoldEco has many parameters, but in running FoldEco (for our purpose), 
only the protein synthesis rate and biophysical parameters were adjustable 
parameters. The biophysical parameters are the folding rate and equilibrium 
constants (kf and Kf), misfolding rate and equilibrium constants (km and Km), and 
aggregation rate and equilibrium constants (ka and Ka	  , which is the equilibrium 
constant when a misfolded monomer is added to an aggregate, i.e., the inverse 
of critical concentration). The other parameters are likely to be independent of, or 
weakly dependent on, the nature of the client protein (Powers et al., 2012). For 
example, the effect of one bound client on a chaperone/co-chaperone interaction 
is likely to be similar to that of other bound clients. In addition, chaperones 
interact with client proteins promiscuously (Aoki et al., 2000; Landry and 
Gierasch, 1991; Rudiger et al., 1997; Wang et al., 1999; Weinstock et al., 2014). 
which means that chaperone-client interaction parameters are also likely to be 
similar for most clients (Cho et al., 2015). The values for such parameters have 
been derived from available literature data (Powers et al., 2012). By adjusting the 
biophysical parameters to fit the FoldEco model to our in vivo data, we can obtain 
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parameters considered to be “effective parameters” since we have applied the 
simple, generic folding mechanism used in FoldEco. 
 The quality of the FoldEco fit to our data is fairly good. The best-fit value of 
[Sol]rel,CRABP1 and [Agg]rel,CRABP1 deviate from experimental data on average by 
0.12 (Fig. 3.8A). However, there are large residuals, particularly in GroELS-low 
and GroELS-high. The effective biophysical parameters are summarized in Table 
B.4. Unfortunately, the fit did not provide us definite parameter estimates. 
However, we were still able to define some relationships based on these 
parameter estimates, and extracted some general features regarding the 
relationship of intrinsic biophysical properties and in vivo folding fate behavior of 
CRABP1(Y133S) (Cho et al., 2015).  
 Fig. 3.8B illustrates certain aspects about the biophysical properties of 
CRABP1(Y133S). Under adapted-basal conditions, our modeling shows that 
CRABP1(Y133S) misfolds faster than it folds (km > kf), and this causes an 
accumulation of misfolded states (Fig. 3.8B). These high levels of misfolded 
states are sensitive to KJE and Lon overexpression as shown by the increase in 
the utilization of KJE and Lon (Fig. 3.8B, red numbers). Here, Lon preferentially 
degrades misfolded states (70%) to unfolded states (30%), thereby decreasing 
the concentration of aggregated protein. Moreover, KJE converts misfolded 
states to unfolded states causing an increase in the concentration of soluble 
protein and a decrease in the concentration of aggregated protein (Fig. 3.8B). 
Unfortunately, the chaperoning function of GroELS cannot be elucidated from the 
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FoldEco fits of CRABP1(Y133S). According to the data acquired after 2 h of 
protein expression, GroELS does not have a significant effect on the fate of 
CRABP1(Y133S) when expressed at 2h (Fig. 3.2; Fig. 3.8A). It could be that 
CRABP1(Y133S) binds to GroELS differently. To determine the extent of the 
interaction of GroEL and CRABP1(Y133S), FoldEco was fit to the in vivo folding 
fate data of CRABP1(Y133S) with varying equilibrium association constant 
between CRABP1(Y133S) and GroEL (KGro–CRABP1). With a KGro–CRABP1 that was 
1000-fold lower than the value derived from literature, the overall fit was 
improved by 20% (mean residuals = 0.10). However, the fit still did not provide 
precise estimates of the biophysical parameters. Since the fit was improved with 
a large decrease in KGro–CRABP1, this suggests that CRABP1(Y133S) binds weakly 
to GroEL (Cho et al., 2015).	  
 
3.3 Discussion 
 We determined how the PN, consisting of molecular chaperones and 
degradation enzymes, modulates the folding fate of three model proteins with 
different intrinsic biophysical properties. Using a diverse set of model proteins 
(CRABP1, DHFR, and RA), our results show that molecular chaperones and 
degradation enzymes modulate the folding fate of a protein by working together 
to maintain proteostasis. The up-regulation of the KJE, GroELS, and Lon 
decreases the aggregation of our model proteins to different extents. These are 
consistent with the previous studies of the effect of up-regulation of chaperones 
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on the yield of overexpressed heterologous proteins (de Marco, 2007; de Marco 
et al., 2007; Makino et al., 2011; Zhang et al., 2014). The KJE, GroELS, and Lon 
pathways form an efficacious triad for maintaining proteostasis. Each pathway 
has a distinct role, and these roles are interconnected to each other towards 
maintaining proteostasis-- “anti-misfolding” by KJE, “pro-folding” by GroELS, and 
“concentration control” by Lon. These three are especially effective when they 
are up-regulated via the expression of σ32 transcription factor.  
 Furthermore, our in vivo folding fate data and two quantitative models 
(phenomenological model and FoldEco) indicate that the contributions of KJE, 
GroELS, and Lon to proteostasis depend on the intrinsic biophysical properties of 
their substrates and on the concentrations of these PN components and 
substrates at any given time. For example, CRABP1(Y133S) (the model protein 
that I discussed thoroughly in this chapter) was ~>70% aggregated under the 
adapted-basal PN condition because of its kinetic and thermodynamic properties 
(explained in Chapter 2) and the fact that the PN is insufficient to aid its folding 
and minimize aggregation (Fig. 3.1). Its folding fate is changed when PN 
conditions are altered, such as when the KJE, GroELS, and Lon pathways are 
up-regulated individually, in pairs, or simultaneously, or when its concentration is 
varied. At low concentrations of CRABP1(Y133S) (when it is expressed for 1 h), 
the up-regulation of KJE, GroELS, and Lon are more effective in decreasing 
aggregation compared to when CRABP1(Y133S) is present at high levels (when 
it is expressed for 2 h) (Fig. 3.2, Fig. 3.4). The sensitivity of CRABP1(Y133S) to 
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PN components depends on the concentration of both CRABP1(Y133S) and the 
PN components. At low and high concentrations of CRABP1(Y133S), the up-
regulation of KJE decreases aggregated protein but not significantly (Fig. 3.2, Fig. 
3.5). It could be that DnaK, DnaJ or GrpE is limiting in this system. One 
possibility is DnaJ as it is shown in the FoldEco simulation (Fig. A.9), in which 
under the adapted-basal condition, the usage for DnaJ is ~80% at 1 h of 
CRABP1(Y133S) expression and ~90% at 2 h of CRABP1(Y133S). With wet lab 
experiments, under the KJE-low and KJE-high conditions, the levels of DnaJ at 1 
h and 2 h of CRABP(Y133S) expression were increased by ~20-fold and ~23-fold, 
respectively (Table B.1, Table B.3). But still, it seems that it is the limiting factor 
(Heldens et al., 2010). Furthermore, the up-regulation of GroELS decreases 
aggregated protein significantly at low CRABP1(Y133S) concentration (Fig. 3.5), 
while it has no effect on the aggregates at high CRABP1(Y133S) concentration 
(Fig. 3.2). An implication of this is that the GroELS system (either GroEL or 
GroES or both) is limiting when concentrations of CRABP1(Y133S) are high. The 
system maybe saturated with high concentrations of unfolded (U) or misfolded 
(M) states. Moreover, up-regulation of Lon (even just by ~2-fold) increases the 
fraction of soluble protein and decreases the fraction of aggregated protein of 
CRABP1(Y133S) when it is at low concentration (Fig. 3.5). Higher levels of Lon 
(~8-fold higher than that of adapted-basal Lon) are needed to increase the 
fraction of soluble CRABP1(Y133S) when it is at high concentration (Fig. 3.2). 
The concentration of total protein decreases significantly when Lon is increased 
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(Fig 3.2). The combinations of KJE, GroELS, and Lon are all effective in 
increasing fraction soluble and decreasing fraction aggregated under low 
concentrations of CRABP1(Y133S); however, at high concentrations of 
CRABP1(Y133S), only the GroELS+Lon and KJE+Lon combinations are effective 
(Fig. 3.3). The up-regulation of all three when expressed via σ32 expression is 
efficient in eliminating aggregates in both low and high concentrations of 
CRABP1(Y133S) (Fig. 3.1, Fig. 3.4). 
 Under the KJE-low and KJE-high conditions (Fig. 3.2 and Fig. 3.5), the 
decrease in total protein may be due to the facilitation of degradation by DnaK or 
DnaJ by delivering substrates to proteases (Sherman and Goldberg, 1992). 
However, based on FoldEco, it is more likely that the decrease in the 
concentration of total protein are due to KJE rescuing misfolded proteins and 
these misfolded proteins being degraded before they can fold or re-aggregate 
(Fig 3.8B). Further, up-regulation of KJE (in KJE-high) and up-regulation of 
GroELS (in GroELS-low) have similar effects on the folding fate of 
CRABP1(Y133S) which suggests that KJE and GroELS can compensate for 
each other, depending on their levels. When the two are combined, they are 
effective in decreasing aggregates. It could be that KJE converts M to U and 
hands it off to GroELS, which in turn helps the U to fold to N.  
 The up-regulation of the whole HSR (particularly, KJE, GroELS, and Lon) 
through σ32 overexpression are beneficial for all CRABP1(Y133S), m-EcDHFR, 
and m-RA114 (Cho et al., 2015). Like CRABP1(Y133S), m-EcDHFR and m-
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RA114 are also sensitive to the up-regulation of PN components; however, their 
folding fates are affected differently. The extent of the effects of individual and 
pairwise up-regulation of KJE, GroELS, and Lon are different for the three model 
proteins. One particular difference is that at 2 h expression of model proteins, up-
regulation of GroELS decreases the aggregates of m-EcDHFR and m-RA114, but 
no significant effect on CRABP1(Y133S).  
 The use of the phenomenological and FoldEco models enabled us to 
understand how KJE, GroELS, and Lon contribute to proteostasis and how their 
effects are dependent on the substrateʼs biophysical properties. The two models 
have two similar features: 1) they only include KJE, GroELS, and Lon as PN 
components, and 2) they have no direct mechanisms by which these 
components collaborate (Cho et al., 2015). The good fits of the models in light of 
the first feature suggest that KJE, GroELS, and Lon are the major contributors to 
proteostasis under the conditions of our experiments. In addition, our results also 
indicate that KJE, GroELS, and Lon act independently under our experimental 
conditions, and that their effects are mostly additive. However, some of the fits 
were not good, and that could be due to not accounting for collaborations 
between KJE, GroELS, and Lon in the model. We are also aware that 
cooperation between chaperone systems and degradation machineries occurs 
and has been reported (Bershtein et al., 2013; Bissonnette et al., 2010; Gragerov 
et al., 1992; Huang et al., 2001; Mogk et al., 1999; Sakr et al., 2010; Thomas and 
Baneyx, 2000; Tomoyasu et al., 2001). Moreover, PN components may “hand off” 
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substrates from one to another. An example is the collaboration of DnaK with 
GroEL (Langer et al., 1992). In our experiments, it could be that a large amount 
of unfolded protein was produced such that chaperones are saturated with newly 
synthesized protein not giving them time to bind to other proteins from other 
chaperones, thus, limiting or avoiding collaboration (Cho et al., 2015).  
 The FoldEco model allows us to extract information about the biophysical 
properties of CRABP1(Y133S) (Fig. 3.8A). For example, the poor fit to the data of 
CRABP1(Y133S) (expressed for 2 h) with the up-regulation of GroELS implies 
weak binding of CRABP1 and GroELS. 
 
3.4 Conclusion 
 We have examined how the PN, consisting of molecular chaperones and 
degradation enzymes, modulates the folding fate of proteins with different 
biophysical properties. The major E. coli PN components, specifically, KJE, 
GroELS, and Lon, work together to maintain proteostasis. KJE is for “anti-
misfolding”, GroELS is for “pro-folding”, and Lon is for “concentration control”. 
These three are especially effective when they are up-regulated via the 
expression of the σ32 transcription factor. Furthermore, the contributions of KJE, 
GroELS, and Lon to proteostasis depend on the intrinsic biophysical properties of 
their substrates and on the concentrations of these PN components and 
substrates at any given time. The use of an integrated experimental and 
computational approach has enabled us to understand how the folding fate of a 
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protein is determined by both its intrinsic biophysical properties and the cellular 
PN. 
 
3.5 Materials and Methods 
3.5.1 E. coli strains and plasmids 
 The E. coli strain, K12 HMS174(DE3) (Novagen) was used as the 
background strain in all the experiments. The cells (K12 HMS174(DE3)) that 
were used in the overexpression experiments were with a plasmid containing the 
PN components under a pBAD promoter and/or pTet promoters on low copy 
number plasmids (Fig. B.1). The levels of PN components were induced with 
different concentrations of L-arabinose (ara) (for individual up-regulation of PN 
components and σ32) and tetracycline (tet) (for the up-regulation of combinations 
of PN components).  
 The genes for CRABP1(Y133S), m-EcDHFR, and m-RA were inserted into 
pET29b vectors (used for the 2 h expression). The CRABP1(Y133S) used in 1 h 
expression experiments had N-terminal (His)10-tag and was inserted into pET16b 
vector. The CRABP1(Y133S) used for the 2 h expression experiments was 
without the His-tag. The His tag does not affect the folding fate of CRABP1. 
Under the adapted-basal PN condition, the folding fates of CRABP1(Y133S) (with 
His tag) expressed for 2 h were similar to those of CRABP1(Y133S) (without His 
tag) expressed for 2 h (see Fig. 2.15 and Fig. 3.1). In addition, the effects of up-
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regulating KJE (in KJE-low condition) and GroELS (in GroELS-low condition) are 
the same for CRABP1(Y133S) with and without the His tag (data not shown).  
 
3.5.2 Protein expression in E. coli 
  Bacterial cultures were grown in LB with appropriate antibiotics at 30 °C 
until OD600 was ~0.4. Different concentrations of arabinose and/or tet were added 
to induce PN components. In KJE-high, GroELS-high, and Lon-high conditions, 
PN components were induced with 0.2% (w/v) arabinose. In KJE-low, GroELS-
low, and Lon-low conditions, PN components were induced with 0.005%, 0.001%, 
or 0.0005% w/v arabinose for the KJE pathway, the GroELS pathway, and Lon, 
respectively. In Lon-med, Lon was induced using 0.002% (w/v) arabinose. For 
the combinations, 0.2% (w/v) arabinose and 5 × 10−7% (w/v) (5 ng / mL) 
tetracycline were added to induce PN components (Fig. 3.9). Control 
experiments under adapted-basal conditions were run in parallel with the same 
cultures, but 0.2% (w/v) D-glucose, which represses the arabinose operon 
(Tokuriki and Tawfik, 2009), was added. After 1 h of adding the necessary 
inducers to express the PN components, CRABP1 expression was induced with 
0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 1 and 2 h. Cells were 
harvested by centrifugation for 15 min. Cells were lysed by resuspending with 
Bacterial Protein Extraction Reagent (BPER-II) (ThermoFisher Scientific), 
lysozyme (0.05 mg/mL) and DNase I (1 μg/mL). Cell lysates were incubated at 
room temperature for ~15-30 min. A fraction of the lysate was transferred to one 
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tube (this was the “T”-total lysate). An equal amount of volume of the lysate was 
transferred to another tube, which was then centrifuged at 13,500xg for 10 min at 
4 °C to partition the supernatant from the pellet. The supernatant was collected 
as soluble (“S”) while the pellet as aggregated (“A”). The pellet was resuspended 
with the same volume of buffer. Gel loading buffer was added to each sample. 
Samples were boiled for 10 min. Samples were loaded on a 12% or 15% glycine 
gel, and were run on sodium dodecyl sulfate-polyacrylamide agarose gel 
electrophoresis (SDS-PAGE). Proteins were detected by Coomassie blue 
staining and imaged with Odyssey Infrared Imaging System (Li-COR 
Biosciences). The same methods were performed for m-EcDHFR and m-
RA114.3 (Cho et al., 2015).  
 
3.5.3 Quantitative Western blotting 
 For the quantitation, recombinant CRABP1 purified proteins with known 
amounts (pmol) were used as standards. These were also loaded on the same 
gel where the samples of unknown amounts were loaded. Each volume of 
sample loaded corresponded to 1x108 cells, which is equivalent to 1 mL of 
bacteria with OD600 ~0.1. After running samples under SDS-PAGE, Western 
blotting was performed. Samples were transferred to a PVDF membrane 
(Millipore), then blocked with 5% milk solution in TBST (1x TBS, 0.02% tween-
20) at room temperature for 1 h, and then incubated with primary antibody (anti-
CRABP1, Abcam, monoclonal, mouse, 1:5000) at room temperature for 1 h, and 
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secondary antibody (Li-COR antibody, anti-mouse, emission at 800 nm, from Li-
COR Biosciences) at room temperature for 1 h. Western blots were visualized 
and quantitated using the Odyssey Infrared Imaging System (Li-COR 
Biosciences).	  A standard curve was generated based on the known amounts of 
proteins, and the value of the unknown was determined by extrapolation. The 
concentration of samples was calculated by dividing the amount of protein (mole) 
by the volume of cell cytoplasm (L). It is assumed that for E. coli grown in LB, the 
total cell volume is 2.9 μL per mL of cells per OD600 unit (Volkmer and 
Heinemann, 2011). Subtracting the periplasm, which is ~10% of the cell volume, 
the volume of cell cytoplasm is 2.6 μL per mL per OD600. The calculated total 
protein was the sum of soluble and aggregated protein. The fractions of soluble 
and aggregated proteins were calculated as the ratio of soluble to the sum of 
soluble and aggregated protein. The total protein (“T”) lane was a control to 
check for mass balance; the sum of soluble and aggregated relative to the total 
should be 1. The mass balance was good in all samples; the difference of the 
total protein lane (T) from the total of soluble and aggregated (S+A) was less 
than 15%. The method in calculating the concentrations of total, soluble and 
aggregated, as well as fractions of soluble and aggregated was similar to that in 
Chapter 2 (see Methods section 2.5.3). 
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3.5.4 Measurement of relative levels of PN components   
 Quantitative Western blotting was performed to determine the fold 
changes of chaperones and Lon. The primary antibodies used were anti-DnaK 
(Enzo Life Sciences, monoclonal, mouse, 1:10000), anti-DnaJ (Enzo Life 
Sciences, polyclonal, rabbit, 1:1000); anti-GrpE (Enzo Life Sciences, polyclonal, 
rabbit, 1,1000), anti-GroEL (Enzo Life Sciences, monoclonal, mouse, 1:2000), 
anti-GroES (Enzo Life Sciences, polyclonal, rabbit, 1:5000); and anti-Lon (kindly 
provided by Prof. R. T. Sauer, 1:10000). The secondary antibodies were Li-COR 
antibodies (emission at 680 or 800 nm, from Li-COR Biosciences). These fold 
changes in the levels of PN components are important in calculating (or 
estimating) the concentrations of PN components needed as inputs for FoldEco 
simulations.  
 
3.5.5 Protein sequences 
The sequences of the proteins are the following. The font in bold letter is the new 
residue from the mutation. 
R131Q/Y133S CRABP1 (CRABP1-Y133S) 
 
PNFAGTWKMR SSENFDELLK ALGVNAMLRK VAVAAASKPH VEIRQDGDQF 
YIKTSTTVRT TEINFKVGEG FEEETVDGRK CRSLPTWENE NKIHCTQTLL 
EGDGPKTYWT RELANDELIL TFGADDVVCT QIYVRE 
 
M42T/H114R EcDHFR (m-EcDHFR): 
 
MISLIAALAV DRVIGMENAM PWNLPADLAW FKRNTLNKPV ITGRHTWESI 
GRPLPGRKNI ILSSQPGTDD RVTWVKSVDE AIAACGDVPE IMVIGGGRVY 
EQFLPKAQKL YLTRIDAEVE GDTHFPDYEP DDWESVFSEF HDADAQNSHS 
YCFEILERR 
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E10K/D120V/N124S/L225P RA114 (m-RA114): 
 
MPRYLKGWLK DVVQLSLRRP SVRASRQRPI ISLNERILEF NKRNITAIIA 
EYKRKDPSGL DVERDPIEYA KFMERYAVGL FISTEEKYFN GSYETLRKIA 
SSVSIPILMY DFIVKESQIV DAYSLGADTV ALIVKILTER ELESLLEYAR 
SYGMEPLIII NDENDLDIAL RIGARFIGIA ARDWETGEIN KENQRKLISM 
IPSNVVKVAK EGISERNEIE ELRKPGVNAF LIGSSLMRNP EKIKELIEGS 
LEHHHHHH 
 
3.5.6 Fits of Equations (1) and (2) and FoldEco to in vivo folding fate data  
 Analyses of protein folding fates were done by (Cho et al., 2015). Details 
can be found in (Cho et al., 2015). 
 Briefly, equations (1) and (2) were fit by linear regression to the in vivo 
folding fates of proteins. FoldEco fits were done with least squares approach. We 
fit FoldEco to our in vivo folding fate data by changing the parameters in FoldEco 
until the output folding fates match our data in vivo and determine the biophysical 
properties of proteins. FoldEco has many parameters, but in running FoldEco (for 
our purpose), only the protein synthesis rate and biophysical parameters were 
adjustable parameters (and thus, the parameters to be estimated). The 
biophysical parameters were the folding rate and equilibrium constants (kf and Kf), 
misfolding rate and equilibrium constants (km and Km), and aggregation rate and 
equilibrium constants (ka and Ka) were adjustable. The other parameters are 
likely to be independent on, or weakly dependent on the nature of the client 
protein (Powers et al., 2012). The values for such parameters were derived from 
available literature data (Powers et al., 2012). The initial concentrations for the 
adapted-basal PN were: trigger factor = 14 μM, DnaK = 23.4 μM, DnaJ = 1.56 
μM, GrpE = 10.4 μM, GroEL tetradecamer = 2.23 μM, GroES heptamer = 3.53 
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μM, Lon hexamer = 0.4 μM, and ClpB hexamer = 0.22 μM. The concentrations of 
these PN components under various conditions were obtained by multiplying the 
adapted-basal concentrations by the fold changes shown in Fig. B.3. The 
synthesis rate was assumed to be similar under all conditions. A range of 
biophysical effective parameters was obtained (from upper and lower, and with 
the best-fit (Table B.2) (Cho et al., 2015). 	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Figure 3.1 Folding fates of CRABP1(Y133S) upon expression in E. coli for 2 
h at 30 °C under adapted-basal PN conditions and  up-regulation of PN 
components through overexpression of I54N σ32 
 
A. Representative gels showing the Western blots for CRABP1(Y133S) when 
overexpressed in E. coli for 2 h at 30 °C under up-regulation of PN components 
through overexpression of I54N σ32. The lane for “T” is for total protein, which is 
the cell lysate before centrifugation. The lane for “S” is for soluble and “A” is for 
aggregated proteins from the supernatant and pellet, respectively, after 
centrifugation of cell lysates for 10 min at 13,500 x g. Y133S was mostly 
aggregated (~>70%) under adapted-basal conditions. B. Bar graph showing the 
cytoplasmic concentration of CRABP1(Y133S) determined by quantitative 
analysis of gels shown in Fig. 3.1A. White, blue and red bars represent the 
concentrations of total (soluble + aggregated), soluble and aggregated proteins, 
respectively. Error bars represent SEM. C. Bar graph showing the concentration 
of soluble and aggregated protein relative to the concentration of their total 
(soluble + aggregated) protein determined from the concentrations in Fig. 3.1B. 
Blue bars (“fsoluble”) represent the fraction of soluble protein. Red bars (“faggregated”) 
represent the fraction of aggregated protein. For the condition with the 
overexpression of I54N σ32, DnaK, DnaJ, and GrpE levels were increased by ~3-, 
5-, and 6-fold, respectively, compared to those in adapted-basal condition; GroEL 
and GroES levels were increased by ~3- and 4-fold; Lon levels were increased 
by ~3-fold (Table B.1) (Modified from (Cho et al., 2015)). 	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Figure 3.2 Folding fates of CRABP1(Y133S) upon expression in E. coli for 2 
h at 30 °C under adapted-basal conditions and with up-regulation of 
individual PN components  
 
A. As in Fig. 3.1, but with the up-regulation of individual PN components. Their 
fold changes relative to basal are shown (Table B.1). “K”-DnaK, “J”-DnaJ, “E”-
GrpE, “EL”-GroEL, “ES”-GroES. (Modified from (Cho et al., 2015)). 	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Figure 3.3 Folding fates of CRABP1(Y133S) upon expression in E. coli for 2 
h at 30 °C under basal conditions and with the pairwise up-regulation of PN 
components  
 
A. As in Fig. 3.2A, but with pairwise up-regulation of PN components. For 
KJE+GroELS, DnaK, DnaJ, and GrpE levels were increased by ~3-, 15-, and 10-
fold, respectively while GroEL and GroES levels were increased by ~3- and 2-
fold, respectively. For KJE+Lon, DnaK, DnaJ, and GrpE levels were increased by 
~2-, 15-, and 5-fold, respectively, while Lon levels were increased by ~3-fold. For 
GroELS+Lon, GroEL and GroES levels were increased by ~3- and 8-fold, 
respectively, while Lon levels were increased by ~3-fold (Table B.1). (Modified 
from (Cho et al., 2015)). 	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Figure 3.4 Folding fates of CRABP1(Y133S) upon expression in E. coli for 1 
h at 30 °C under adapted-basal conditions and on conditions with 
overexpression of I54N σ32 
 
As in Fig. 3.1, but CRABP1(Y133S) was expressed for 1 h. For I54N σ32, DnaK, 
DnaJ, and GrpE levels were increased by ~3-, 8-, and 1.1-fold, respectively; 
GroEL and GroES levels were increased by ~2- and 4-fold; Lon levels were 
increased by ~3-fold (Table B.3). 	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Figure 3.5 Folding fates of CRABP1(Y133S) upon expression in E. coli for 1 
h at 30 °C under adapted-basal conditions and with up-regulation of 
individual PN components  
 
As in Fig. 3.2, but CRABP1(Y133S) was expressed for 1 h. Conditions have 
varying levels of KJE, GroELS, and Lon, and their fold changes compared to 
adapted-basal levels are shown.  	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Figure 3.6 Folding fates of CRABP1(Y133S) upon expression in E. coli for 1 
h at 30 °C under adapted-basal conditions and with the pairwise up-
regulation of PN components  
 
As in Fig. 3.3, but CRABP1(Y133S) was expressed for 1 h. Conditions have 
varying levels of KJE, GroELS, and Lon. For KJE+GroELS, DnaK, DnaJ, and 
GrpE levels were increased by ~2-, 15-, and 1.3-fold, respectively while GroEL 
and GroES levels were increased by ~6- and 8-fold, respectively. For KJE+Lon, 
DnaK, DnaJ, and GrpE levels were increased by ~2-, 11-, and 1.3-fold, 
respectively, while Lon levels were increased by ~2-fold. For GroELS+Lon, 
GroEL and GroES levels were increased by ~6- and 11-fold, respectively, while 
Lon levels were increased by ~2-fold (Table B. 3). 	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Figure 3.7 Dependence of CRABP1(Y133S) protein folding fates on 
different PN components based on phenomenological fits of in vivo folding 
fate data  
 
A. Plot of the experimental values of [Agg]rel,CRABP1 and [Sol]rel,CRABP1 of 
CRABP1(Y133S) from Fig. 3.2 and Fig 3.3 vs. the corresponding model-derived 
values from the fits of Equations (1) or (2). Red data points- for [Agg]rel,CRABP1, fit 
with Equation (1). Blue data points- for [Sol]rel,CRABP1, fit with Equation (2). Dashed 
line- Line through the origin, slope of 1; the closer the points to the line, the better 
the fits. 
 
B. Bar graph for the gradient parameters and SEM from the best-fits of Equations 
(1) (red bars) and (2) (blue bars) to the relative concentration. Positive values 
mean that increasing the concentration of a PN component increases the 
concentration of the aggregated (red bars) or soluble (blue bars) protein. 
Negative values indicate the opposite. The p-values are indicated as follows: *** 
for p < 0.0001; ** for p < 0.001; * for p < 0.01; and n.s. indicates p > 0.05. 
(Reproduced from (Cho et al., 2015)). 	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Figure 3.8 Results of FoldEco-derived fit of experimental (in vivo) folding 
fate data from the overexpression of CRABP1(Y133S) for 2 h 
 
A. As in Fig. 3.7A, except that these are determined from the FoldEco fits to the 
data. The circled points are those for CRABP1 under the GroELS-low and 
GroELS-high conditions, which have large residuals (shown by the circled data 
points). (Modified from (Cho et al., 2015)). 
 
B. Summary diagram (laid out as in Fig. 1.11) of folding fates of CRABP1 
overexpressed for 2 h under adapted-basal conditions based on FoldEco 
simulations.  
 
The concentrations for each state (native (N), unfolded (U), misfolded (M), and 
aggregated (A)) are written below the circles. The radii of the colored circles are 
proportional to the cube roots of the concentrations. Cube roots are used to show 
both the lowest and highest concentrations on one diagram. The concentrations 
of synthesized and degraded protein are represented as circles for “synthesis” 
and “degradation”, respectively. Blue text- qualitative descriptors for biophysical 
processes. Red numbers- percentages of misfolded states that involve in KJE 
recovery, aggregate, or engage the Lon degradation. Black italic numbers- 
percentages of degraded protein either from the unfolded or misfolded states. 
(Modified from (Cho et al., 2015)). 	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Figure 3.9 Schematic for experimental methods 
 
The individual PN components were co-expressed with CRABP1 under 
orthogonal promoters so that they can be induced independently. First, KJE, 
GroELS, and Lon were induced with arabinose, and then after 1 h, CRABP1 was 
induced for 1 and 2 h. 	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CHAPTER 4 
 
CONCLUSIONS 
 
 
4.1 Summary 
 
 The overarching goal of my thesis was to determine how a protein folds 
inside the cell, and how the cellular environment maintains levels of functional 
proteins. Specifically, I addressed the question, “How does the proteostasis 
network (PN), consisting of molecular chaperones and degradation enzymes, 
modulate the folding fate of proteins with different intrinsic biophysical properties?” 
I utilized a holistic approach, in which I integrated computation and experiments, 
to understand the cooperation and/or competition among the PN components 
when they are present and operating simultaneously. I performed wet lab 
experiments in E. coli by expressing proteins with different biophysical properties 
and determining their folding fates in vivo. In addition, I used FoldEco and 
provided us insight into how the PN functions as a whole.  
 I have shown that a proteinʼs intrinsic biophysical properties and the 
cellular PN determine the folding fate of a protein inside the cell, through kinetic 
partitioning. The folding fate of a protein is under a thermo-kinetic limitation, 
which indicates that the fate depends on either the kinetics or thermodynamics, 
but (for the most part) not on both at the same time. Specifically, folding is limited 
by the Limiting Folding Parameter (LFP), misfolding by the Limiting Misfolding 
Parameter (LMP), and aggregation by the Limiting Aggregation Parameter (LAP). 
Different proteins behave according to their particular values of these properties. 
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Kinetic partitioning occurs between folding, aggregation, and degradation. In 
Chapter 2, we understood the influence of intrinsic biophysical properties on the 
fate of a protein under one set of conditions, that is, the adapted-basal PN. In 
Chapter 3, I have shown that the PN components, consisting of molecular 
chaperones and degradation enzymes, modulate the folding fate of a protein by 
working together to maintain proteostasis. I dissected the components of the PN 
to determine which chaperones and/or degradation enzymes are beneficial to 
proteins of low stabilities and high aggregation propensities. I was able to 
determine the individual and collective contributions of chaperones and 
degradation enzymes to proteostasis. Results show that PN components, 
particularly, KJE, GroELS, and Lon, work together to maintain proteostasis. 
These three systems form an efficacious triad for maintaining proteostasis: KJE 
is for “anti-misfolding”, GroELS is for “pro-folding”, and Lon is for “concentration 
control”. Furthermore, the contributions of KJE, GroELS, and Lon to proteostasis 
depend on the intrinsic biophysical properties of their substrates and on the 
concentrations of these PN components and substrates at any given time. 
   
4.2 Significance of findings 
 The outcome of my research is a model for the interplay of a proteinʼs 
intrinsic biophysical properties and the cellular proteostasis network (PN), 
consisting of molecular chaperones and degradation enzymes, in determining a 
proteinʼs folding fate. This research extends our knowledge of how proteostasis is 
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maintained in the cell. This contribution is significant because it helps us design 
ways to modulate the PN, which may be therapeutically useful in the case of 
diseases such as Alzheimerʼs disease, amyotrophic lateral sclerosis (ALS), 
Parkinsonʼs disease, and others. My work shows that one can enhance 
proteostasis by modulating a proteinʼs biophysical properties and/or regulating 
the proteostasis network. The findings also further advance the protein folding 
field. The use of integrated experimental and computational approach has 
enabled us to understand how a protein folds inside the cell, where proteins 
really fold. Using a holistic approach, I have translated a proteinʼs folding fate in 
vivo into information about its intrinsic biophysical properties, rather than the 
usual reductionist approach in which protein folding is analyzed in vitro to 
understand its behavior in vivo.  
  
4.3 Future directions 
 I have shown that a proteinʼs biophysical properties and the cellular PN 
determine folding fate. However, there are still unresolved questions that need to 
be addressed.  
 
4.3.1 Biophysical properties  
 The CRABP1 variants that were used in this study had mutations that 
changed both the rate and equilibrium constants of the protein. While these have 
been useful in addressing our questions, it is not very clear how rate and 
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equilibrium constant contribute to the fate of the protein. We need a system that 
can only change either one of the parameters. The use of ligand binding can be 
used since ligands only bind to native states, and that only the effective 
equilibrium constant is changed, and not the folding rate constant, and other 
parameters. Furthermore, with FoldEco I have estimated effective parameters 
(LFP, LMP, and LAP) for the CRABP1 variants. We know the limiting parameter 
for folding, which is kf, but we do not know yet the limiting parameters for 
misfolding and aggregation. Studies in vitro should be done to identify such 
parameters. How can we measure misfolding and aggregation parameters in 
vitro or in vivo? Are the effective parameters consistent with these experimental 
values?  
 Moreover, in the simulations, the degradation rate was set as constant. 
Based on in vivo experiments, more CRABP1(Y133S) proteins were degraded at 
a given time. Future research should be carried out to determine the degradation 
rate constant and equilibrium constant for Lon and CRABP1 measured in vitro 
and in vivo. These values will be input to FoldEco for simulations and test the 
effect of changing degradation parameters on the fate of a protein. 
 It would be interesting to assess kinetic partitioning between folding, 
aggregation, and degradation, to test the predictions from FoldEco. For example, 
in the case when proteins do not misfold and do not aggregate, folding and 
degradation only compete for unfolded states (U). How about the partitioning 
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between folding, aggregation, and degration for proteins that misfold and 
aggregate?  
 
4.3.2 Proteostasis network 
 Further work needs to be done to establish that PN fails due to saturation 
of some PN components. Our results indicate that GroEL and/or GroES are 
limiting when the concentrations of CRABP1(Y133S) are high. It would be 
interesting to perform titration experiments and determine the extent of the 
beneficial effect of GroELS on the folding fate of CRABP1(Y133S). Moreover, a 
future study could investigate the interaction between CRABP1(Y133S) and 
GroEL and/or GroES.  
 Future versions of FoldEco should be refined and expanded. As 
mentioned in the previous sections, the present form of FoldEco does not have 
direct mechanisms for the PN components to collaborate. The inclusion of direct 
collaborations among PN components should provide a better understanding 
about how the whole PN functions as a system. Moreover, although, our results 
suggest that HtpG and IbpA/B are not required for us to model folding fate under 
our conditions, it would be interesting to include them in FoldEco such that the 
whole E. coli PN will be well represented. Furthermore, FoldEco would also be 
improved with the addition of heat shock response, more sophisticated folding 
mechanisms, and when multiple proteins can be synthesized at a time.  
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APPENDIX A 
 
SUPPLEMENTARY MATERIAL FOR INFLUENCE OF INTRINSIC 
BIOPHYSICAL PROPERTIES ON PROTEIN FOLDING FATE IN E. COLI 
UNDER THE BASAL PROTEOSTASIS NETWORK 
 
 
 
 
Table A.1 Concentrations of components in an adapted-basal PN  
 
The concentrations of PN components under the “adapted-basal” PN. The values 
given are the concentrations when they are active. Values taken from Cho et al. 
(2015). 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
 
 
 
 
 
 
 
 
 Concentration (μM), active 
Trigger factor, active as monomer 14 
DnaK, active as monomer 23.4 
DnaJ, active as dimer 1.56 
GrpE, active as dimer 10.4 
GroEL, active as 14-mer 2.23 
GroES, active as 7-mer 3.53 
ClpB, active as 6-mer 0.4 
Lon, active as 6-mer 0.22 
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Figure A.1 Fold changes of DnaK, GroEL, and Lon in cells expressing 
CRABP1 relative to cells not expressing CRABP1 
 
The levels of DnaK, GroEL, and Lon in cells expressing CRABP1 (A. WT* B. 
M9A C. V67A D. L118V E. Y133S), at 1, 2, and 3 h of induction were ~10-30% 
lower or ~10-20% higher than those in cells not expressing CRABP1.  	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Figure A.2 Total protein concentration of CRABP1(WT*) and 
CRABP1(Y133S) upon expression in E. coli under -Lon and +Lon 
conditions 
 
Cytoplasmic concentration for (A) CRABP1(WT*) and                    (B) 
CRABP1(Y133S) expressed under –Lon and +Lon E. coli cells at 30 °C for 0.5, 1, 
and 2 h. There are more proteins in cells without Lon compared to those with Lon 
in both proteins.  	  	  	  	  
B. 
A. 
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Figure A.3 Fraction of soluble protein when either kf or Kf is at maximum 
value 
 
At maximum Kf (108), as kf increases from 0.001 s-1 to 1000 s-1, the fraction of 
soluble protein increases from 0.1 to 0.9. At maximum kf (1000 s-1), as Kf 
increases from 102 to 108, the fraction of soluble protein also increases. 
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Figure A4. Sample for protein concentration quantitation using standards  
 
Increasing amounts of purified proteins (in picomoles) are loaded. Standard 
curves are used to calculate the absolute concentrations of test proteins. A. 
Coomassie stain of CRABP1. B. Standard curve. This same method is also used 
in quantitation of proteins detected by Western blotting.   
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  
pmol       10     20      30      40       50 
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B. 
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Table A.2 Summary for the quantitation of protein folding fates of CRABP1 
variants upon expression in E. coli under basal conditions 
 
T-total, S-soluble, A-aggregated, D-degraded; fsol-fraction of soluble, fagg-fraction 
of aggregated 
 
*Total protein- This is the total existing protein (not total protein synthesized). 
**Based on control experiments with CRABP1(WT*) expressed in Δlon E. coli 
K12 cells, in which ~1/3 of the protein that is synthesized is degraded. The total 
amount of protein synthesized is ~405 μM in all cases. 	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Variant Time (h) 
Concentration (µM) Relative concentration 
T* S A D** fsol fagg 
WT* 1 95±15 95±15 0±0 40 1.00±0.00 0±0 
 2 202±25 192±22 10±5 68 0.95±0.02 0.05±0.02 
 3 275±28 251±19 24±9 130 0.92±0.03 0.08±0.03 
M9A 1 115±17 111±14 4±4 20 0.97±0.03 0.03±0.03 
 2 202±27 189±24 13±3 68 0.94±0.01 0.06±0.01 
 3 281±36 240±29 41±6 124 0.85±0.00 0.15±0.00 
V67A 1 125±5 108±6 17±2 10 0.86±0.02 0.14±0.02 
 2 189±11 159±11 30±5 81 0.84±0.02 0.16±0.02 
 3 294±32 240±27 54±5 111 0.82±0.00 0.18±0.00 
L118V 1 94±11 82±5 12±7 41 0.88±0.06 0.12±0.06 
 2 182±44 156±35 26±13 88 0.87±0.07 0.13±0.07 
 3 257±86 212±64 45±23 148 0.84±0.05 0.16±0.05 
Y133S 1 67±5 22±1 45±4 68 0.33±0.01 0.67±0.01 
 
2 109±13 34±2 75±12 160 0.32±0.03 0.68±0.03 
 
3 125±25 35±7 90±18 280 0.28±0.02 0.72±0.02 
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Table A.3 Effective folding parameters for the different variants of CRABP1 
 
The kf and Kf values were derived from in vitro experiments. The km, Km, ka, and 
Ka values were based from FoldEco simulations.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
CRABP1 
variant 
kf 
(s-1) Kf 
km 
(s-1) Km 
ka 
(μM-1 s-1) 
Ka 
(μM-1)  
WT* 0.77 2.17 x 107 0.077 0.3 0.3 1 
M9A 0.31 1.04 x 106 3.1 10 250 1000 
V67A 0.57 8.23 x 104 15 30 250 80 
L118V 0.41 4.45 x 105 20 30 250 100 
Y133S 0.080 6.53 x 103 8 30 100 80 
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1 h 
2 h 
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Figure A.5 FoldEco simulation image for WT* at 1, 2, and 3 h 
 
The arrows show fluxes of proteins  
 
TF (trigger factor), KJE (DnaK/DnaJ/GrpE), ClpB+KJE (ClpB+DnaK/DnaJ/GrpE), 
GroELS (GroEL/GroES), Deg (degradation), 
N (native), U (unfolded), A (aggregate), M (misfolded) 
Each circle is 1 μM.  
 
On the image, the middle part shows where the fluxes of proteins from one state 
(or chaperone) to another are going. On the left is the time of simulation and % 
chaperone use. On the right is the total protein, % of ongoing degradation, and 
ATP use. On the bottom is the list of the concentrations of each species (either 
bound to chaperones or free) at a given time. 	  	  	  	  	  	  	  	  
3 h 
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Figure A.6 FoldEco simulation image for M9A at 1, 2, and 3 h 
 
The arrows show fluxes of proteins  
 
TF (trigger factor), KJE (DnaK/DnaJ/GrpE), ClpB+KJE (ClpB+DnaK/DnaJ/GrpE), 
GroELS (GroEL/GroES), Deg (degradation), 
N (native), U (unfolded), A (aggregate), M (misfolded) 
Each circle is 1 μM.  
 
On the image, the middle part shows where the fluxes of proteins from one state 
(or chaperone) to another are going. On the left is the time of simulation and % 
chaperone use. On the right is the total protein, % of ongoing degradation, and 
ATP use. On the bottom is the list of the concentrations of each species (either 
bound to chaperones or free) at a given time. 	  	  	  	  	  	  
3 h 
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Figure A.7 FoldEco simulation image for V67A at 1, 2, and 3 h 
 
The arrows show fluxes of proteins  
 
TF (trigger factor), KJE (DnaK/DnaJ/GrpE), ClpB+KJE (ClpB+DnaK/DnaJ/GrpE), 
GroELS (GroEL/GroES), Deg (degradation), 
N (native), U (unfolded), A (aggregate), M (misfolded) 
Each circle is 1 μM.  
 
On the image, the middle part shows where the fluxes of proteins from one state 
(or chaperone) to another are going. On the left is the time of simulation and % 
chaperone use. On the right is the total protein, % of ongoing degradation, and 
ATP use. On the bottom is the list of the concentrations of each species (either 
bound to chaperones or free) at a given time. 	  	  	  	  	  	  
3 h 
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Figure A.8 FoldEco simulation image for L118V at 1, 2, and 3 h 
 
The arrows show fluxes of proteins  
 
TF (trigger factor), KJE (DnaK/DnaJ/GrpE), ClpB+KJE (ClpB+DnaK/DnaJ/GrpE), 
GroELS (GroEL/GroES), Deg (degradation), 
N (native), U (unfolded), A (aggregate), M (misfolded) 
Each circle is 1 μM.  
 
On the image, the middle part shows where the fluxes of proteins from one state 
(or chaperone) to another are going. On the left is the time of simulation and % 
chaperone use. On the right is the total protein, % of ongoing degradation, and 
ATP use. On the bottom is the list of the concentrations of each species (either 
bound to chaperones or free) at a given time. 	  	  	  	  	  	  	  
3 h 
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Figure A.9 FoldEco simulation image for Y133S at 1, 2, and 3 h 
 
The arrows show fluxes of proteins  
 
TF (trigger factor), KJE (DnaK/DnaJ/GrpE), ClpB+KJE (ClpB+DnaK/DnaJ/GrpE), 
GroELS (GroEL/GroES), Deg (degradation), 
N (native), U (unfolded), A (aggregate), M (misfolded) 
Each circle is 1 μM.  
 
On the image, the middle part shows where the fluxes of proteins from one state 
(or chaperone) to another are going. On the left is the time of simulation and % 
chaperone use. On the right is the total protein, % of ongoing degradation, and 
ATP use. On the bottom is the list of the concentrations of each species (either 
bound to chaperones or free) at a given time. 
 	  	  	  	  	  
3 h 
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APPENDIX B 
 
SUPPLEMENTARY MATERIAL FOR DISSECTING THE IMPACT OF THE 
PROTEOSTASIS NETWORK ON PROTEIN FOLDING FATE  
 
 
 
 
 
 
 
 
Figure B.1 Schematic for the plasmids used for the up-regulation of PN 
components 
 
Individual up-regulation of PN components were induced with L-arabinose. Up-
regulation of combinations of PN components were induced with L-arabinose and 
tetracycline. (Reproduced from (Cho et al., 2015)). 
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Table B.1 Fold changes of the levels of KJE, GroELS, and Lon in cells 
overexpressing these proteins relative to cells under adapted-basal 
conditions, and when CRABP1 was expressed for 2 h 
 
*Data from (Cho et al., 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fold Change 
(relative to 
adapted-basal)* 
KJE-low 
DnaK 2.1 
DnaJ 10.1 
GrpE 4.6 
KJE-high 
DnaK 3.7 
DnaJ 23.4 
GrpE 10.4 
GroELS-low GroEL 3.4 GroES 2.1 
GroELS-high GroEL 7.5 GroES 5.1 
Lon-low Lon 2.9 
Lon-med Lon 3.8 
Lon-high Lon 7.8 
KJE+GroELS 
DnaK 2.6 
DnaJ 14.6 
GrpE 10.2 
GroEL 2.9 
GroES 2.2 
KJE+Lon 
DnaK 2.0 
DnaJ 15.4 
GrpE 4.8 
Lon 2.8 
GroELS+Lon 
GroEL 3.4 
GroES 8.2 
Lon 2.7 
I54N σ32 
DnaK 3.1 
DnaJ 4.9 
GrpE 6.5 
GroEL 3.0 
GroES 4.4 
Lon 2.6 
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Figure B.2 Fold changes of the levels of KJE, GroELS, and Lon in cells 
overexpressing these proteins relative to cells under adapted-basal 
conditions 
 
Bar graph showing the fold changes (relative to adapted-basal) of the levels of 
PN components when PN components (KJE, GroELS, and Lon) were up-
regulated A. individually and B. simultaneously, 1 h prior to CRABP1(Y133S) 
induction for 2 h.  DnaK, DnaJ, GrpE, GroEL, GroES, and Lon were up-regulated 
to different extents. 
*Data from (Cho et al., 2015) (Reproduced from (Cho et al., 2015)). 
B. 
A. 
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Figure B.3 Folding fates of CRABP1(Y133S) upon expression in E. coli for 2 
h at 30 °C under adapted-basal conditions and with up-regulation of other 
PN components 
 
As in Fig. 3.3, but for other PN components. (Reproduced from (Cho et al., 
2015)). 
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Table B.2 Data on the partitioning of CRABP1(Y133S) when induced at 
30 °C for 1 h under different PN conditions 
 
The concentrations of total, soluble and aggregated proteins are shown under 
different conditions. The concentration of total protein was derived from soluble + 
aggregated. The soluble and aggregated proteins were from the supernatant and 
pellet, respectively, after centrifugation of cell lysates for 10 min at 13,500 x g. 
The fraction of soluble (“fsol”) and fraction of aggregated (“fagg”) were also shown.  
 
 
 
 
 
 
 
 
 
 
 
 
Conditions Concentration (µM) Relative concentration 
Total Soluble Aggregated fsol fagg 
Adapted-basal 57 ± 4 17 ± 3 40 ± 1 0.29 ± 0.04 0.71 ± 0.04 
KJE-low  42 ± 10 16 ± 5 26 ± 6 0.38 ± 0.02 0.62 ± 0.02 
KJE-high        35 ± 10 17 ± 5 18 ± 5 0.50 ± 0.01 0.50 ± 0.01 
GroELS-low 53 ± 4 26 ± 2 27 ± 2 0.49 ± 0.01 0.51 ± 0.01 
GroELS-high 45 ± 9 35 ± 4 10 ± 5 0.79 ± 0.06 0.21 ± 0.06 
Lon-low 25 ± 2 22 ± 1 3 ± 1 0.87 ± 0.01 0.13 ± 0.01 
Lon-med 12 ± 1 11 ± 1 1 ± 0 0.91 ± 0.01 0.09 ± 0.01 
Lon-high 0.6 ± 0.2 0.6 ± 0.2 0 ± 0 1.00 ± 0.00 0 ± 0 
KJE+GroELS 41 ± 20 37 ± 17 4 ± 3 0.94 ± 0.04 0.06 ± 0.04 
KJE+Lon 43 ± 11 35 ± 7 8 ± 4 0.82 ± 0.04 0.18 ± 0.04 
GroELS+Lon 54 ± 3      50 ± 2 4 ± 2 0.92 ± 0.03 0.08 ± 0.03 
I54N σ32  3 ± 0        3 ± 0 0 ± 0 1.00 ± 0.00 0 ± 0 
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Table B.3 Fold changes of the levels of KJE, GroELS, and Lon in cells 
overexpressing these proteins relative to cells under adapted-basal 
conditions, and when CRABP1 was expressed for 1 h 
 
*Data from (Cho et al., 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fold Change 
(relative to 
adapated-basal) 
KJE-low 
DnaK 1.8 ± 0.2 
DnaJ 8.9 ± 1.6 
GrpE 0.82 ± 0.08 
KJE-high 
DnaK 3.0 ± 0.3 
DnaJ 21 ± 6 
GrpE 1.4 ± 0.1 
GroELS-low GroEL 3.3 ± 0.2 GroES 3.3 
GroELS-high GroEL 8.0 ± 0.8 GroES 12 
Lon-low Lon 2.1 ± 0.3 
Lon-med Lon 2.9 ± 0.6 
Lon-high Lon 7.4 ± 1.7 
KJE+GroELS 
DnaK 2.2 ± 0.3 
DnaJ 15 ± 9 
GrpE 1.3 ± 0.1 
GroEL 6.0 ± 0.4 
GroES 8.5 
KJE+Lon 
DnaK 1.6 ± 0.1 
DnaJ 11 ± 7 
GrpE 1.3 ± 0.2 
Lon 2.4 ± 0.4 
GroELS+Lon 
GroEL 6.2 ± 0.0 
GroES 11 
Lon 2.2 ± 0.3 
I54N σ32 
DnaK 2.9 ± 0.4 
DnaJ 8.1 ± 4.2 
GrpE 1.1 ± 0.0 
GroEL 2.5 ± 0.0 
GroES 4.2 
Lon 3.4 ± 0.8 
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Figure B.4 Fold changes of the levels of KJE, GroELS, and Lon in cells 
overexpressing these proteins relative to cells under adapted-basal 
conditions 
 
A. Table showing the fold changes (relative to adapted-basal) of the levels of PN 
components when PN components (KJE, GroELS, and Lon) were upregulated 
individually and simultaneously 1 h prior to CRABP1(Y133S) induction for 1 h. 
DnaK, DnaJ, GrpE, GroEL, GroES, and Lon were upregulated to different extents. 
 B, C. Bar graph of the table in (A). 
 
  KJE+GroELS   KJE+Lon 
  
GroELS+Lon    I54N σ32 
 
   KJE(2) 
  
 
  KJE(1) 
 
GroELS(1) 
 
GroELS(2) 
 
      Lon(1) 
  
  Lon(2) 
  
  Lon(3) 
  
 KJE GroELS Lon 
A. 
B. 
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Table B.4 Effective biophysical parameters for CRABP1(Y133S)  
 
The best fit values and the 90% confidence internals are shown. 
 
(Data from (Cho et al., 2015)). 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 CRABP1(Y133S) 
  90% confidence interval 
Parameters Best Lower Upper 
kf (s-1) 0.03 0.0005 2 
Kf N/A 400 N/A 
km (s-1) 40 1 1200 
Km 13 0.1 1800 
ka (μM-1 s-1) 250 8 8100 
Ka (μM-1) 80 30 170 
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